
<html lang="en"     class="pb-page"  data-request-id="9bcc8111-b6cf-45fb-9403-62151570c4ad"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-10;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b00109;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders" /></meta><meta name="dc.Creator" content="Marta  Serafini" /></meta><meta name="dc.Creator" content="Alessia  Griglio" /></meta><meta name="dc.Creator" content="Silvio  Aprile" /></meta><meta name="dc.Creator" content="Fabio  Seiti" /></meta><meta name="dc.Creator" content="Cristina  Travelli" /></meta><meta name="dc.Creator" content="Franco  Pattarino" /></meta><meta name="dc.Creator" content="Giorgio  Grosa" /></meta><meta name="dc.Creator" content="Giovanni  Sorba" /></meta><meta name="dc.Creator" content="Armando A.  Genazzani" /></meta><meta name="dc.Creator" content="Sara  Gonzalez-Rodriguez" /></meta><meta name="dc.Creator" content="Laura  Butron" /></meta><meta name="dc.Creator" content="Isabel  Devesa" /></meta><meta name="dc.Creator" content="Asia  Fernandez-Carvajal" /></meta><meta name="dc.Creator" content="Tracey  Pirali" /></meta><meta name="dc.Creator" content="Antonio  Ferrer-Montiel" /></meta><meta name="dc.Description" content="Despite being an old molecule, capsaicin is still a hot topic in the scientific community, and the development of new capsaicinoids is a promising pharmacological approach in the management of skin..." /></meta><meta name="Description" content="Despite being an old molecule, capsaicin is still a hot topic in the scientific community, and the development of new capsaicinoids is a promising pharmacological approach in the management of skin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 3, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00109" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00109" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00109" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00109" /></link>
        
    
    

<title>Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00109" /></meta><meta property="og:title" content="Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0017.jpeg" /></meta><meta property="og:description" content="Despite being an old molecule, capsaicin is still a hot topic in the scientific community, and the development of new capsaicinoids is a promising pharmacological approach in the management of skin disorders related to inflammation and pruritus. Here we report the synthesis and the evaluation of capsaicin soft drugs that undergo deactivation by the hydrolyzing activity of skin esterases. The implanting of an ester group in the lipophilic moiety of capsaicinoids by the Passerini multicomponent reaction affords both agonists and antagonists that retain transient receptor potential vanilloid 1 channel (TRPV1) modulating activity and, at the same time, are susceptible to hydrolysis. The most promising antagonist identified shows in vivo anti-nociceptive activity on pruritus and hyperalgesia without producing hyperthermia, thus validating it as novel treatment for dermatological conditions that implicate TRPV1 channel dysfunction." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00109"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00109">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00109&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00109&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00109&amp;href=/doi/10.1021/acs.jmedchem.8b00109" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4436-4455</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00096" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00114" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Marta Serafini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Serafini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Serafini">Marta Serafini</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Alessia Griglio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessia Griglio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessia++Griglio">Alessia Griglio</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Silvio Aprile</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvio Aprile</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvio++Aprile">Silvio Aprile</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Fabio Seiti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabio Seiti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Seiti">Fabio Seiti</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Cristina Travelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristina Travelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Travelli">Cristina Travelli</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Franco Pattarino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Franco Pattarino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Franco++Pattarino">Franco Pattarino</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Giorgio Grosa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giorgio Grosa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giorgio++Grosa">Giorgio Grosa</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Giovanni Sorba</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giovanni Sorba</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Sorba">Giovanni Sorba</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Armando A. Genazzani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Armando A. Genazzani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Armando+A.++Genazzani">Armando A. Genazzani</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sara Gonzalez-Rodriguez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sara Gonzalez-Rodriguez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de BiologÃ­a Molecular y Celular, Universitas Miguel Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sara++Gonzalez-Rodriguez">Sara Gonzalez-Rodriguez</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Laura Butron</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Butron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de BiologÃ­a Molecular y Celular, Universitas Miguel Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Butron">Laura Butron</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Isabel Devesa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabel Devesa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">AntalGenics, SL. Ed. Quorum III, Parque CientÃ­fico UMH, Av de la Universidad s/n, 03202 Elche, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabel++Devesa">Isabel Devesa</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Asia Fernandez-Carvajal</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Asia Fernandez-Carvajal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de BiologÃ­a Molecular y Celular, Universitas Miguel Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>(A.F.-C.) Phone: +34 96 665 8454. E-mail: <a href="/cdn-cgi/l/email-protection#4c2d3f252d622a293e222d222829360c39212462293f"><span class="__cf_email__" data-cfemail="2d4c5e444c034b485f434c434948576d58404503485e">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Asia++Fernandez-Carvajal">Asia Fernandez-Carvajal</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Tracey Pirali</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tracey Pirali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, UniversitÃ  del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>(T.P.) Phone: +39 0321 375852. E-mail: <a href="/cdn-cgi/l/email-protection#1e6a6c7f7d7b67306e776c7f72775e6b70776b6e7130776a"><span class="__cf_email__" data-cfemail="80f4f2e1e3e5f9aef0e9f2e1ece9c0f5eee9f5f0efaee9f4">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tracey++Pirali">Tracey Pirali</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3936-4787" title="Orcid link">http://orcid.org/0000-0003-3936-4787</a></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Antonio Ferrer-Montiel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Ferrer-Montiel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de BiologÃ­a Molecular y Celular, Universitas Miguel Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Ferrer-Montiel">Antonio Ferrer-Montiel</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00109&amp;href=/doi/10.1021%2Facs.jmedchem.8b00109" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4436â4455</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 3, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 January 2018</li><li><span class="item_label"><b>Published</b> online</span>3 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00109" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00109</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4436%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarta%2BSerafini%252C%2BAlessia%2BGriglio%252C%2BSilvio%2BAprile%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D10%26contentID%3Dacs.jmedchem.8b00109%26title%3DTargeting%2BTransient%2BReceptor%2BPotential%2BVanilloid%2B1%2B%2528TRPV1%2529%2BChannel%2BSoftly%253A%2BThe%2BDiscovery%2Bof%2BPasserini%2BAdducts%2Bas%2Ba%2BTopical%2BTreatment%2Bfor%2BInflammatory%2BSkin%2BDisorders%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4455%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00109"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1860</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00109" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Serafini&quot;},{&quot;first_name&quot;:&quot;Alessia&quot;,&quot;last_name&quot;:&quot;Griglio&quot;},{&quot;first_name&quot;:&quot;Silvio&quot;,&quot;last_name&quot;:&quot;Aprile&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Seiti&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Travelli&quot;},{&quot;first_name&quot;:&quot;Franco&quot;,&quot;last_name&quot;:&quot;Pattarino&quot;},{&quot;first_name&quot;:&quot;Giorgio&quot;,&quot;last_name&quot;:&quot;Grosa&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Sorba&quot;},{&quot;first_name&quot;:&quot;Armando&quot;,&quot;last_name&quot;:&quot;A. Genazzani&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;Gonzalez-Rodriguez&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Butron&quot;},{&quot;first_name&quot;:&quot;Isabel&quot;,&quot;last_name&quot;:&quot;Devesa&quot;},{&quot;first_name&quot;:&quot;Asia&quot;,&quot;last_name&quot;:&quot;Fernandez-Carvajal&quot;},{&quot;first_name&quot;:&quot;Tracey&quot;,&quot;last_name&quot;:&quot;Pirali&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Ferrer-Montiel&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4436-4455&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00109&quot;},&quot;abstract&quot;:&quot;Despite being an old molecule, capsaicin is still a hot topic in the scientific community, and the development of new capsaicinoids is a promising pharmacological approach in the management of skin disorders related to inflammation and pruritus. Here we report the synthesis and the evaluation of capsaicin soft drugs that undergo deactivation by the hydrolyzing activity of skin esterases. The implanting of an ester group in the lipophilic moiety of capsaicinoids by the Passerini multicomponent reaction affords both agonists and antagonists that retain transient receptor potential vanilloid 1 channel (TRPV1) modulating activity and, at the same time, are susceptible to hydrolysis. The most promising antagonist identified shows in vivo anti-nociceptive activity on pruritus and hyperalgesia without producing hyperthermia, thus validating it as novel treatment for dermatological conditions that implicate TRPV1 channel dysfunction.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00109&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00109" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00109&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00109" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00109&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00109" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00109&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00109&amp;href=/doi/10.1021/acs.jmedchem.8b00109" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00109" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00109" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00109%26sid%3Dliteratum%253Aachs%26pmid%3D29722529%26genre%3Darticle%26aulast%3DSerafini%26date%3D2018%26atitle%3DTargeting%2BTransient%2BReceptor%2BPotential%2BVanilloid%2B1%2B%2528TRPV1%2529%2BChannel%2BSoftly%253A%2BThe%2BDiscovery%2Bof%2BPasserini%2BAdducts%2Bas%2Ba%2BTopical%2BTreatment%2Bfor%2BInflammatory%2BSkin%2BDisorders%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D10%26spage%3D4436%26epage%3D4455%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291208" title="Hydrolysis">Hydrolysis</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/jmcmar.2018.61.issue-10/20180524/jmcmar.2018.61.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Despite being an old molecule, capsaicin is still a hot topic in the scientific community, and the development of new capsaicinoids is a promising pharmacological approach in the management of skin disorders related to inflammation and pruritus. Here we report the synthesis and the evaluation of capsaicin soft drugs that undergo deactivation by the hydrolyzing activity of skin esterases. The implanting of an ester group in the lipophilic moiety of capsaicinoids by the Passerini multicomponent reaction affords both agonists and antagonists that retain transient receptor potential vanilloid 1 channel (TRPV1) modulating activity and, at the same time, are susceptible to hydrolysis. The most promising antagonist identified shows in vivo anti-nociceptive activity on pruritus and hyperalgesia without producing hyperthermia, thus validating it as novel treatment for dermatological conditions that implicate TRPV1 channel dysfunction.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44563" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44563" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">TRPV1 is arguably the best-characterized member of the transient receptor potential (TRP) family: it is a calcium permeable nonselective ion channel gated by noxious heat, extracellular protons, and bioactive lipids. Its role in pain physiology and neurogenic inflammation is widely validated,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> but there is accumulating evidence that TRPV1 has additional functional roles away from sensory nerve activity. Indeed, different reports have unambiguously identified the presence of TRPV1 on numerous non-neuronal cell types, such as both epidermal and hair follicle keratinocytes, mast cells, dendritic cells, and sebocytes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Particular attention has been recently given to the physiologic role of TRPV1 in keratinocytes, which has been related not only to differentiation, proliferation, and homeostasis of the epidermal barrier, but also to cutaneous immunological function.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> By virtue of its dual âsensoryâ and ânon-sensoryâ localization, TRPV1 plays a fundamental role in the pathogenesis of dermatological pathologies especially related to inflammation and pruritus.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Early studies on TRPV1 modulators were centered on agonists, as they lead to the opening of TRPV1, followed by desensitization of the channel which is linked to their therapeutic potential. The most notorious clinical limitation of capsaicin and related vanilloids is the TRPV1-coupled acute excitation of the sensory C-afferents, which paradoxically results in a marked burning sensation and reduced patient compliance.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Besides the algogenic side-effect, capsaicin is a very lipophilic, non-water-soluble compound and can reside in human skin relatively unchanged for a long period of time, leading to frequent erythema reactions depending on drug concentration in stratum corneum.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Recently, it has been reported that chronic, long-term topical application of capsaicin increases skin carcinogenesis in mice treated with a tumor promoter.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These results might imply that caution should be exercised when using capsaicin-containing topical applications in the presence of a tumor promoter, such as for example sunlight. Hence, existing research is trying to circumvent these side-effects with a focus on (i) increasing the local concentration of TRPV1 agonists either by site-specific injections or topical patches;<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (ii) developing agonists which cause only minor excitation, but hold strong desensitization power;<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (iii) using pore permeable capsaicinoids which target only hyperactive channels;<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (iv) developing photoswitchable agonists that are applied globally, but activated only locally under the control of light.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Besides agonists, a number of potent, small molecule antagonists have been developed.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> To date, at least 15 compounds entered Phase 1 clinical trials, and five of these agents have progressed into Phase 2 clinical trials, but none of them have advanced beyond, due to their undesirable side effects that led to the termination of several drug development programs.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Yet, TRPV1 antagonists show worrisome adverse effects, largely arising from interference with the physiological function of TRPV1-expressing cells. The failure of the first TRPV1 antagonist, Amgenâs AMG-517, in Phase I clinical trial was due to marked hyperthermia and alerted the scientific community about the potential of hyperthermic risk associated with systemic absorption of this class of molecules.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> To circumvent the systemic side effects of these agents, a number of topical formulations are being developed, but this might not be enough. Indeed, similar to capsaicin, long treatment with AMG-9810 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), a typical antagonist, has been shown to promote tumor development through the EGFR/Akt/mTOR signaling pathway in preclinical murine models,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and this evidence has warned about the topical use of TRPV1 antagonists. Very recently, this risk has been discharged by in vitro and in vivo experiments with respect to AMG-9810 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), SB-705498 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), PAC-14028 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), and capsazepine (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and the correlation between the topical use of antagonists and tumor development is still a subject for debate. Taken together, topical TRPV1 modulators, either alone or in conjunction with other agents, have the potential to alleviate a host of skin conditions associated with inflammation and/or pruritus, but have limitations in patient compliance and safety that drive the need for novel therapeutic strategies.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Topical Agonists and Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Here we address this issue and report the synthesis and the evaluation of capsaicin soft drugs designed to undergo deactivation by the hydrolyzing activity of esterases. Soft drugs are active analogues of a lead compound that are deactivated in a predictable and controlled way (preferentially hydrolytically) after having exerted their biological activity. The desired activity is generally local, and the soft drug is applied or administered near the site of action. Therefore, they usually produce their therapeutic effect locally, but their distribution away from the site results in a metabolic deactivation that prevents undesired systemic activity or toxicity. Examples for practical use of soft drugs are provided in the literature, covering the area of antimicrobials, anti-cholinergics, corticosteroids, and ACE inhibitors,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and have resulted in a number of already marketed drugs (e.g., esmolol, remifentanil). Here we report that the implanting of an ester group in the tail of capsaicinoids provides TRPV1 agonists and antagonists that retain the modulating activity, while being susceptible to deactivation by hydrolysis (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The most promising antagonist, compound <b>36</b>, attenuates in vivo hyperalgesia and pruritus when administered systemically and locally, without affecting the thermal sensitivity nor body temperature. Thus, our capsaicin-based soft antagonists have the potential to be topically deactivated and to minimize both the side reactions associated with the systemic manipulation of TRPV1 and the burning effect of topical application of capsacin, pointing to a promising, cost-effective, and well-tolerated new strategy for treating those refractory cutaneous diseases where TRPV1 plays a pivotal role.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Soft Analogues of Capsaicin</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">Multicomponent reactions (MCRs)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> are those transformations where three or more substrates combine in one step to give a product that contains essential parts of all of them, allowing the generation of complex molecules in very few synthetic steps. Driven by high atom and step economy, MCRs have emerged over the last 15 years as perfectly suited tools for the synthesis of collections of drug-like compounds to be used in the realm of drug discovery.<a onclick="showRef(event, 'cit18a ref19'); return false;" href="javascript:void(0);" class="ref cit18a ref19">(18a,19)</a></div><div class="NLM_p">Among MCRs, the Passerini reaction<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> is less described in medicinal chemistry, and the reason resides in the fact that the Passerini adduct contains an amide together with an ester moiety, the latter being hydrolytically unstable under in vivo conditions, and therefore precluding a systemic use of these compounds. Nevertheless, in some circumstances this problem can be turned into an opportunity, and we have exploited this multicomponent reaction to generate soft drugs of capsaicin. The soft drug principles is based on bioactive molecules which undergo predictable metabolism to inactive metabolites, after exerting their therapeutic effect.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Capsaicin is accommodated in the TRPV1 intracellular vanilloid pocket in a âtail-up, head-downâ configuration, where the aliphatic tail points toward the membrane face of TRPV1 and interacts with the channel through van der Waals forces, while the vanillyl moiety and the amide function face toward the cytoplasmic side of TRPV1 and form crucial hydrogen bonds with residues of S513, E571, and T551, together with other minor interactions.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> As a proof of principle, we inserted via Passerini reaction an ester moiety in the lipophilic tail of capsaicin and synthesized product <b>12</b>, demonstrating that the activity on TRPV1 was retained, despite the change in terms of polarity and electronic properties. Moreover, we demonstrated that the corresponding metabolite <b>49</b> was devoid of activity on TRPV1. Proven the validity of our strategy, we then proceeded to synthesize two different series of modulators, the first as putative agonists and the second as putative antagonists of the TRPV1 channel. Indeed, simply changing the C-6â² substitution of vanillyl isocyanide (noniodinated or iodinated), agonists and antagonists were easily accessed (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). This is in accordance with similar observations done on resiniferatoxin,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and on capsaicinoids,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which demonstrated that the iodination at C-6â² causes a dramatic switch in functional activity, generating compounds that behave as TRPV1 antagonists rather than agonists.</div><div class="NLM_p">As depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, the preparation of the vanillyl isocyanides <b>3</b> and <b>4</b> was straightforward. The vanillylamine was formylated and subsequently <i>tert</i>-butyldimethyl silyl (TBDMS) was protected at the phenolic group. The use of a protecting group was required for the success of the dehydrative reaction. The common formamide intermediate <b>54</b> was directly dehydrated or selectively iodinated at 6â² first and dehydrated thereafter.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the Vanillyl Isocyanides <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (1) Na<sub>2</sub>CO<sub>3</sub>, THF; (2) methyl formate, THF, 35 Â°C, 16 h, 96%. (b) imidazole, TBDMSCl, DMAP, dry DMF, rt, 2 h, 54%. (c) POCl<sub>3</sub>, TEA, dry CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 1 h, 84â87%. (d) CF<sub>3</sub>COOAg, I<sub>2</sub>, CHCl<sub>3</sub>, rt, 1 h, 84%.</p></p></figure><div class="NLM_p">For the first series of compounds, a carboxylic acid <b>1</b>, formalin <b>2</b>, and the TBDMS-protected vanillyl isocyanide <b>3</b> reacted to form Î±-acyloxy vanillylamides <b>7</b>â<b>25</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). After completion of the reaction, the crude material was directly deprotected in the presence of tetra-<i>n</i>-butylammonium fluoride (TBAF) and acetic acid. The latter was necessary in order to avoid the partial hydrolysis of the ester moiety during the reaction and to increase the yield. Indeed, fluoride ion, because of its pronounced basicity, mediates the basic hydrolisis of the ester group displayed by the Passerini adduct, causing low yields of the final product in this two-step sequence. On the other hand, we have demonstrated that the addition of acetic acid during the deprotection buffers the reaction mixture and subsequently improves the yield of the reaction.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the First Series of Agonists (<b>7</b>â<b>25</b>) and Antagonists (<b>26</b>â<b>44</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 37% aqueous CH<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 40 Â°C, 20 h. (b) TBAF 1 M in THF, CH<sub>3</sub>COOH, THF, 0 Â°C, 30 min, 24â99%.</p></p></figure><div class="NLM_p">In parallel, a second series of products (<b>26</b>â<b>44</b>) was prepared starting from 6â²-iodovanillyl isocyanide <b>4</b> in a similar way (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><div class="NLM_p">A vast array of carboxylic acids <b>1</b> from the fatty pools was screened, and the choice of the carboxylic partner in the Passerini reaction was inspired by the results described in the literature by modifying the acyl moiety of capsaicin.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The only exception is represented by 1,1â²,2-<i>tris</i>-<i>nor</i>-squalene acid, as this substructure has never been reported in capsaicinoid modulators.</div><div class="NLM_p">Previous reports where capsaicinoids with a 3,4-cathecolic moiety retained TRPV1 activity<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> prompted us to investigate whether the removal of the methyl group at 3â² position affected the agonism/antagonism on TRPV1 channel. To this aim, we prepared the two isocyanides <b>5</b> and <b>6</b> according to <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. After protection of the cathecolic moiety, the benzylamine was formylated and directly dehydrated to give the isocyanide <b>5</b>, or alternatively, selectively iodinated at 6â² and dehydrated thereafter.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of the 3,4-Dyhydroxybenzyl Isocyanides <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) imidazole, TBDMSCl, dry CH<sub>2</sub>Cl<sub>2</sub>, rt, 22 h, 76%. (b) ethyl formate, 52 Â°C, 28 h, 97%. (c) POCl<sub>3</sub>, TEA, dry CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 2 h, 65â87%. (d) CF<sub>3</sub>COOAg, I<sub>2</sub>, CHCl<sub>3</sub>, rt, 4 h, 66%.</p></p></figure><div class="NLM_p">With these isocyanides in our hands, two agonists and two antagonists were synthesized via Passerini reaction followed by deprotection (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of the Second Series of Agonists and Antagonists <b>45</b>â<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 37% aqueous CH<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 40 Â°C, 4 h. (b) TBAF 1 M in THF, CH<sub>3</sub>COOH, THF, 0 Â°C, 3 h, 39â63%.</p></p></figure><div class="NLM_p">Metabolites (<b>49</b>â<b>52</b>) deriving from the hydrolysis of the two series of compounds were prepared according to <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Metabolites <b>49</b>â<b>52</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, H<sub>2</sub>O, THF, rt, 5 h, 47â82%. (b) 2-hydroxymethyl benzoic acid, 37% aqueous CH<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 40 Â°C, 16 h. (c) TBAF 1 M in THF, CH<sub>3</sub>COOH, THF, 0 Â°C, 3 h, 70â76%.</p></p></figure><div class="NLM_p">Vanillyl hydroxyamides (<b>49</b> and <b>50</b>) were simply synthesized by basic hydrolysis of the Passerini products <b>12</b> and <b>31</b>, while the metabolites displaying the cathecolic moiety needed a specifically tailored synthetic procedure. Indeed, all the attempts made to synthesize these products by saponification of the Passerini adducts failed, as the cathecolic function was prone to oxidation and reacted giving complex reaction mixtures. Therefore, we designed a synthetic procedure made of two steps. The first one is a truncated Passerini reaction where the 2-hydroxymethyl benzoic acid furnishes a pseudomolecule of water,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> avoiding the use of acidic promoters and allowing the retention of the protecting groups. The second reaction is the deprotection of the TBDMS moieties in the presence of TBAF. Thanks to this synthetic strategy we were able to access the metabolites <b>51</b> and <b>52</b> in high yields.</div><div class="NLM_p last">The 42 synthesized agonists and antagonists and the 4 hydroxyamide metabolites were then biologically evaluated.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Screening of Synthesized Compounds by Ca<sup>2+</sup>-Fluorimetry</h3><div class="NLM_p">All compounds were tested at three different concentrations (100, 10, and 1 Î¼M) on TRPV1 channels stably expressed in the human neuroblastoma SH-SY5Y cell line. The agonist-induced intracellular Ca<sup>2<i>+</i></sup> signals were measured using a fluorescent Ca<sup>2+</sup> indicator, in the absence and in the presence of test compounds. Capsaicin was used as TRPV1 agonist and ruthenium red as TRPV1 antagonist. The EC<sub>50</sub> and IC<sub>50</sub> values were calculated for compounds displaying a percentage of activity higher than 50% of the reference compound at 1 Î¼M (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a> for concentrationâresponse curves).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Agonists, Antagonists, and Metabolites: Yields (over Two Steps), Percentage of Activity at 1 Î¼M and EC<sub>50</sub>/IC<sub>50</sub> Values for the Selected Compounds<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0015.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> of capsaicin is 1 Â± 0.02 Î¼M, while IC<sub>50</sub> of ruthenium red is 0.51 Â± 0.03 Î¼M.</p></div></div><div></div></div><div class="NLM_p">Regarding the noniodinated compounds with a saturated and linear chain, compounds <b>7</b>â<b>10</b>, <b>12</b>â<b>14</b>, and <b>16</b>â<b>19</b> show a bell-shaped activity/chain-length curve (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), with a plateau in correspondence of a number of acyl carbons of eight (<b>13</b>, 80.2%). Increasingly shorter (<b>7</b>-<b>10</b>, <b>12</b>) or longer chains (<b>14</b>, <b>16</b>â<b>19</b>) cause a progressive decrease in activity.</div><figure id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Percentage of TRPV1 evoked activity of compounds <b>7</b>â<b>10</b>, <b>12</b>â<b>14</b>, and <b>16</b>â<b>19</b> plotted against its number of acyl carbons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The presence of <i>E</i> unsaturations in <b>10</b> (<b>11</b>; 32.0%) at 1 and 3 positions does not improve the activity of compound <b>10</b> (38.9%). In a similar way, the introduction of double bonds at 2 (<i>E</i>) and 6 positions, together with branching, in compound <b>13</b> (80.2%) slightly decreases the agonistic activity (<b>15</b>, 59.8%). On the other hand, the insertion of a double bond (<i>Z</i>) at position 8 (<b>20</b>) in the stearic substructure (<b>19</b>) significantly improves the TRPV1 agonism, while the simultaneous introduction of a hydroxyl group (R) at position 11 (<b>21</b>) causes a drop in activity, in contrast with reported observations done on olvanil.<a onclick="showRef(event, 'cit24a'); return false;" href="javascript:void(0);" class="ref cit24a">(24a)</a> Esterification of such hydroxyl group with phenylacetic acid does not ameliorate the activity (<b>22</b>). The arachidonic substructure still allows for an activity on TRPV1 channel (<b>24</b>, 54.7%), while the longer erucic portion (<b>23</b>, 22.7%) decreases the agonism. Finally, squalene substructure displaying six unsaturations (<b>25</b>, 71.8%) significantly improves the activity. As the use of the squalene-incorporating capsaicinoids has never been reported, it is interesting to stress that the conjugate with 1,1â²,2-<i>tris</i>-<i>nor</i>-squalene acid displayed a high potency on TRPV1 channel. This serendipitous discovery paves the way for further evaluations from a pharmaceutical standpoint as squalene derivatives are known to form self-assembled nanostructures and the squalenoylation approach is finding applications in several contexts.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Removal of the methyl at 3â² position on the aromatic ring did not affect the agonism, leading to two compounds (<b>45</b>, <b>46</b>) which conserve an activity comparable to the corresponding methylated analogues (<b>15</b>, <b>25</b>).</div><div class="NLM_p last">Iodination of the 6â² carbon atom of the vanillyl moiety abolished the agonist activity, caused a reversal of vanilloid activity in all cases, and led to the discovery of two potent antagonists (<b>34</b>, <b>36</b>), with an IC<sub>50</sub> value in the sub-micromolar range (0.09 Î¼M; 0.93 Î¼M). A good correlation was found between the potency of agonists and their corresponding 6â²-iodo derivatives as antagonists, except for compounds <b>25</b> and <b>46</b>, which show good activities in terms of TRPV1 activation in contrast to the lower potencies displayed by the antagonists (<b>44</b> and <b>48</b>, respectively) with the same acyl carbon chain. As for agonists, the optimal length of the side chain is eight acyl carbon atoms (<b>32</b>), while the unsaturation and branching displayed by the geranic substructure increase the activity (<b>34</b>). A significant antagonism is also seen when lauric acid is used in the Passerini reaction (<b>36</b>), while, in contrast to the noniodinated series, the removal of the methyl at 3â² position is detrimental for the activity (<b>47</b>, <b>48</b>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Metabolic Stability</h3><div class="NLM_p">Considering calcium fluorimetry results, 11 compounds (8 agonists and 3 antagonists) were selected and evaluated in terms of hydrolytic stability (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a> for full experimental data and chromatographic methods).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">For this task, a combined approach based on HaCaT (a spontaneously immortalized male human keratinocyte cell line) homogenate, human plasma and liver S9 fraction was exploited, considering the relevance of these three systems in esterase activity. In particular, the hydrolytic stability was evaluated by HPLC-UV analysis monitoring the disappearance of substrate over incubation time with respect to the initial amount (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) and assessing the presence of peaks related to the metabolites <b>49</b>â<b>51</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Metabolic Stability Data<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cpd</th><th class="colsep0 rowsep0" align="center">HaCaT (<i>t</i>Â =Â 240 min)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">plasma (<i>t</i>Â =Â 20 min)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">liver S9 (<i>t</i>Â =Â 60 min)<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">keratinocytes (<i>t</i>Â =Â 120 min)<a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">fibroblasts (<i>t</i>Â =Â 120 min)<a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">capsaicin</td><td class="colsep0 rowsep0" align="center">99.3</td><td class="colsep0 rowsep0" align="center">99.0</td><td class="colsep0 rowsep0" align="center">96.0</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">TRPV1 Agonists</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">98.9</td><td class="colsep0 rowsep0" align="center">98.0</td><td class="colsep0 rowsep0" align="center">63.2</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">84.5</td><td class="colsep0 rowsep0" align="center">89.6</td><td class="colsep0 rowsep0" align="center">0.0</td><td class="colsep0 rowsep0" align="center">22.2</td><td class="colsep0 rowsep0" align="center">19.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">83.8</td><td class="colsep0 rowsep0" align="center">95.7</td><td class="colsep0 rowsep0" align="center">21.1</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">92.6</td><td class="colsep0 rowsep0" align="center">92.5</td><td class="colsep0 rowsep0" align="center">53.7</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="center">96.9</td><td class="colsep0 rowsep0" align="center">98.8</td><td class="colsep0 rowsep0" align="center">26.0</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">98.2</td><td class="colsep0 rowsep0" align="center">78.1</td><td class="colsep0 rowsep0" align="center">71.8</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="center">103.6</td><td class="colsep0 rowsep0" align="center">100.7</td><td class="colsep0 rowsep0" align="center">2.2</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">97.9</td><td class="colsep0 rowsep0" align="center">105.1</td><td class="colsep0 rowsep0" align="center">70.9</td><td class="colsep0 rowsep0" align="center">70.2</td><td class="colsep0 rowsep0" align="center">59.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">TRPV1 Antagonists</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="center">84.5</td><td class="colsep0 rowsep0" align="center">32.1</td><td class="colsep0 rowsep0" align="center">2.9</td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="center">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="center">99.5</td><td class="colsep0 rowsep0" align="center">100.5</td><td class="colsep0 rowsep0" align="center">50.1</td><td class="colsep0 rowsep0" align="center">103.5</td><td class="colsep0 rowsep0" align="center">100.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="center">98.6</td><td class="colsep0 rowsep0" align="center">82.0</td><td class="colsep0 rowsep0" align="center">0.0</td><td class="colsep0 rowsep0" align="center">22.6</td><td class="colsep0 rowsep0" align="center">13.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup><sup>a</sup></sup><p class="last">Residual substrate percentage after hydrolysis of the selected compounds incubated in HaCaT homogenate, human plasma, liver S9, keratinocytes, and fibroblasts. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a> for hydrolytic stability full data.</p></div><div class="footnote" id="t2fn1"><sup><sup>b</sup></sup><p class="last">Substrate concentration 25 Î¼M, incubation time points 0, 60, 240 min.</p></div><div class="footnote" id="t2fn2"><sup><sup>c</sup></sup><p class="last">Substrate concentration 100 Î¼M, incubation time points 0, 10, 20 min.</p></div><div class="footnote" id="t2fn3"><sup><sup>d</sup></sup><p class="last">Substrate concentration 50 Î¼M, incubation time points 0, 15, 30, 60 min.</p></div><div class="footnote" id="t2fn4"><sup><sup>e</sup></sup><p class="last">Substrate concentration 50 Î¼M, incubation time points 0, 120 min.</p></div></div></div><div class="NLM_p">Overall, all the tested compounds were rather stable toward HaCaT homogenate incubation. Only the agonists <b>17</b>, <b>18</b>, and <b>20</b> underwent a mild substrate depletion, with the residual substrate ranging from 83.8 to 92.6%. In human plasma incubations, all the tested TRPV1 agonists showed an overall good stability, the compounds <b>17</b>, <b>20</b>, and <b>25</b> being slightly hydrolyzed with residual substrates after 20 min of 89.6, 92.5, and 78.1%, respectively. Conversely, the tested TRPV1 antagonist <b>32</b>, which displays a short, saturated, and linear chain, was largely unstable in plasma with a residual substrate of 32.1%, while the longer <b>36</b> was slowly hydrolyzed (82.0%) and the branched and unsaturated <b>34</b> was exceptionally stable (100.5%). In liver S9 fraction, all the compounds were less stable than in HaCaT homogenate and plasma. The most resistant compounds toward hepatic esterases were the squalene derivatives <b>25</b> and <b>46</b> (residual substrate 71.8 and 70.9%, respectively), whereas the long linear (<b>20</b>) and branched esters (<b>15</b> and <b>34</b>) were quite stable, the residual substrate being 53.7, 63.2, and 50.1%, respectively. The esters displaying linear alkyl chains containing up to 12 acyl carbon atoms (<b>17</b>, <b>32</b>) were totally depleted within 15 min. Curiously, among the compounds displaying the geranic substructure, <b>45</b> underwent faster hydrolysis (residual substrate 2.2%) compared to <b>15</b> (63.2%) in S9 incubations. This suggests that, for compounds featuring the geranic residue, the presence of the catecholic moiety might increase the reactivity toward liver esterases, as confirmed also for the iodinated analogues <b>47</b> (3.6%) and <b>34</b> (50.1%).</div><div class="NLM_p">According to both their potency in vitro and hydrolytic behavior, the agonists <b>17</b> and <b>46</b> and the antagonists <b>34</b> and <b>36</b> were selected for further evaluation of their metabolic stability in both primary adult epidermal keratinocytes and dermal fibroblasts homogenates (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). It should be noticed that, unlike what is predicted, the hydrolytic behavior in HaCaT was not as informative for the selection, and this was the main reason to perform further metabolic assays.</div><div class="NLM_p">As expected, <b>17</b> and the corresponding iodinated derivative <b>36</b> are significantly hydrolyzed, while <b>46</b> is slowly metabolized and <b>34</b> was hydrolytically stable. The significant difference in biotransformation capacity among the three skin cell lines is ascribable to the different levels of expression and activity between immortalized and primary cell cultures.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Furthermore, in order to evaluate the role of human carboxylesterases (hCEs) in the hydrolysis, the four selected compounds were incubated in the presence of recombinant hCE isoforms 1 and 2 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Whereas nonspecific esterase activity has been demonstrated in human skin and cultured skin cells, investigations into the expression of specific CEs in skin were controversial in the literature.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Indeed, both Zhu and Fu examined the expression of CEs in HaCaT cell line and detected CE2 mRNA, whereas the CE1 counterpart was undetectable,<a onclick="showRef(event, 'ref29 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref31">(29,31)</a> while a more recent proteomic analysis of human skin highlighted the presence of only the CE1 isoform.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> It is known that the preferential substrates for hCE1 are compounds esterified by small alcohols, while those for hCE2 are compounds esterified by relatively large alcohols.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> On the basis of these considerations, our TRPV1 modulators are expected to be preferential substrate for the hCE2 isoform. Indeed, while the four TRPV1 modulators were substrate for both hCE1 and hCE2, the hCE2 in vitro clearance for compounds <b>34</b> and <b>36</b> is markedly higher if compared with the other isoform. Moreover, the results were consistent with the hydrolytic activity observed in human liver S9 incubations. Indeed, linear alkanoates <b>17</b> and <b>36</b> showed the highest metabolic clearance, whereas the branched and long alkanoates <b>34</b> and <b>46</b> were hydrolyzed to a lesser extent.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Pharmacokinetic Parameters Calculated for Incubation of Selected TRPV1 Modulators in hCE<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Cpd</th><th class="colsep0 rowsep0" align="center">(mg/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i>Â (min<sup>â1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub>Â (min)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>intÂ inÂ vitro</sub> (Î¼L/min/mg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char="."><i><b>hCE1</b></i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.0465</td><td class="colsep0 rowsep0" align="char" char=".">14.9</td><td class="colsep0 rowsep0" align="char" char=".">215</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.0129</td><td class="colsep0 rowsep0" align="char" char=".">53.8</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.0255</td><td class="colsep0 rowsep0" align="char" char=".">27.2</td><td class="colsep0 rowsep0" align="char" char=".">118</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.0608</td><td class="colsep0 rowsep0" align="char" char=".">11.4</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center" char="."><i><b>hCE2</b></i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.0376</td><td class="colsep0 rowsep0" align="char" char=".">18.6</td><td class="colsep0 rowsep0" align="char" char=".">172</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.0877</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.0555</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="char" char=".">256</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.0497</td><td class="colsep0 rowsep0" align="char" char=".">14.0</td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a> for substrate depletion curves.</p></div></div></div><div class="NLM_p last">Despite their good in vitro potencies, <b>34</b> was discarded because of its marked hydrolytic stability which goes against the soft drug principle, while <b>46</b> was not selected for further investigations as the cathecolic function is theoretically prone to microsomal oxidation and formation of reactive <i>ortho</i>-quinone species. Indeed, albeit at low levels compared to hydrolysis we were able to demonstrate in vitro this behavior by detection and characterization by mass spectrometry of the corresponding glutathione (GSH) hydroquinone adducts <b>46-GSH</b> and <b>51-GSH</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a>). The propensity of the cathecolic function to form <i>ortho</i>-quinone species together with their unknown role in vivo is the reason why in our structureâactivity relationship (SAR) study only four compounds (<b>45</b>â<b>48</b>) displaying the cahecolic moiety were synthesized, despite their significant activity on TRPV1.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vitro Effects of Compound <b>36</b> on TRPV1 Mediated Neuronal Excitability</h3><div class="NLM_p">As iodinated compounds are devoid of the initial aversive side-effects related to the opening of the TRPV1 channel, we focused our efforts on the antagonists and especially on <b>36</b>, as it shows a good potency (IC<sub>50</sub> = 930 nM), it features a controlled rate of hydrolysis in the skin, it displays the lauric acid substructure which is not susceptible to isomerization or oxidation side-reactions, and it shows a good chemical stability<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and excellent synthetic accessibility.</div><div class="NLM_p">To study the potential effects of compound <b>36</b> on sensory neuronal excitability, planar multielectrode arrays technology (MEA) was used to monitor TRPV1-evoked electrical activity in rat dorsal root ganglion (DRGs) cultures with established neuronal networks. For this purpose, high-density DRGs neurons were cultured on arrays in close contact with electrodes. Capsaicin application promoted action potentials and consequent neuronal spiking detection (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). As expected, a second pulse of capsaicin partly reduced electrical activity due to desensitization of TRPV1 channel (ratio P2/P1 mean spike frequency = 0.87 Â± 0.04). As expected, compound <b>36</b> significantly suppressed TRPV1-mediated neuronal excitability in a concentration-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). At 10 Î¼M, compound <b>36</b> inhibited 43% capsaicin-evoked action potentials (ratio P2/P1 mean spike frequency = 0.53 Â± 0.03; ****<i>p</i> < 0.0001) as compared with the neuronal activity recorded in vehicle treated cells. These results highlight the potential of compound <b>36</b> of suppressing excessive nociceptor excitability triggered by activation of TRPV1.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of compound <b>36</b> on TRPV1-mediated neuronal excitability. (A) Representative MEA recording showing TRPV1-mediated neuronal spiking upon two repetitive 15-s applications of 500 nM capsaicin (P1, P2). Compound <b>36</b> at 10, 1, or 0.1 Î¼M, or vehicle or capsazepine at 10 Î¼M, applied together with second pulse of capsaicin. Finally, 40 mM KCl to ensure cell viability and excitability. (B) Concentration response effects of compound <b>36</b> on TRPV1-mediated neuronal excitability. Mean spike frequency ratio (P2/P1) (were normalized (%) to that of vehicle-treated cells (black bar), capsazepine is representated by a white bar. Statistical analysis was one-way ANOVA followed by BonferronÃ­s post-test; ****<i>p</i> < 0.0001. Data are expressed as mean Â± SEM, <i>N</i> = 3 independent nociceptor primary cultures, <i>n</i> > 100 total registered electrodes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vivo Biological Evaluation of Compound <b>36</b></h3><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> In Vivo Analgesic Activity</h4><div class="NLM_p">It is well documented that CFA-induced thermal hyperalgesia is mediated by overactivation of TRPV1.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> To demonstrate the ability of compound <b>36</b> to produce analgesia, we have tested its in vivo anti-hyperalgesic activity. More in detail, we have evaluated the compound on an inflammatory pain animal model induced by intraplantar (i.pl.) injection of the complete Freundâs adjuvant (CFA) that produces long-lasting inflammation, accompanied by thermal hyperalgesia and mechanical allodynia which are evaluated by Hargreaves and Von Frey tests, respectively. The in vivo activity of compound <b>36</b> was evaluated 24 h after CFA injection in the ipsilateral paw, when an inflammation had occurred, and thermal hyperalgesia had developed. Compound <b>36</b> (10â100 Î¼g) was administered (i.pl.) in the ipsilateral paw, and the thermal sensitivity was measured every 30 min up to 120 min (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). As illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, compound <b>36</b> dose-dependently and transiently ablated CFA-induced thermal hyperalgesia. The anti-hyperalgesic activity was evident at 30 min, the maximum anti-hyperalgesic activity was observed at 60 min, and the activity lasted for 90 min for the highest dose (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Local administration of compound <b>36</b> in the ipsilateral paw did not affect the thermal nociception of the contralateral paw (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of intraplantar administration of compound <b>36</b> on CFA-induced thermal hyperalgesia. (A) CFA injected paw (ipsilateral); (B) contralateral paw. Compound <b>36</b> was injected at the doses indicated; vehicle was used as a control. Compound <b>36</b> and vehicle were administered in the ipsilateral paw. First thermal measurement was performed upon compound/vehicle administration. Data expressed as mean Â± SEM, <i>n</i> = 5 mice per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni est by multiple comparison. ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; **<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar to the intraplantar instillation, compound <b>36</b> administered intravenous (i.v.), 24 h after CFA administration, also attenuated, in a dose-dependent fashion and transiently, the thermal hyperalgesia induced by the algogen in the ipsilateral paw (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), without affecting the thermal nociception of the contralateral paw (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). For the 1 mg/kg dose, the anti-hyperalgesic effect was observed 30 min after i.v. administration and lasted for 60 min. For a higher dose (3 mg/kg) the antihyperalgesic effect appeared at 60 min and lasted for 90 min, while for 10 mg/kg, anti-hyperalgesia was only significant 60 min after administration. The transient pharmacodynamic effect of compound <b>36</b> upon the intraplantar and intravenous administration may be due to its sensitivity to dermal and plasma esterases, respectively.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of intravenous injection on CFA-induced thermal hyperalgesia. (A) CFA injected paw (ipsilateral); (B) contralateral paw. Compound <b>36</b> was injected at the doses indicated; vehicle was used as a control. Animals with an inflammation received vehicle intravenously and were used as control. First thermal measurement was performed upon compound/vehicle administration. Data expressed as mean Â± SEM, <i>n</i> = 5 animals per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison. ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; **<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> In Vivo Antipruritic Activity</h4><div class="NLM_p">As for CFA-induced inflammation, it has been documented that both histaminergic and non-histaminergic pruritus are related to TRPV1 activation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> To examine the in vivo antipruritic activity of compound <b>36</b>, two models have been used: (i) histaminergic pruritus, induced by local application of histamine; and, (ii) non-histaminergic pruritus provoked by local administration of chloroquine. Pruritus effect has been measured by monitoring paw licking upon administration of the pruritogenic compounds, for a period of 25 min.</div><div class="NLM_p">In the case of the histaminergic pruritus, the licking behavior observed after the local injection of histamine (125 Î¼g) in healthy mice started immediately after injection, peaked 10â15 min after the administration of the pruritogen, and lasted for 25â30 min. Intraplantar administration of 100 Î¼g of compound <b>36</b>, 30 min before histamine injection, notably attenuated the licking time provoked by the pruritogenic agent, exhibiting a statistically discernible effect at 10â15 min and 15â20 min after histamine instillation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>36</b> on histaminergic pruritus. The transient effect induced by histamine was observed during 30 min having the peak at 10â15 min interval after injection. White bars denote animals administered with vehicle; black bars, denote animals instillated with compound <b>36</b>. The licking time was measured in the 5 min interval denoted in the <i>x</i>-axis. Data expressed as mean Â± SEM, <i>n</i> = 6 animals per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the non-histaminergic mediated pruritus, the licking behavior observed after the local injection of chloroquine (200 Î¼g) in healthy mice started immediately after injection, peaked 5â10 min after the administration of the pruritogen, and lasted for 20â25 min. Intraplantar administration of 100 Î¼g of compound <b>36</b>, 30 min before choloroquine injection, notably reduced the licking time provoked by the pruritogenic agent, exhibiting a statistically discernible effect at 5â10 min and 10â15 min after chloroquine instillation (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>36</b> on non-histaminergic pruritus. The transient effect induced by chloroquine was observed during 25 min having the peak at 5â10 min interval after injection. White bars denote animals administered with vehicle; black bars, denote animals instillated with compound <b>36</b>. The licking time was measured in the 5 min interval denoted in the <i>x</i>-axis. Data expressed as mean Â± SEM, <i>n</i> = 6 mice per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison ****<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By a straightforward multicomponent approach based on the Passerini reaction, 21 agonists and 21 antagonists were synthesized in very good yields,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> together with the four metabolites of hydrolysis, which proved to be inactive, a necessary condition for the development of capsaicin soft analogues.</div><div class="NLM_p">Our functional results indicated that the synthesized compounds modulate the TRPV1 activity with different efficacies that depend mainly on the length and the number of double bonds present in the aliphatic tail, the most effective being those compounds with a length between 8 and 21 acyl carbon atoms and multiple double bonds.</div><div class="NLM_p">In contrast to the rapid metabolism of capsaicin by hepatic enzymes, its in vitro biotransformation is very slow in human skin.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In particular, after incubation with human skin, capsaicin is slowly metabolized by hydrolysis of the amide bond producing vanillylamine, which is further oxidized into vanillin and vanillic acid. Thus, the implication for topical capsaicin-containing products is that capsaicin can reside in the skin relatively unchanged for a long period of time, leading to inevitable chronic side-effects. Unlike capsaicin, the described ester soft drugs are susceptible to in situ topical deactivation, and their degree of softness can be finely tuned simply changing the nature of the acyl substructure. As expected, although in HaCaT incubations all the tested compounds showed an overall stability, the short-chain aliphatic esters (e.g., <b>32</b>) resulted more hydrolyzed in comparison to esters containing long linear alkanoates (e.g., <b>3</b>) or branched esters (e.g., <b>34</b>). Furthermore, after incubation in both keratinocytes and fibroblasts homogenate, <b>17</b> and <b>36</b> resulted more hydrolyzed with respect to the squalenic esters <b>46</b> or the branched alkanoate <b>34</b>, the latter being totally stable in plasma and all tested skin models.</div><div class="NLM_p">Except for the short-chain aliphatic esters (e.g., <b>32</b>) our TRPV1 modulators were more stable in human plasma than in S9 fraction, demonstrating their susceptibility to CEs dependent hydrolysis (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">TRPV1 antagonists are highly attractive therapeuticals because of (i) the implication of TRPV1 in the etiology of inflammatory cutaneous nociception, including pain and pruritus; and, (ii) the absence of burning sensation produced by capsaicin which seriously limits patient adherence to the treatment. Thus, we questioned whether compound <b>36</b> exhibits analgesic activity in vivo in preclinical models of inflammatory pain and pruritus. Our findings show that compound <b>36</b> completely reverses the CFA-induced thermal hyperalgesia at therapeutic doses (10 mg/kg, i.v.). However, the antihyperalgesic effect is short (<2 h), implying the sensitivity of compound <b>36</b> to dermal and plasma esterases. Remarkably, the compound exhibits its analgesic activity without affecting the thermal nociception, as shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B, nor altering the body temperature (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) in contrast to the TRPV1 antagonist BCTC.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Furthermore, compound <b>36</b> is able to reduce both histaminergic and non-histaminergic mediated pruritus in vivo. It is also remarkable to note that compound <b>36</b> does not exhibit any toxicity nor conspicuous behavioral or motor deficits when administered intravenously at 10 mg/kg. Moreover, at a local dose as high as 100 Î¼g/g of <b>36</b>, no signs of discomfort such as burning sensation or pain were observed, indicating that this antagonist is well tolerated when administered locally.</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0008.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compounds after IV administration on body temperature in mice. BCTC at 3 mg/kg, compound <b>36</b> at 10 mg/kg and vehicle (1% DMSO in saline). Data are expressed as mean Â± SEM (<i>n</i> = 5 mice). Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison test compared with the vehicle-treated group, *<i>p</i> < 0.05; ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our TRPV1 modulators display significant differences in terms of stability to hydrolysis. This tunability is a key property as it implies divergent therapeutic uses for these compounds. Indeed, the different residence times in the skin and absorption velocity might bring some of these compounds to act only on peripheral ends and keratinocytes in the epidermis, while others may reach and target cells located in the dermis or the hypodermis. Compounds with a greater hydrolysis rate might target relatively benign situations such as those associated with sensitive skin (transient pruritus). Conversely, soft TRPV1 targeting agents that are more stable to epidermis hydrolysis and able to reach the dermis would also interact with TRPV1 in dermal sensory neurons, sebocytes, and dendritic cells. This means that such compounds might be clinically useful for diseases associated with inflammation, chronic itch, lipid overproduction, and/or pain (e.g., osteoarthritis). Most significantly, thanks to the hydrolysis occurring in skin, liver, and/or plasma, the reported soft compounds would be devoid of the local and systemic side-effects that have plagued the administration of TRPV1 modulators, particularly the well-known hyperthermia, as exhibited by compound <b>36</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, by using a multicomponent approach, we have developed a class of soft analogues of capsaicin displaying an ester moiety in the side chain. Modifications of length, unsaturation, and branching allow for a fine and effective modulation of TRPV1 activity and hydrolytic stability. A series of non-iodinated agonists have been developed with EC<sub>50</sub> values in the low nanomolar range (<b>13</b>, <b>25</b>, <b>46</b>). Among all the synthesized iodinated antagonists, compound <b>36</b> is able to antagonize TRPV1 channel with an IC<sub>50</sub> value of 930 nM, to suppress excessive nociceptor excitability related to TRPV1, and to significantly reduce thermal hyperalgesia and pruritus in vivo. Additionally, due to susceptibility to hydrolysis by cutaneous esterases, it is conceivable that <b>36</b> will not reside for a long time in the skin and, even in the case it reaches the systemic circulation, will be rapidly inactivated by blood or liver esterases, thereby reducing the systemic side-effects. Moreover, <b>36</b> shows a good chemical stability and an excellent synthetic feasibility.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Because of its excellent pharmacological properties and in vivo efficacy, <b>36</b> was selected for further evaluation in human clinical trials for the treatment of pruritus.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Experimental Methods</h4><div class="NLM_p">Commercially available reagents and solvents were used as purchased without further purification. Carboxylic acids are commercially available with the exception of (4<i>E</i>,8<i>E</i>,12<i>E</i>,16<i>E</i>)-4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenoic acid,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (<i>E</i>)-3,7-dimethylocta-2,6-dienoic acid,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and (Z)-12-(2-phenylacetoxy)octadec-9-enoic acid,<a onclick="showRef(event, 'cit24b'); return false;" href="javascript:void(0);" class="ref cit24b">(24b)</a> synthesized following synthetic methodology already reported in the literature.</div><div class="NLM_p">Column chromatography was performed on silica gel Merck Kieselgel 70-230 mesh ASTM. Thin layer chromatography (TLC) was carried out on 5 cm Ã 20 cm plates with a layer thickness of 0.25 mm (Merck silica gel 60 F254). When necessary, TLC plates were visualized with aqueous KMnO<sub>4</sub>. Melting points were determined in open glass capillary. All the target compounds were checked by IR (FT-IR Thermo-Nicolet Avatar), <sup>1</sup>H and <sup>13</sup>C APT (Jeol ECP 300 MHz), and mass spectrometry (Thermo Finningan LCQ-deca XP-plus) equipped with an ESI source and an ion trap detector. Chemical shifts are reported in parts per million (ppm). Optical rotation was determined by a Jasco P1010 polarimeter. Specific rotations [Î±]<sup>20</sup><sub>D</sub> are given in deg cm<sup>3</sup> g<sup>â1</sup> dm<sup>â1</sup>.</div><div class="NLM_p last">The purity of compounds was determined by high performance liquid chromatography (HPLC) using the instrumentation and methods reported in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a>. Purity of all final compounds was 95% or higher.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>tert</i>-Butyl(4-(isocyanomethyl)-2-methoxyphenoxy)dimethylsilane, (<b>3</b>)</h4><div class="NLM_p">The 4-hydroxy-3-methoxybenzylamine hydrochloride (2.30 g, 12.13 mmol, 1 equiv) was solubilized in aqueous saturated Na<sub>2</sub>CO<sub>3</sub> solution and extracted with THF (Ã3). The collected organic layers were evaporated. 4-(Aminomethyl)-2-methoxyphenol was then solubilized in THF (70 mL), and methyl formate (2.22 mL, 36.39 mmol, 3 equiv) was added. The reaction was stirred overnight at 35 Â°C. Removal of volatile under vacuo yielded <i>N</i>-(4-hydroxy-3-methoxybenzyl)formamide as a dark yellow oil (2.10 g, 11.59 mmol, 96%).</div><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 8.87 (s, 1H), 8.38 (br s, 1H), 8.08 (s, 1H), 6.82 (s, 1H), 6.72â6.64 (m, 2H), 4.17 (d, <i>J</i> = 5.8 Hz, 2H), 3.73 (s, 3H). MS (ESI): <i>m</i>/<i>z</i>: 182 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of <i>N</i>-(4-hydroxy-3-methoxybenzyl)formamide (2.10 g, 11.59 mmol, 1 equiv) in dry DMF (22 mL) TBDMSCl (2.10 g, 13.91 mmol, 1.2 equiv), <i>N</i>,<i>N</i>-dimethylaminopyridine (28 mg, 0.23 mmol, 0.02 equiv) and imidazole (868 mg, 12.75 mmol, 1.1 equiv) were added under nitrogen. The reaction was stirred at room temperature for 2 h, and then was washed with water (Ã1) and extracted with diethyl ether (Ã1). The organic layer was dried over sodium sulfate, and the volatile was removed under vacuo. The crude material, after purification by column chromatography using petroleum ether/ethyl acetate 6:4 and then petroleum ether/ethyl acetate 4:6 as eluent, yielded <i>N</i>-(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxybenzyl)formamide (1.85 g, 6.27 mmol, 54%) as a yellow oil.</div><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 8.04 (s, 1H), 6.92 (br s, 1H), 6.68 (d, <i>J</i> = 8.0 Hz, 1H), 6.65 (d, <i>J</i> = 1.9 Hz, 1H), 6.60 (dd, <i>J</i><sub>s</sub> = 8.0, 1.9 Hz, 1H), 4.22 (d, <i>J</i> = 6.1 Hz, 2H), 3.66 (s, 3H), 0.91 (s, 9H), 0.06 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 161.5, 151.0, 144.3, 131.4, 120.9, 120.1, 111.7, 55.4, 41.9, 25.8, 18.5, â4.6. IR (KBr): <i>á¹¼</i> = 3306, 2360, 1662, 1511, 781 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 296 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>N</i>-(4-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methoxybenzyl)formamide (1.85 g, 6.27 mmol, 1 equiv) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (18 mL) at 0 Â°C, and TEA (4.36 mL, 31.35 mmol, 5 equiv) was added under nitrogen. A solution of POCl<sub>3</sub> (880 Î¼L, 9.41 mmol, 1.5 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (18 mL) was added dropwise, and the reaction was stirred for 1 h at 0 Â°C. Aqueous saturated NaHCO<sub>3</sub> solution was then added, and the mixture was left to reach room temperature and stirred for additional 10 min. Then, the reaction was extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried over sodium sulfate, and evaporated. The crude material was purified by column chromatography using petroleum ether/ethyl acetate 4:6 as eluent, yielding compound <b>3</b> (1.52 g, 5.48 mmol, 87%) as a dark yellow oil.</div><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.83â6.73 (m, 3H), 4.52 (s, 2H), 3.78 (s, 3H), 0.97 (s, 9H), 0.13 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 157. 2, 151.4, 145.2, 125.9, 121.1, 119.3, 110.6, 55.6, 45.3, 25.5, 18.5, â4.6. IR (neat): <i>á¹¼</i> = 2360, 2148, 1738, 1514, 782 cm<sup>â1</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>tert</i>-Butyl(5-iodo-4-(isocyanomethyl)-2-methoxyphenoxy)dimethylsilane, (<b>4</b>)</h4><div class="NLM_p">To a solution of <i>N</i>-(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxybenzyl)formamide (1.65 g, 5.59 mmol, 1 equiv) in CHCl<sub>3</sub> (17 mL) silver trifluoroacetate (1.23 g, 5.59 mmol, 1 equiv) and a solution of iodine (1.42 g, 5.59 mmol, 1 equiv) in CHCl<sub>3</sub> (14 mL) were added. The reaction was stirred for 1 h and filtered under vacuo over a pad of Celite. The filtrate was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with aqueous saturated NaHCO<sub>3</sub> solution (Ã1) and with aqueous saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (Ã1). The organic layer was dried over sodium sulfate and evaporated to give <i>N</i>-(4-((<i>tert</i>-butyldimethylsilyl)oxy)-2-iodo-5-methoxybenzyl)formamide as a yellow solid (1.98 g, 4.70 mmol, 84%).</div><div class="NLM_p">mp 116â116.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 8.12 (s, 1H), 7.16 (s, 1H), 6.78 (s, 1H), 6.74 (br t, 1H), 4.31 (d, J 6.0 Hz, 2H), 3.78 (s, 3H) 0.91 (s, 9H), 0.07 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 161.3, 151.4, 145.2, 133.2, 130.9, 113.2, 86.8, 55.6, 46.5, 25.7, 18.5, â4.6. IR (KBr): <i>á¹¼</i> = 3277, 2958, 2929, 2858, 2359, 1661, 1496, 1203 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 422 [M + H]<sup>+</sup>.</div><div class="NLM_p">A solution of POCl<sub>3</sub> (300 Î¼L, 3.21 mmol, 1.5 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added dropwise to a solution of <i>N</i>-(4-((<i>tert</i>-butyldimethylsilyl)oxy)-2-iodo-5-methoxybenzyl)formamide (900 mg, 2.14 mmol, 1 equiv) and TEA (1.49 mL, 10.7 mmol, 5 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at 0 Â°C and under nitrogen. The reaction was stirred for 1 h at 0 Â°C, quenched adding aqueous saturated NaHCO<sub>3</sub> solution, and stirred for an addition 10 min at room temperature.</div><div class="NLM_p">Then, the reaction was extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried over sodium sulfate, and evaporated. The crude material was purified by column chromatography using petroleum ether/ethyl acetate 4:6 as eluent, yielding compound <b>4</b> (722 mg, 1.79 mmol, 84%) as a yellow solid.</div><div class="NLM_p last">mp 92â92.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.25 (s, 1H), 6.96 (s, 1H), 4.52 (s, 2H), 3.79 (s, 3H), 0.96 (s, 9H), 0.14 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 158.8, 151.8, 145.9, 131.1, 127.9, 111.7, 85.0, 55.7, 50.7, 25.8, 18.5, â4.5. IR (KBr): <i>á¹¼</i> = 2956, 2932, 2859, 2153, 1497, 1301, 1206 cm<sup>â1</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> ((4-(Isocyanomethyl)-1,2-phenylene)bis(oxy))bis(<i>tert</i>-butyldimethylsilane), (<b>5</b>)</h4><div class="NLM_p">To a solution of 3,4-dihydroxybenzylamine hydrobromide (4.50 g, 20.44 mmol, 1 equiv) and imidazole (4.17 g, 61.32 mmol, 3 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) a solution of TBDMSCl (6.16 g, 40.88 mmol, 2 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added dropwise under nitrogen.</div><div class="NLM_p">The reaction was stirred at room temperature overnight. The volatile was evaporated under reduced pressure and ethyl acetate was added. The organic phase was washed with water (Ã4), dried over sodium sulfate, and evaporated. The crude material was purified by column chromatography using petroleum ether/ethyl acetate 2:8 and then ethyl acetate/methanol 8:2 as eluent, yielding (3,4-bis((<i>tert</i>-butyldimethylsilyl)oxy)phenyl)methanamine (5.69 g, 15.47 mmol, 76%) as a dark yellow oil.</div><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.79â6.76 (m, 3H), 3.78 (s, 2H), 1.01â0.93 (m, 18H), 0.19â0.15 (m, 12H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 146.9, 146.2, 134.2, 121.3, 121.2, 120.5, 45.1, 26.2, 26.0, 18.5 (2C), â3.9, â4.0. IR (neat): <i>á¹¼</i> = 2950, 2930, 2858, 1509, 1296, 1252, 903, 835, 779 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 369 [M + H]<sup>+</sup>.</div><div class="NLM_p">A solution of (3,4-bis((<i>tert</i>-butyldimethylsilyl)oxy)phenyl)methanamine (4.95 g, 13.46 mmol, 1 equiv) in ethyl formate (50 mL) was heated at reflux for 28 h. The volatile was removed under vacuo, yielding <i>N</i>-(3,4-bis((<i>tert</i>-butyldimethylsilyl)oxy)benzyl)formamide (5.17 g, 13.06 mmol, 97%) as a deep yellow oil.</div><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = refer to the main rotamer; Î´ 8.22 (s, 1H), 6.78â6.72 (m, 3H), 4.34 (d, J 3.2 Hz, 2H), 0.97â0.87 (m, 18H), 0.21â0.18 (m, 12H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = refer to the main rotamer; Î´ 161.2, 147.3, 146.6, 130.7, 121.2, 120.9 (2C), 41.9, 26.0 (2C), 18.5 (2C), â3.9, â4.0. IR (neat): <i>á¹¼</i> = 2950, 2930, 2858, 1662, 1509, 1299, 905, 836, 779 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 397 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of <i>N</i>-(3,4-bis((<i>tert</i>-butyldimethylsilyl)oxy)benzyl)formamide (2.17 g, 5.48 mmol, 1 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (22 mL) TEA (3.81 mL, 27.4 mmol, 5 equiv) was added under nitrogen, and the resulting mixture was cooled to 0 Â°C. A solution of POCl<sub>3</sub> (769 Î¼L, 8.22 mmol, 1.5 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added dropwise, and the reaction was stirred for 2 h. The reaction was quenched with aqueous saturated NaHCO<sub>3</sub> solution, and the mixture was left to reach room temperature. Then, the organic phase was washed with aqueous saturated NaHCO<sub>3</sub> solution and dried over sodium sulfate, and the volatile was evaporated under reduced pressure. The crude material was purified by column chromatography using petroleum ether/ethyl acetate 98:2 and then petroleum ether/ethyl acetate 9:1 as eluent to give compound <b>5</b> (1.35 g, 3.57 mmol, 65%) as a yellow solid.</div><div class="NLM_p last">mp 45â46 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.83â6.81 (m, 2H), 6.76 (d, J 8.2 Hz, 1H), 4.50 (s, 2H), 1.04â0.92 (m, 18H), 0.26â0.19 (m, 12H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 157.4, 147.4, 147.2, 125.6, 121.4, 119.8, 119.7, 45.2, 26.0 (2C), 18.5 (2C), â4.0 (2C). IR (KBr): <i>á¹¼</i> = 2956, 2928, 2858, 2151, 1508, 1300, 932, 899 cm<sup>â1</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> ((4-Iodo-5-(isocyanomethyl)-1,2-phenylene)bis(oxy))bis(<i>tert</i>-butyldimethylsilane), (<b>6</b>)</h4><div class="NLM_p">A solution of iodine (1.54 g, 6.06 mmol, 1 equiv) in CHCl<sub>3</sub> (18 mL) was added dropwise to a solution of <i>N-</i>(3,4-bis((<i>tert</i>-butyldimethylsilyl)oxy)benzyl)formamide (2.40 g, 6.06 mmol, 1 equiv) and silver trifluoroacetate (1.34 g, 6.06 mmol, 1 equiv) in CHCl<sub>3</sub> (25 mL). The reaction was stirred for 4 h. The mixture was filtered under vacuo over a pad of Celite, and the filtrate was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with aqueous saturated NaHCO<sub>3</sub> solution (Ã1) and with aqueous saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (Ã1). The organic layer was dried over sodium sulfate and evaporated. The crude material was subjected to column chromatography with petroleum ether/ethyl acetate 9:1 and then petroleum ether/ethyl acetate 7:3 as eluent, giving <i>N</i>-(4,5-bis((<i>tert</i>-butyldimethylsilyl)oxy)-2-iodobenzyl)formamide (2.08 g, 3.99 mmol, 66%) as an amorphous orange solid.</div><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = refer to the main rotamer; Î´ 8.22 (s, 1H), 7.23 (s, 1H), 6.89 (s, 1H), 5.90 (br s, 1H), 4.39 (d, J 6.1 Hz, 2H), 1.04â0.90 (m, 18H), 0.24â0.18 (m, 12H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = refer to the main rotamer; Î´ 162.0, 147.6, 147.4, 133.1, 132.3, 122.4, 87.3, 46.3, 26.0, 25.9, 18.5 (2C), â4.0, â4.1. IR (KBr): <i>á¹¼</i> = 3284, 2930, 2858, 1663, 1487, 1255, 878, 784 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 523 [M + H]<sup>+</sup>.</div><div class="NLM_p">A solution of POCl<sub>3</sub> (530 Î¼L, 5.67 mmol, 1.5 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise at 0 Â°C to a solution of <i>N</i>-(4,5- bis((<i>tert</i>-butyldimethylsilyl)oxy)-2-iodobenzyl)formamide (1.97 g, 3.78 mmol, 1 equiv) and TEA (2.63 mL, 18.9 mmol, 5 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (15 mL) under nitrogen. The reaction was stirred for 2 h, and then aqueous saturated NaHCO<sub>3</sub> solution was added. The mixture was left to reach room temperature and stirred for additional 10 min. The organic phase was washed with aqueous saturated NaHCO<sub>3</sub> solution, dried over sodium sulfate, and evaporated. The crude material, after purification by column chromatography using petroleum ether/ethyl acetate 95:5 as eluent, yielded compound <b>6</b> as a deep yellow solid (1.65 g, 3.28 mmol, 87%).</div><div class="NLM_p last">mp 57â58 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.28 (s, 1H), 7.03 (s, 1H), 4.54 (s, 2H), 1.08â0.98 (m, 18H), 0.22â0.19 (m, 12H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 158.7, 148.1, 147.9, 131.5, 127.8, 120.5, 85.0, 50.4, 26.1, 26.0, 18.6, 18.5, â3.9, â4.1. IR (KBr): <i>á¹¼</i> = 2952, 2857, 2148, 1557, 1494, 1304, 906, 846 cm<sup>â1</sup>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for the Synthesis of Compounds <b>7</b>â<b>25</b></h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl(4-(isocyanomethyl)-2-methoxyphenoxy)dimethylsilane <b>3</b> (194.2 mg, 0.70 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (3.5 mL) 37% aqueous formaldehyde solution (210 Î¼L, 2.8 mmol, 4 equiv) and carboxylic acid (0.70 mmol, 1 equiv) were added, and the resulting mixture was stirred at 40 Â°C for 3 h and then was left to reach room temperature and stirred overnight. Then, the volatile was removed under vacuo, and the product was solubilized in THF (2 mL). The reaction was cooled to 0 Â°C. At this temperature, acetic acid (48 Î¼L, 0.84 mmol, 1.2 equiv) and TBAF (0.84 mL, 0.84 mmol, 1.2 equiv) were added. The reaction was stirred for 30 min. The volatile was evaporated and ethyl acetate was added and washed with water (Ã1) and aqueous saturated NaHCO<sub>3</sub> solution (Ã1). The collected organic layers were dried over sodium sulfate and evaporated. Purification by column chromatography using petroleum ether/ethyl acetate 9:1 and then petroleum ether/ethyl acetate 5:5 as eluent yielded compounds <b>7</b>â<b>25</b>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Characterization of Compounds <b>7</b>â<b>25</b></h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl butyrate, (<b>7</b>)</h4><div class="NLM_p last">Yellowish solid; yield 59% (117 mg, 0.42 mmol); mp 75.5â76.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.85â6.65 (m, 3H), 6.59 (br t, <i>J</i> = 5.8 Hz, 1H), 6.14 (br s, 1H), 4.54 (s, 2H), 4.33 (d, <i>J</i> = 5.8 Hz, 2H), 3.80 (s, 3H), 2.31 (t, <i>J</i> = 7.4 Hz, 2H), 1.60 (sext, <i>J</i> = 7.4 Hz, 2H), 0.89 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.3, 147.0, 145.4, 129.6, 120.7, 114.7, 110.9, 62.9, 56.0, 43.1, 35.8, 18.3, 13.6. IR (neat): <i>á¹¼</i> = 3377, 2964, 2934, 2050, 1749, 1269, 460 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 282 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl pentanoate, (<b>8</b>)</h4><div class="NLM_p last">White solid; yield 60% (124 mg, 0.42 mmol); mp 74â75 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.80â6.60 (m, 3H), 6.31 (br t, <i>J</i> = 5.5 Hz, 1H), 4.52 (s, 2H), 4.31 (d, <i>J</i> = 5.5 Hz, 2H), 3.77 (s, 3H), 2.32 (t, <i>J</i> = 7.4 Hz, 2H), 1.54 (quint, <i>J</i> = 7.4 Hz, 2H), 1.26 (sext, <i>J</i> = 7.4 Hz, 2H), 0.83 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.6, 167.4, 147.1, 145.4, 129.5, 120.7, 114.7, 110.9, 62.8, 56.0, 43.1, 33.6, 26.8, 22.2, 13.7. IR (neat): <i>á¹¼</i> = 3347, 2933, 2874, 1735, 1170, 497, 452 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 296 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl 3-methylbutanoate, (<b>9</b>)</h4><div class="NLM_p last">Yellow oil; yield 65% (135 mg, 0.46 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.80â6.65 (m, 3H), 4.53 (s, 2H), 4.32 (d, <i>J</i> = 5.8 Hz, 2H), 3.78 (s, 3H), 2.20 (d, <i>J</i> = 6.9 Hz, 2H), 2.05â2.01 (m, 1H), 0.91 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 171.8, 167.4, 147.1, 145.4, 129.5, 120.7, 114.7, 110.9, 62.8, 56.0, 43.1, 42.9, 25.7, 22.4. IR (neat): <i>á¹¼</i> = 3327, 2960, 2360, 2341, 1662, 1515, 909, 728 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 296 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Hexanoate, (<b>10</b>)</h4><div class="NLM_p last">Yellow oil; yield 35% (77 mg, 0.25 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.83 (d, <i>J</i> = 8.0 Hz, 1H), 6.78 (d, <i>J</i> = 1.6 Hz, 1H), 6.73 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 6.43 (br t, <i>J</i> = 5.8 Hz, 1H), 4.57 (s, 2H), 4.37 (d, <i>J</i> = 5.8 Hz, 2H), 3.84 (s, 3H), 2.35 (t, <i>J</i> = 7.4 Hz, 2H), 1.59 (quint, <i>J</i> = 7.4 Hz, 2H), 1.28â1.24 (m, 4H), 0.85 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.5, 167.2, 146.9, 145.4, 129.6, 120.8, 114.6, 110.8, 62.9, 56.0, 43.2, 34.0, 31.2, 24.5, 22.3, 13.9. IR (neat): <i>á¹¼</i> = 3337, 2955, 2360, 1740, 1658, 1515, 1366, 1156 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 310 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (2<i>E</i>,4<i>E</i>)-2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl hexa-2,4-dienoate, (<b>11</b>)</h4><div class="NLM_p last">Colorless oil; yield 65% (139 mg, 0.45 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.24â7.22 (m, 1H), 6.77 (d, <i>J</i> = 7.9 Hz, 1H), 6.73 (d, <i>J</i> = 1.7 Hz, 1H), 6.71â6.70 (m, 2H), 6.13â6.11 (m, 1H), 5.74 (d, <i>J</i> = 15.0 Hz, 1H), 4.60 (s, 2H), 4.33 (d, <i>J</i> = 5.8 H, 2H), 3.78 (s, 3H), 1.79 (d, <i>J</i> = 4.7 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 167.5, 165.9, 147.0, 146.9, 145.3, 141.2, 129.6, 129.5, 120.7, 117.1, 114.6, 110.8, 62.8, 55.9, 43.0, 18.7. IR (neat): <i>á¹¼</i> = 3391, 3302, 2941, 2883, 1716, 1644, 1519 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 304 [M - H]<sup>â</sup>.</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Heptanoate, (<b>12</b>)</h4><div class="NLM_p last">White solid; yield 60% (136 mg, 0.42 mmol); mp 72â72.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.90â6.68 (m, 3H), 6.51 (br t, <i>J</i> = 5.5 Hz, 1H), 4.56 (s, 2H), 4.36 (d, <i>J</i> = 5.5 Hz, 2H), 3.83 (s, 3H), 2.34 (t, <i>J</i> = 7.4 Hz, 2H), 1.58 (quint, <i>J</i> = 7.4 Hz, 2H), 1.40â1.10 (m, 6H), 0.83 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.5, 167.3, 147.0, 145.4, 129.5, 120.8, 114.6, 110.8, 62.9, 56.0, 43.1, 34.0, 31.4, 28.8, 24.8, 22.5, 14.0. IR (neat): <i>á¹¼</i> = 3354, 2934, 2867, 1755, 1276, 1030, 416 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 324 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Octanoate, (<b>13</b>)</h4><div class="NLM_p last">White solid; yield 57% (135 mg, 0.40 mmol); mp 49â49.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.73â6.65 (m, 4H), 4.50 (s, 2H), 4.28 (d, <i>J</i> = 5.5 Hz, 2H), 3.74 (s, 3H), 2.29 (t, <i>J</i> = 7.2 Hz, 2H), 1.53 (quint, <i>J</i> = 7.2 Hz, 2H), 1.30â1.12 (m, 8H), 0.80 (t, <i>J</i> = 4.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.7, 167.5, 147.1, 145.4, 129.5, 120.6, 114.7, 110.9, 62.8, 55.9, 43.0, 33.8, 31.6, 29.0, 28.9, 24.7, 22.6, 14.1. IR (neat): <i>á¹¼</i> = 3337, 2927, 2855, 2360, 2341, 1515, 1154, 668, 634 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 338 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Nonanoate, (<b>14</b>)</h4><div class="NLM_p last">Yellow oil; yield 32% (78 mg, 0.22 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.78 (d, <i>J</i> = 8.0, 1H), 6.73 (s, 1H), 6.67 (d, <i>J</i> = 8.0 Hz, 1H), 6.62 (br t, <i>J</i> = 5.5 Hz, 1H), 4.53 (s, 2H), 4.32 (d, <i>J</i> = 5.5 Hz, 2H), 3.79 (s, 3H), 2.32 (t, <i>J</i> = 7.7 Hz, 2H), 1.58â1.53 (m, 2H), 1.20â1.14 (m, 10H), 0.82 (t, <i>J</i> = 7.7 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.6, 167.4, 147.0, 145.4, 129.5, 120.7, 114.7, 110.9, 62.8, 56.0, 43.1, 33.9, 31.8, 29.2, 29.1 (2C), 24.8, 22.7, 14.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>E</i>)-2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl 3,7-dimethylocta-2,6-dienoate, (<b>15</b>)</h4><div class="NLM_p last">Yellow oil; yield 73% (184 mg, 0.51 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.79 (d, <i>J</i> = 8.0 Hz, 1H), 6.75 (s, 1H), 6.70 (d, <i>J</i> = 8.0 Hz, 1H), 6.61 (br t, <i>J</i> = 6.1 Hz, 1H), 5.67 (s, 1H), 5.00 (t, <i>J</i> = 6.3 Hz, 1H), 4.57 (s, 2H), 4.35 (d, <i>J</i> = 6.1 Hz, 2H), 3.80 (s, 3H), 2.11 (m, 7H), 1.62 (s, 3H), 1.55 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 167.8, 165.0, 163.5, 147.0, 145.4, 132.8, 129.6, 122.8, 120.7, 114.6, 114.1, 110.8, 62.3, 56.0, 43.1, 41.1, 26.0, 25.7, 19.1, 17.7. IR (neat): <i>á¹¼</i> = 3342, 2970, 2360, 1725, 1648, 1515, 1136 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 360 [M â H]<sup>â</sup>.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Decanoate, (<b>16</b>)</h4><div class="NLM_p last">Pale yellow oil; yield 61% (157 mg, 0.43 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.77â6.64 (m, 4H), 4.51 (s, 2H), 4.30 (d, <i>J</i> = 5.5 Hz, 2H), 3.76 (s, 3H), 2.31 (t, <i>J</i> = 7.4 Hz, 2H), 1.54 (quint, <i>J</i> = 7.4 Hz, 2H), 1.30â1.12 (m, 12H), 0.81 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.6, 167.4, 147.1, 145.4, 129.5, 120.7, 114.7, 110.9, 62.8, 55.9, 43.1, 33.9, 31.9, 29.4 (2C), 29.3, 29.1, 24.8, 22.7, 14.1. IR (neat): <i>á¹¼</i> = 3326, 2924, 2854, 2360, 1515, 1274, 1154,668, 624 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 366 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Dodecanoate, (<b>17</b>)</h4><div class="NLM_p last">White solid; yield 98% (271 mg, 0.69 mmol); mp 58.5â59.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.80 (d, <i>J</i> = 8.0 Hz, 1H), 6.75 (s, 1H), 6.70 (d, <i>J</i> = 8.0 Hz, 1H), 6.55 (br t, <i>J</i> = 5.8, 1H), 4.54 (s, 2H), 4.34 (d, <i>J</i> = 5.8, 2H), 3.81 (s, 3H), 2.33 (t, <i>J</i> = 7.3 Hz, 2H), 1.57 (quint, <i>J</i> = 7.3 Hz, 2H), 1.24â1.21 (m, 16H), 0.84 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.5, 167.3, 147.0, 145.4, 129.5, 120.7, 114.6, 110.8, 62.9, 56.0, 43.1, 34.0, 32.0, 29.6 (2C), 29.5, 29.4, 29.3, 29.1, 24.8, 22.8, 14.2. IR (KBr): <i>á¹¼</i> = 3394, 3314, 2918, 2849, 1732, 1650, 1519, 1169 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 392 [M â H]<sup>â</sup>.</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Pentadecanoate, (<b>18</b>)</h4><div class="NLM_p last">White solid; yield 73% (222 mg, 0.51 mmol); mp 78â79 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.84 (d, <i>J</i> = 8.0 Hz, 1H), 6.78 (d, <i>J</i> = 1.9 Hz, 1H), 6.75 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 6.41 (br t, <i>J</i> = 5.8 Hz, 1H), 4.57 (s, 2H), 4.38 (d, <i>J</i> = 5.8 Hz, 2H), 3.85 (s, 3H), 2.35 (t, <i>J</i> = 7.3 Hz, 2H), 1.59 (quint, <i>J</i> = 7.3 Hz, 2H), 1.23â1.18 (m, 22H), 0.86 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.2, 146.9, 145.4, 129.6, 120.8, 114.6, 110.8, 62.9, 56.0, 43.2, 34.0, 32.0, 29.7 (3C), 29.6 (2C), 29.5, 29.4, 29.3, 29.1, 24.9, 22.8, 14.2. IR (KBr): <i>á¹¼</i> = 3527, 3271, 2918, 2851, 2359, 1751, 1661, 1519, 1275, 1159 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 434 [M â H]<sup>â</sup>.</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Stearate, (<b>19</b>)</h4><div class="NLM_p last">White solid; yield 24% (81 mg, 0.17 mmol); mp 74.5â75.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.86 (d, <i>J</i> = 8.0 Hz, 1H), 6.80 (d, <i>J</i> = 1.6 Hz, 1H), 6.75 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 6.32 (br t, <i>J</i> = 2.9 Hz, 1H), 4.59 (s, 2H), 4.40 (d, <i>J</i> = 2.9 Hz, 2H), 3.87 (s, 3H), 2.36 (t, <i>J</i> = 7.5 Hz, 2H), 1.27â1.15 (m, 33H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.1, 146.9, 145.4, 129.6, 120.9, 114.5, 110.7, 63.0, 56.1, 43.2, 34.0, 32.0, 29.8 (2C), 29.7, 29.6, 29.5, 29.4 (2C), 29.3 (2C), 29.2 (2C), 29.1, 24.9, 22.8, 14.2. IR (KBr): <i>á¹¼</i> = 3275, 2917, 2850, 1752, 1660, 1276, 1158, 1032 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 476 [M â H]<sup>â</sup>.</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl Oleate, (<b>20</b>)</h4><div class="NLM_p last">Yellow oil; yield 37% (124 mg, 0.26 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.80 (d, <i>J</i> = 8.2 Hz, 1H), 6.76 (d, <i>J</i> = 1.6 Hz, 1H), 6.70 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 6.51 (br t, <i>J</i> = 5.8 Hz, 1H), 5.33â5.31 (m, 2H), 4.55 (s, 2H), 4.35 (d, <i>J</i> = 5.8 Hz, 2H), 3.82 (s, 3H), 2.34 (t, <i>J</i> = 7.4 Hz, 2H), 1.98â1.94 (m, 4H), 1.60â1.55 (m, 2H), 1.23 (m, 20H), 0.84 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.5, 167.3, 145.0, 145.4, 130.1, 129.7, 129.5, 120.8, 114.6, 110.8, 62.9, 56.0, 43.2, 34.0, 32.0, 29.8, 29.7, 29.6, 29.4 (2C), 29.2, 29.1 (2C), 27.3, 27.2, 24.9, 22.8, 14.2. IR (neat): <i>á¹¼</i> = 3299, 2925, 2854, 1745, 1663, 1517, 1277, 1157 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 477 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>R,Z</i>)-2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl 12-Hydroxyoctadec-9-enoate, (<b>21</b>)</h4><div class="NLM_p last">Yellow oil; yield 81% (280 mg, 0.57 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.80 (d, <i>J</i> = 8.0, 1H), 6.75 (s, 1H), 6.68 (d, <i>J</i> = 8.0 Hz, 1H), 6.51 (br t, <i>J</i> = 5.5 Hz, 1H), 5.50â5.45 (m, 1H), 5.39â5.32 (m, 1H), 4.54 (s, 2H), 4.34 (d, <i>J</i> = 5.5 Hz, 2H), 3.80 (s, 3H), 3.57 (quint, <i>J</i> = 6.6 Hz, 1H), 2.32 (t, <i>J</i> = 7.4 Hz, 2H), 2.16 (t, <i>J</i> = 6.6 Hz, 2H), 2.00â1.96 (m, 2H), 1.58â1.54 (m, 2H), 1.41 (m, 2H), 1.23â1.16 (m, 16H), 0.83 (t, <i>J</i> = 5.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.5, 167.2, 147.0, 145.5, 133.2, 129.5, 125.4, 120.7, 114.7, 110.9, 71.6, 62.9, 56.0, 43.1, 36.9, 35.4, 33.9, 31.9, 29.6, 29.4, 29.2, 29.1, 29.0, 27.4, 25.8, 24.8, 22.7, 14.4. IR (neat): <i>á¹¼</i> = 3321, 2928, 2855, 1744, 1665, 1516, 735 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 491 [M â H]<sup>â</sup>. [Î±]<sup>20</sup><sub>D</sub>: + 0.94 deg cm<sup>3</sup> g<sup>â1</sup> dm<sup>â1</sup> (<i>c</i> 0.023 g cm<sup>â3</sup> in CHCl<sub>3</sub>).</div></div><div id="sec5_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>R</i>,<i>Z</i>)-2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl 12-(2-phenylacetoxy)octadec-9-enoate, (<b>22</b>)</h4><div class="NLM_p last">Colorless oil; yield 87% (371 mg, 0.61 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.35â7.18 (m, 5H), 6.77 (d, <i>J</i> = 7.9 Hz, 1H), 6.74 (d, <i>J</i> = 1.6 Hz, 1H), 6.69â6.58 (m, 2H), 5.40 (m, 1H), 5.22 (m, 1H), 4.83 (quint, <i>J</i> = 6.3 Hz, 1H), 4.53 (s, 2H), 4.32 (d, <i>J</i> = 5.8 Hz, 2H), 3.78 (s, 3H), 3.54 (s, 2H), 2.32 (t, <i>J</i> = 7.4 Hz, 2H), 2.21 (m, 2H), 1.95 (m, 2H), 1.56 (m, 2H), 1.48 (m, 2H), 1.22â1.10 (m, 16H), 0.82 (t, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.5, 171.5, 167.3, 147.0, 145.4, 134.4, 132.7, 129.6, 129.3, 128.5, 127.0, 124.3, 120.7, 114.7, 110.9, 74.6, 62.9, 56.0, 43.1, 41.8, 33.9, 33.6, 32.0, 31.7, 29.5, 29.2, 29.1 (2C), 29.0, 27.3, 25.2, 24.8, 22.6, 14.1. IR (neat): <i>á¹¼</i> = 3355, 2928, 2855, 2360, 1736, 1669, 1516, 1157 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 608 [M â H]<sup>â</sup>. [Î±]<sup>20</sup><sub>D</sub>: + 13.10 (<i>c</i> 0.026 g cm<sup>â3</sup> in CHCl<sub>3</sub>).</div></div><div id="sec5_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>Z</i>)-2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl docos-13-enoate, (<b>23</b>)</h4><div class="NLM_p last">Amorphous white solid; yield 85% (315 mg, 0.59 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.80 (d, <i>J</i> = 8.0 Hz, 1H), 6.75 (d, <i>J</i> = 1.4 Hz, 1H), 6.70 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 6.52 (br t, <i>J</i> = 5.8 Hz, 1H), 6.05 (br s, 1H), 5.36â5.26 (m, 2H), 4.55 (s, 2H), 4.35 (d, <i>J</i> = 5.8 Hz, 2H), 3.82 (s, 3H), 2.33 (t, <i>J</i> = 7.5 Hz, 2H), 2.00â1.95 (m, 4H), 1.58 (quint, <i>J</i> = 7.5 Hz, 2H), 1.23â1.17 (m, 28H), 0.85 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.5, 167.3, 147.0, 145.4, 129.9, 129.5, 120.8, 114.6, 110.8 (2C), 62.9, 56.0, 43.1, 34.0, 32.0, 29.8 (2C), 29.7 (4C), 29.6, 29.5 (2C), 29.4, 29.3, 29.2, 27.3 (2C), 25.1, 23.4, 14.2. IR (KBr): <i>á¹¼</i> = 3355, 2916, 2850, 1759, 1654, 1277 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 530 [M â H]<sup>â</sup>.</div></div><div id="sec5_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl icosa-5,8,11,14-tetraenoate, (<b>24</b>)</h4><div class="NLM_p last">Yellow oil; yield 57% (199 mg, 0.40 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.79 (d, <i>J</i> = 8.0 Hz, 1H), 6.75 (d, <i>J</i> = 1.9 Hz, 1H), 6.69 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 6.57 (br t, <i>J</i> = 5.8 Hz, 1H), 5.38â5.27 (m, 8H), 4.54 (s, 2H), 4.33 (d, <i>J</i> = 5.8 Hz, 2H), 3.80 (s, 3H), 2.81â2.73 (m, 6H), 2.35 (t, <i>J</i> = 7.7 Hz, 2H), 2.10â1.98 (m, 4H), 1.67 (quint, <i>J</i> = 7.7 Hz, 2H), 1.26 (m, 6H), 0.85 (t, <i>J</i> = 7.7 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.3, 167.3, 147.0, 145.4, 130.6, 129.5, 129.2, 128.7, 128.6, 128.4, 128.1, 127.9, 127.6, 120.7, 114.7, 110.8, 62.9, 56.0, 43.1, 33.3 (2C), 31.6, 29.4, 27.3, 26.5, 25.7 (2C), 24.6, 22.6, 14.1. IR (neat): <i>á¹¼</i> = 3323, 3011, 2926, 2360, 1744, 1662, 1516, 1274, 1152 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 498 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (4<i>E</i>,8<i>E</i>,12<i>E</i>,16<i>E</i>)-2-((4-Hydroxy-3-methoxybenzyl)amino)-2-oxoethyl 4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenoate, (<b>25</b>)</h4><div class="NLM_p last">Colorless oil; yield 50% (210 mg, 0.35 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.83 (d, <i>J</i> = 7.9 Hz, 1H), 6.78â6.73 (m, 2H), 6.38 (br t, <i>J</i> = 5.8 Hz, 1H), 5.79 (br s, 1H), 5.20â5.04 (m, 5H), 4.58 (s, 2H), 4.39 (d, <i>J</i> = 5.8 Hz, 2H), 3.86 (s, 3H), 2.48 (t, <i>J</i> = 7.4 Hz, 2H), 2.28 (t, <i>J</i> = 7.4 Hz, 2H), 2.10â1.90 (m, 16H), 1.65â1.50 (m, 18H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.0, 167.1, 146.9, 145.4, 135.2, 135.0, 134.8, 132.9, 131.3, 129.6, 125.6, 124.6, 124.5, 124.3 (2C), 120.8, 114.5, 110.7, 63.0, 59.9, 59.6, 56.0, 43.1, 39.8, 39.6, 34.4, 32.8, 28.3, 26.8, 26.7, 26.6, 25.8 (2C), 17.7 (2C), 16.1, 15.9. IR (neat): <i>á¹¼</i> = 2917, 2359, 2342, 1663, 1515, 1153, 1034, 630 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 592 [M â H]<sup>â</sup>.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> General Procedure for the Synthesis of Compounds <b>26</b>â<b>44</b></h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl(5-iodo-4-(isocyanomethyl)-2-methoxyphenoxy)dimethylsilane <b>4</b> (201.6 mg, 0.5 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (3.5 mL) 37% aqueous formaldehyde solution (150 Î¼L, 2.0 mmol, 4 equiv) and carboxylic acid (0.5 mmol, 1 equiv) were added, and the resulting mixture was stirred at reflux for 3 h and then was left to reach room temperature and stirred overnight. Then, the volatile was removed under vacuo, and the product was solubilized in THF (2 mL). The reaction was cooled to 0 Â°C. At this temperature, acetic acid (34 Î¼L, 0.6 mmol, 1.2 equiv) and TBAF (600 Î¼L, 0.6 mmol, 1.2 equiv) were added. The reaction was stirred for 30 min. The volatile was evaporated and ethyl acetate was added, washed with water (Ã1) and with aqueous saturated NaHCO<sub>3</sub> solution (Ã1). The organic layer was dried over sodium sulfate and evaporated. The crude material was then purified by column chromatography using petroleum ether/ethyl acetate 9:1 and then petroleum ether/ethyl acetate 6:4 as eluent, affording compounds <b>26</b>â<b>44</b>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Characterization of Compounds <b>26</b>â<b>44</b></h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Butyrate, (<b>26</b>)</h4><div class="NLM_p last">White solid; yield 60% (122 mg, 0.30 mmol); mp 113â114 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.35 (s, 1H), 6.93 (s, 1H), 4.58 (s, 2H), 4.45 (d, <i>J</i> = 5.8 Hz, 2H), 3.88 (s, 3H), 2.39 (t, <i>J</i> = 7.4 Hz, 2H), 1.80â1.60 (m, 2H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.2, 167.2, 147.3, 146.2, 131.7, 124.8, 112.8, 87.7, 62.9, 61.2, 47.3, 35.9, 18.4, 13.7. IR (neat): <i>á¹¼</i> = 3364, 2962, 2874, 1736, 1500, 1271, 1173, 428 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 406 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Pentanoate, (<b>27</b>)</h4><div class="NLM_p last">Yellowish solid; yield 51% (107 mg, 0.25 mmol); mp 102.5â103.5 Â°C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ = 7.21 (s, 1H), 6.87 (s, 1H), 4.57 (d, <i>J</i> = 8.8 Hz, 2H), 4.32 (s, 2H), 3.83 (s, 3H), 2.43 (t, <i>J</i> = 7.2 Hz, 2H), 1.60 (quint, <i>J</i> = 7.2 Hz, 2H), 1.36â1.32 (m, 2H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR 75 MHz, CD<sub>3</sub>OD): Î´ = 173.5, 168.9, 148.4, 146.5, 131.0, 125.1, 111.8, 85.7, 62.3, 55.2, 47.3, 33.0, 26.6, 21.9, 12.8. IR (neat): <i>á¹¼</i> = 3322, 2949, 2444, 1739, 1172, 410, 403 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 420 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl 3-Methylbutanoate, (<b>28</b>)</h4><div class="NLM_p last">White solid; yield 74% (156 mg, 0.37 mmol); mp 90â90.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.26 (s, 1H), 6.84 (s, 1H), 6.76 (br t, <i>J</i> = 6.1 Hz, 1H), 4.55 (s, 2H), 4.38 (d, <i>J</i> = 6.1 Hz, 2H), 3.77 (s, 3H), 2.25 (d, <i>J</i> = 6.6 Hz, 2H), 2.10â2.08 (m, 1H), 0.91 (d, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 171.8, 167.4, 147.4, 146.2, 131.5, 124.9, 112.8, 87.6, 62.8, 56.1, 47.4, 43.0, 25.7, 22.5. IR (neat): <i>á¹¼</i> = 3348, 2956, 2871, 1730, 1271, 573 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 420 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Hexanoate, (<b>29</b>)</h4><div class="NLM_p last">White solid; yield 99% (215 mg, 0.49 mmol); mp 116â117 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.31 (s, 1H), 6.89 (s, 1H), 6.75 (br t, <i>J</i> = 5.8 Hz, 1H), 4.58 (s, 2H), 4.43 (d, <i>J</i> = 5.8 Hz, 2H), 3.81 (s, 3H), 2.38 (t, <i>J</i> = 7.4 Hz, 2H), 1.60 (quint, <i>J</i> = 7.4 Hz, 2H), 1.30â1.25 (m, 4H), 0.85 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.2, 147.3, 146.2, 131.7, 124.8, 112.8, 87.7, 62.9, 56.2, 47.3, 34.0, 31.3, 24.6, 22.36, 13.9. IR (KBr): <i>á¹¼</i> = 3329, 2945, 2359, 1749, 1633, 1506, 1158 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 434 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (2<i>E</i>,4<i>E</i>)-2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl hexa-2,4-dienoate, (<b>30</b>)</h4><div class="NLM_p last">White solid; yield 47% (102 mg, 0.24 mmol); mp 160â161 Â°C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d6</i>): Î´ = 9.39 (br s, 1H), 8.52 (br t, <i>J</i> = 4.7 Hz, 1H), 7.35â7.20 (m, 1H), 7.18 (s, 1H), 6.82 (s, 1H), 6.40â6.20 (m, 2H), 5.95 (d, <i>J</i> = 15.4 Hz, 1H), 4.60 (s, 2H), 4.14 (d, <i>J</i> = 4.7 Hz, 2H), 3.74 (s, 3H), 1.83 (d, <i>J</i> = 3.8 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d6</i>): Î´ = 167.6, 166.6, 148.6, 147.1, 146.4, 141.2, 131.5, 130.2, 125.3, 118.7, 112.7, 86.9, 63.0, 56.1, 40.6, 19.1. IR (neat): <i>á¹¼</i> = 3296, 2941, 2488, 1707, 1643, 1144, 452 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 430 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Heptanoate, (<b>31</b>)</h4><div class="NLM_p last">White solid; yield 78% (175 mg, 0.39 mmol); mp 119â120 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.30 (s, 1H), 6.88 (s, 1H), 6.73 (br t, <i>J</i> = 5.8 Hz, 1H), 4.57 (s, 2H), 4.42 (d, <i>J</i> = 5.8 Hz, 2H), 3.82 (s, 3H), 2.38 (t, <i>J</i> = 7.7 Hz, 2H), 1.62 (quint, <i>J</i> = 7.7 Hz, 2H), 1.40â1.15 (m, 6H), 0.85 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.3, 147.3, 146.2, 131.7, 124.8, 112.8, 87.7, 62.9, 56.1, 47.3, 34.1, 31.5, 28.8, 24.9, 22.5, 14.1. IR (neat): <i>á¹¼</i> = 3299, 2933, 1740, 1272, 1164, 423, 410 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 448 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Octanoate, (<b>32</b>)</h4><div class="NLM_p">White solid; yield 52% (120 mg, 0.26 mmol); mp 125.5â126.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.32 (s, 1H), 6.90 (s, 1H), 6.67 (br t, <i>J</i> = 6.1 Hz, 1H), 5.89 (br s, 1H), 4.57 (s, 2H), 4.43 (d, <i>J</i> = 6.1 Hz, 2H), 3.85 (s, 3H), 2.39 (t, <i>J</i> = 7.4 Hz, 2H), 1.63 (quint, <i>J</i> = 7.4 Hz, 2H), 1.40â1.15 (m, 8H), 0.86 (t, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.2, 147.2, 146.1, 131.8, 124.8, 112.8, 87.8, 62.9, 56.1, 47.3, 34.1, 31.7, 29.1, 29.0, 24.9, 22.7, 14.1. IR (neat): <i>á¹¼</i> = 3312, 2929, 1743, 1270, 1165, 866, 423, 414 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 464 [M + H]<sup>+</sup>.</div><div class="NLM_p last">1. IR (neat): <i>á¹¼</i> = 3342, 2926, 2360, 1740, 1659, 1516, 1366 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 352 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Nonanoate, (<b>33</b>)</h4><div class="NLM_p last">White solid; yield 94% (224 mg, 0.47 mmol); mp 117â118 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.30 (s, 1H), 6.88 (s, 1H), 6.71 (br t, <i>J</i> = 6.3 Hz, 1H), 4.56 (s, 2H), 4.41 (d, <i>J</i> = 6.3 Hz, 2H), 3.81 (s, 3H), 2.38 (t, <i>J</i> = 7.3 Hz, 2H), 1.62 (quint, <i>J</i> = 7.3 Hz, 2H), 1.25â1.18 (m, 10H), 0.85 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.3, 147.3, 146.2, 131.7, 124.8, 112.8, 87.7, 62.9, 56.2, 47.3, 34.1, 31.9, 29.3, 29.2 (2C), 24.9, 22.7, 14.2. IR (KBr): <i>á¹¼</i> = 3308, 2927, 1749, 1635, 1506, 1165 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 476 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>E</i>)-2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl 3,7-dimethylocta-2,6-dienoate, (<b>34</b>)</h4><div class="NLM_p last">White solid; yield 66% (161 mg, 0.33 mmol); mp 66.5â67.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.87â6.72 (m, 2H), 6.50 (br t, <i>J</i> = 4.1 Hz, 1H), 5.01 (s, 1H), 4.90â4.80 (m, 1H), 4.57 (s, 2H), 4.38 (d, <i>J</i> = 4.1 Hz, 2H), 3.75 (s, 3H), 2.20â2.00 (m, 7H), 1.63 (s, 3H), 1.55 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 167.9, 164.5, 164.1, 147.4, 146.2, 132.8, 131.5, 124.9, 122.8, 114.0, 112.6, 87.5, 62.3, 56.1, 47.4, 41.1, 26.0, 25.8, 19.2, 17.8. IR (neat): <i>á¹¼</i> = 3293, 2968, 1713, 1500, 1275, 1156, 862, 403 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 486 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Decanoate, (<b>35</b>)</h4><div class="NLM_p last">Whitish solid; yield 70% (172 mg, 0.35 mmol); mp 105â106 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.28 (s, 1H), 6.86 (s, 1H), 6.75 (br t, <i>J</i> = 6.1 Hz, 1H), 4.56 (s, 2H), 4.41 (d, <i>J</i> = 6.1 Hz, 2H), 3.80 (s, 3H), 2.38 (t, <i>J</i> = 7.4 Hz, 2H), 1.62 (quint, <i>J</i> = 7.4 Hz, 2H), 1.35â1.15 (m, 12H), 0.85 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.3, 147.3, 146.2, 131.6, 124.8, 112.8, 87.7, 62.8, 56.1, 47.3, 34.1, 31.9, 29.5, 29.3 (2C), 29.2, 24.9, 22.8, 14.2. IR (neat): <i>á¹¼</i> = 3308, 2924, 1750, 1505, 1163, 866, 442, 418 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 490 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Dodecanoate, (<b>36</b>)</h4><div class="NLM_p last">Whitish solid; yield 70% (182 mg, 0.35 mmol); mp 88.5â89.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.29 (s, 1H), 6.88 (s, 1H), 6.75 (br t, <i>J</i> = 6.1 Hz, 1H), 4.56 (s, 2H), 4.41 (d, <i>J</i> = 6.1 Hz, 2H), 3.81 (s, 3H), 2.38 (t, <i>J</i> = 7.6 Hz, 2H), 1.61 (quint, <i>J</i> = 7.6 Hz, 2H), 1.28â1.23 (m, 16H), 0.85 (t, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 167.3, 147.3, 146.2, 131.7, 124.8, 112.8, 87.7, 62.9, 56.1, 47.3, 34.1, 32.0, 29.7, 29.5 (2C), 29.4, 29.3, 29.2, 24.9, 22.8, 14.2. IR (neat): <i>á¹¼</i> = 3296, 2918, 2851, 1748, 1654, 1163, 514 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 518 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Pentadecanoate, (<b>37</b>)</h4><div class="NLM_p last">White solid; yield 82% (230 mg, 0.41 mmol); mp 86â87 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.31 (s, 1H), 6.90 (s, 1H), 6.67 (br t, <i>J</i> = 6.1 Hz, 1H), 4.56 (s, 2H), 4.43 (d, <i>J</i> = 6.1 Hz, 2H), 3.84 (s, 3H), 2.38 (t, <i>J</i> = 7.2 Hz, 2H), 1.63 (quint, <i>J</i> = 7.2 Hz, 2H), 1.26â1.19 (m, 22H), 0.86 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.3, 167.1, 147.2, 146.1, 131.8, 124.8, 112.8, 87.8, 62.9, 56.2, 47.3, 34.1, 31.9, 29.7 (3C), 29.5 (2C), 29.4 (2C), 29.3, 29.2, 24.9, 23.2, 14.2. IR (KBr): <i>á¹¼</i> = 3303, 2917, 2850, 2360, 1742, 1646, 1505, 1167 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 560 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Stearate, (<b>38</b>)</h4><div class="NLM_p last">White solid; yield 90% (271 mg, 0.45 mmol); mp 99.5â100.5 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.34 (s, 1H), 6.91 (s, 1H), 6.66 (br t, <i>J</i> = 4.7 Hz, 1H), 4.57 (s, 1H), 4.44 (d, <i>J</i> = 4.7 Hz, 2H), 3.86 (s, 3H), 2.39 (t, <i>J</i> = 7.5 Hz, 3H), 1.64 (quint, <i>J</i> = 7.5 Hz, 2H), 1.40â1.10 (m, 28H), 0.87 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 171.0, 147.2, 146.1, 131.8, 124.7, 112.8, 87.8, 62.9, 56.2, 47.3, 34.1, 32.0 (2C), 29.8 (2C), 29.5 (2C), 29.4 (2C), 29.3 (2C), 29.2 (2C), 24.9 (2C), 22.8, 14.2. IR (neat): <i>á¹¼</i> = 3297, 2919, 2850, 1749, 1655, 1508, 1162, 856 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 602 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl Oleate, (<b>39</b>)</h4><div class="NLM_p last">Amorphous yellow solid; yield 50% (150 mg, 0.25 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.31 (s, 1H), 6.90 (s, 1H), 6.68 (br t, <i>J</i> = 6.1 Hz, 1H), 5.33â5.31 (m, 2H), 4.56 (s, 2H), 4.42 (d, <i>J</i> = 6.1 Hz, 2H), 3.83 (s, 3H), 2.38 (t, <i>J</i> = 7.7 Hz, 2H), 2.00â1.96 (m, 4H), 1.62 (quint, <i>J</i> = 7.7 Hz, 2H), 1.27â1.19 (m, 20H), 0.86 (t, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.3, 167.2, 147.3, 146.2, 131.8, 130.1, 129.7, 124.8, 112.8, 87.8, 62.9, 56.2, 47.3, 34.1, 32.0, 29.8, 29.7 (2C), 29.6, 29.4 (2C), 29.2, 29.1, 27.3, 27.2, 24.9, 22.7, 14.2. IR (KBr): <i>á¹¼</i> = 3314, 2926, 2851, 2359, 1748, 1507 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 600 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>R,Z</i>)-2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl 12-hydroxyoctadec-9-enoate, (<b>40</b>)</h4><div class="NLM_p last">Amorphous white solid; yield 82% (253 mg, 0.41 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.29 (s, 1H), 6.88 (s, 1H), 6.68 (br t, <i>J</i> = 6.0 Hz, 1H), 5.51â5.49 (m, 1H), 5.38â5.35 (m, 1H), 4.56 (s, 2H), 4.41 (d, <i>J</i> = 6.0 Hz, 2H), 3.81 (s, 3H), 3.60â3.57 (m, 1H), 2.27 (t, <i>J</i> = 7.1 Hz, 2H), 2.18 (t, <i>J</i> = 6.3 Hz, 2H), 1.63â1.59 (m, 2H), 1.29â1.22 (m, 20H), 0.84 (t, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.3, 167.2, 147.4, 146.2, 133.3, 131.7, 125.4, 124.9, 112.9, 87.7, 56.2, 47.3, 36.9, 35.4, 34.1, 31.9, 29.6, 29.4, 29.2 (2C), 29.1 (2C), 27.4, 25.8, 24.9, 22.7, 14.3, 14.2. IR (KBr): <i>á¹¼</i> = 3513, 3313, 2925, 2852, 1733, 1634, 1506, 1164 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 616 [M - H]<sup>â</sup>. [Î±]<sup>20</sup><sub>D</sub>: + 2.23 (<i>c</i> 0.029 g cm<sup>â3</sup> in CHCl<sub>3</sub>).</div></div><div id="sec5_6_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>R</i>,<i>Z</i>)-2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl 12-(2-phenylacetoxy)octadec-9-enoate, (<b>41</b>)</h4><div class="NLM_p last">Amorphous white solid; yield 92% (338 mg, 0.46 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.31â7.20 (m, 6H), 6.86 (s, 1H), 6.74 (br t, <i>J</i> = 6.0 Hz, 1H), 5.42â5.39 (m, 1H), 5.28â5.25 (m, 1H), 4.83 (quint, <i>J</i> = 6.3 Hz, 1H), 4.55 (s, 2H), 4.39 (d, <i>J</i> = 6.0 Hz, 2H), 3.79 (s, 3H), 3.55 (s, 2H), 2.36 (t, <i>J</i> = 7.4 Hz, 2H), 2.27â2.23 (m, 2H), 1.96â1.93 (m, 2H), 1.62â1.58 (m, 2H), 1.51â1.48 (m, 2H), 1.22â1.11 (m, 16H), 0.82 (t, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.4, 171.5, 167.3, 147.4, 146.2, 134.4, 132.7, 131.6, 129.3, 128.5, 127.0, 124.9, 124.3, 112.8, 87.6, 74.6, 62.9, 60.5, 56.1, 47.3, 41.8, 34.0, 33.6, 32.0, 31.7, 29.6, 29.2 (2C), 29.1, 27.3, 25.2, 24.9, 22.6, 14.1. IR (neat): <i>á¹¼</i> = 3354, 2970, 2360, 1737, 1670, 1365, 1204 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 734 [M â H]<sup>â</sup>. [Î±]<sup>20</sup><sub>D</sub>: + 12.41 (<i>c</i> 0.019 g cm<sup>â3</sup> in CHCl<sub>3</sub>).</div></div><div id="sec5_6_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (<i>Z</i>)-2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl docos-13-enoate, (<b>42</b>)</h4><div class="NLM_p last">Amorphous white solid; yield 58% (191 mg, 0.29 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.32 (s, 1H), 6.91 (s, 1H), 6.67 (br t, <i>J</i> = 6.0 Hz, 1H), 5.40â5.31 (m, 2H), 4.57 (s, 2H), 4.42 (d, <i>J</i> = 6.0 Hz, 2H), 3.86 (s, 3H), 2.38 (t, <i>J</i> = 5.8 Hz, 2H), 2.0 (m, 4H), 1.63 (quint, <i>J</i> = 5.8 Hz, 2H), 1.40â1.15 (m, 28H), 0.87 (t, <i>J</i> = 5.8 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.3, 167.2, 147.2, 146.1, 131.8, 130.0 (2C), 124.8, 112.8, 87.8, 62.9, 56.2, 47.3, 42.6 (2C), 34.1, 32.0, 29.9 (2C), 29.7 (2C), 29.5 (2C), 29.4 (2C), 29.2 (2C), 27.3 (2C), 24.9, 22.8, 14.2. IR (neat): <i>á¹¼</i> = 3292, 2917, 2851, 1752, 1652, 1157, 858, 591, 562 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 656 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl icosa-5,8,11,14-tetraenoate, (<b>43</b>)</h4><div class="NLM_p last">Amorphous yellow solid; yield 82% (255 mg, 0.41 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.31 (s, 1H), 6.89 (s, 1H), 6.68 (br t, <i>J</i> = 6.0 Hz, 1H), 5.36â5.33 (m, 8H), 4.56 (s, 2H), 4.42 (d, <i>J</i> = 6.0 Hz, 2H), 3.83 (s, 3H), 2.79â2.77 (m, 6H), 2.40 (t, <i>J</i> = 7.5 Hz, 2H), 2.08 (m, 4H), 1.72 (quint, <i>J</i> = 7.5 Hz, 2H), 1.29â1.26 (m, 6H), 0.86 (t, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.1, 167.1, 147.3, 146.2, 131.7, 130.6, 129.3, 128.7, 128.6 (2C), 128.4, 128.1, 127.9, 127.6, 124.8, 112.9, 87.8, 62.9, 56.2, 47.3, 33.4, 31.6, 29.4, 27.3, 26.5, 25.7 (2C), 24.7, 22.6, 14.2. IR (KBr): <i>á¹¼</i> = 3358, 3011, 2926, 1736, 1683, 1500, 1268 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 622 [M â H]<sup>â</sup>.</div></div><div id="sec5_6_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (4<i>E</i>,8<i>E</i>,12<i>E</i>,16<i>E</i>)-2-((4-Hydroxy-2-iodo-5-methoxybenzyl)amino)-2-oxoethyl 4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenoate, (<b>44</b>)</h4><div class="NLM_p last">Amorphous white solid; yield 72% (259 mg, 0.36 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.31 (s, 1H), 6.89 (s, 1H), 6.68 (br t, <i>J</i> = 6.1 Hz, 1H), 5.94 (br s, 1H), 5.20â5.05 (m, 5H), 4.56 (s, 2H), 4.42 (d, <i>J</i> = 6.1 Hz, 2H), 3.83 (s, 3H), 2.50 (t, <i>J</i> = 7.3 Hz, 2H), 2.31 (t, <i>J</i> = 7.3 Hz, 2H), 2.10â1.90 (m, 16H), 1.65â1.50 (m, 18H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.0, 167.2, 147.3, 146.1, 135.2, 135.0, 134.8, 132.8, 131.7, 131.3, 125.7, 124.8, 124.6, 124.5, 124.3 (2C), 112.7, 87.7, 62.9, 59.8, 59.1, 56.1, 47.3, 39.8, 39.6, 34.5, 33.0, 28.3, 26.8, 26.7 (2C), 25.8 (2C), 17.8 (2C), 16.1, 16.0. IR (neat): <i>á¹¼</i> = 3354, 2918, 2359, 2342, 1736, 1499, 1202, 1159, 668, 632 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 718 [M â H]<sup>â</sup>.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> General Procedure for the Synthesis of Compounds <b>45</b>â<b>46</b></h3><div class="NLM_p">To a solution of ((4-(isocyanomethyl)-1,2-phenylene)bis(oxy))bis(<i>tert</i>-butyldimethylsilane) <b>5</b> (264.4 mg, 0.70 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (4.5 mL) 37% aqueous formaldehyde solution (210 Î¼L, 2.8 mmol, 4 equiv) and carboxylic acid (0.70 mmol, 1 equiv) were added, and the resulting mixture was stirred at 40 Â°C for 4 h. Then, the volatile was removed under vacuo, the product was solubilized in THF (3 mL), and the mixture was cooled to 0 Â°C. At this temperature, acetic acid (136 Î¼L, 2.38 mmol, 3.4 equiv) and TBAF (2.38 mL, 2.38 mmol, 3.4 equiv) were added. The reaction was stirred for 3 h. The volatile was evaporated and ethyl acetate was added, washed with water (Ã2), dried over sodium sulfate, and evaporated.</div><div class="NLM_p last">The crude material was subjected to column chromatography with petroleum ether/ethyl acetate 8:2 and then petroleum ether/ethyl acetate 7:3 as eluent.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Characterization of Compounds <b>45</b>â<b>46</b></h3><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>E</i>)-2-((3,4-Dihydroxybenzyl)amino)-2-oxoethyl 3,7-dimethylocta-2,6-dienoate, (<b>45</b>)</h4><div class="NLM_p last">White solid; yield 47% (115 mg, 0.33 mmol). mp 93â94 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 6.86â6.78 (m, 2H), 6.66 (br s, 1H), 6.63 (d, <i>J</i> = 7.7 Hz, 1H), 5.70 (s, 1H), 5.04 (t, <i>J</i> = 6.2 Hz, 1H), 4.63 (s, 2H), 4.36 (d, <i>J</i> = 5.8 Hz, 2H), 2.20â2.15 (m, 7H), 1.67 (s, 3H), 1.59 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 168.7, 165.2, 164.0, 144.5, 144.2, 132.8, 129.4, 122.8, 120.0, 115.4, 115.0, 113.9, 62.1, 43.1, 41.2, 26.0, 25.7, 19.2, 17.8. IR (KBr): <i>á¹¼</i> = 3240, 2909, 1721, 1641, 1436, 1390, 1136, 945, 808 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 346 [M â H]<sup>â</sup>.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (4<i>E</i>,8<i>E</i>,12<i>E</i>,16<i>E</i>)-2-((3,4-Dihydroxybenzyl)amino)-2-oxoethyl 4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenoate, (<b>46</b>)</h4><div class="NLM_p last">Amorphous yellow solid; yield 56% (226 mg, 0.39 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 0.6.81â6.79 (m, 2H), 6.64 (d, <i>J</i> = 7.7 Hz, 1H), 6.55 (br s, 1H), 5.12â5.10 (m, 5H), 4.60 (s, 2H), 4.35 (d, <i>J</i> = 4.9 Hz, 2H), 2.45 (t, <i>J</i> = 7.4 Hz, 2H), 2.28 (t, <i>J</i> = 7.4 Hz, 2H), 2.04â1.99 (m, 16H), 1.67â1.60 (m, 18H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.7, 168.3, 144.5, 144.1, 135.2, 135.0, 134.9, 132.9, 131.3, 129.4, 125.6, 124.5, 124.4 (2C), 120.0, 115.5, 115.0, 62.7, 43.1, 39.8 (2C), 39.6, 34.4, 32.8, 29.8, 28.4 (2C), 26.9 (2C), 26.7. 25.8, 17.8, 16.1 (2C), 16.1, 15.9. IR (KBr): <i>á¹¼</i> = 3344, 2962, 2915, 1744, 1646, 1439, 1372, 1142, 945, 810 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 578 [M â H]<sup>â</sup>.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> General Procedure for the Synthesis of Compounds <b>47</b>â<b>48</b></h3><div class="NLM_p last">To a solution of ((4-iodo-5-(isocyanomethyl)-1,2-phenylene)bis(oxy))bis(<i>tert</i>-butyldimethylsilane) <b>6</b> (251.6 mg, 0.5 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (4.5 mL) 37% aqueous formaldehyde solution (150 Î¼L, 2 mmol, 4 equiv) and carboxylic acid (0.5 mmol, 1 equiv) were added, and the resulting mixture was stirred at 40 Â°C for 4 h. Then, the volatile was removed under reduced pressure, and the product was solubilized in THF (2.5 mL). The mixture was cooled to 0 Â°C. At this temperature, acetic acid (97 Î¼L, 1.7 mmol, 3.4 equiv) and TBAF (1.70 mL, 1.7 mmol, 3.4 equiv) were added. The reaction was stirred for 3 h. The volatile was evaporated and ethyl acetate was added, washed with water (Ã2), dried over sodium sulfate, and evaporated. The crude material was subjected to column chromatography with petroleum ether/ethyl acetate 9:1 and then petroleum ether/ethyl acetate 8:2 as eluent.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Characterization of Compounds <b>47</b>â<b>48</b></h3><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>E</i>)-2-((4,5-Dihydroxy-2-iodobenzyl)amino)-2-oxoethyl 3,7-dimethylocta-2,6-dienoate, (<b>47</b>)</h4><div class="NLM_p last">Sticky orange solid; yield 39% (92 mg, 0.19 mmol). mp 127â128 Â°C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.26 (s, 1H), 7.08 (br t, <i>J</i> = 6.0 Hz, 1H), 6.98 (s, 1H), 5.73 (s, 1H), 5.05 (t, <i>J</i> = 5.4 Hz, 1H), 4.62 (s, 2H), 4.40 (d, <i>J</i> = 6.0 Hz, 2H), 2.17â2.15 (m, 7H), 1.70 (s, 3H), 1.60 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 169.9, 165.0, 164.1, 145.5, 144.9, 132.9, 131.3, 125.3, 122.8, 116.9, 113.9, 86.0, 62.0, 47.3, 41.2, 26.1, 25.7, 19.3, 17.8. IR (KBr): <i>á¹¼</i> = 3462, 3318, 2930, 1721, 1644, 1413, 1146, 866, 817 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 472 [M â H]<sup>â</sup>.</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (4<i>E</i>,8<i>E</i>,12<i>E</i>,16<i>E</i>)-2-((4,5-Dihydroxy-2-iodobenzyl)amino)-2-oxoethyl 4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenoate, (<b>48</b>)</h4><div class="NLM_p last">Amorphous orange solid; yield 63% (221 mg, 0.31 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.29 (s, 1H), 7.04 (s, 1H), 7.00 (br s, 1H), 5.81 (br s, 2H), 5.11â5.09 (m, 5H), 4.60 (s, 2H), 4.43 (d, <i>J</i> = 6.1 Hz, 2H), 2.52 (t, <i>J</i> = 7.1 Hz, 2H), 2.32 (t, <i>J</i> = 7.1 Hz, 2H), 2.06â1.99 (m, 16H), 1.67 (s, 3H), 1.60â1.58 (m, 15H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ = 172.3, 168.5, 145.5, 144.8, 135.2, 135.0, 134.9, 132.8, 131.3, 131.1, 125.8, 125.2, 124.6, 124.5, 124.4 (2C), 116.9, 86.1, 62.7, 47.4, 39.8 (2C), 39.6, 34.5, 32.9, 28.4 (2C), 26.9 (2C), 26.8, 25.8, 17.8, 16.2 (2C), 16.1, 16.0. IR (KBr): <i>á¹¼</i> = 3391, 2920, 1734, 1653, 1429, 1376, 1161, 877, 812 cm<sup>â1</sup>. MS (ESI): <i>m</i>/<i>z</i>: 704 [M â H]<sup>â</sup>.</div></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> General Procedure for the Synthesis of Compounds <b>49</b>â<b>50</b></h3><div class="NLM_p last">To a solution of compound <b>12</b> or <b>31</b> (0.62 mmol, 1 equiv) in THF (2 mL) H<sub>2</sub>O (2 mL) and NaOH (74.4 mg, 1.86 mmol, 3 equiv) were added, and the resulting mixture was stirred at room temperature for 5 h. Then, the reaction was diluted with ethyl acetate and washed with aqueous saturated NaHCO<sub>3</sub> solution (Ã1). The organic phase was dried over sodium sulfate and evaporated. The crude material was subjected to column chromatography with ethyl acetate and then ethyl acetate/MeOH 8:2 as eluent.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Characterization of Compounds <b>49</b>â<b>50</b></h3><div id="sec5_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-Hydroxy-<i>N</i>-(4-hydroxy-3-methoxybenzyl)acetamide, (<b>49</b>)</h4><div class="NLM_p last">Pale yellow solid; yield 82% (108 mg, 0.51 mmol). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ = 8.20 (br s, 1H), 6.89 (s, 1H), 6.75â6.72 (m, 2H), 4.32 (s, 2H), 4.00 (s, 2H), 3.82 (s, 3H). MS (ESI): <i>m</i>/<i>z</i>: 212 [M + H]<sup>+</sup>.</div></div><div id="sec5_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-Hydroxy-N-(4-hydroxy-2-iodo-5-methoxybenzyl)acetamide, (<b>50</b>)</h4><div class="NLM_p last">White solid; yield 47% (98 mg, 0.29 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ = 7.23 (s, 1H), 6.90 (s, 1H), 4.36 (s, 2H), 4.02 (s, 2H), 3.81 (s, 3H). MS (ESI): <i>m</i>/<i>z</i>: 336 [M â H]<sup>â</sup>.</div></div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> General Procedure for the Synthesis of Compounds <b>51</b>â<b>52</b></h3><div class="NLM_p">To a solution of isocyanide <b>5</b> or <b>6</b> (0.9 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (7 mL) 37% aqueous formaldehyde solution (99.82 Î¼L, 3.6 mmol, 4 equiv) and 2-hydroxymethyl benzoic acid (136.9 mg, 0.9 mmol, 1 equiv) were added, and the resulting mixture was stirred at 40 Â°C overnight.</div><div class="NLM_p">The volatile was then removed under vacuo and ethyl acetate was added. The organic phase was washed with aqueous saturated NaHCO<sub>3</sub> solution (Ã2), dried over sodium sulfate, and evaporated.</div><div class="NLM_p last">The crude material was then solubilized in THF (5 mL) and cooled to 0 Â°C. At this temperature, acetic acid (113.3 Î¼L, 1.98 mmol, 2.2 equiv) and TBAF (1.98 mL, 1.98 mmol, 2.2 equiv) were added. The reaction was stirred for 3 h. The volatile was evaporated and ethyl acetate was added, washed with water (Ã2), dried over sodium sulfate, and evaporated. The crude material was subjected to column chromatography with ethyl acetate and then ethyl acetate/MeOH 8:2 as eluent.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Characterization of Compounds <b>51</b>â<b>52</b></h3><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-(3,4-Dihydroxybenzyl)-2-hydroxyacetamide, (<b>51</b>)</h4><div class="NLM_p last">Pale yellow oil; yield 70% (124 mg, 0.63 mmol). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ = 6.86 (br s, 1H), 6.77 (br s, 1H), 6.73 (s, 1H), 6.69 (d, <i>J</i> = 7.9 2H), 6.61 (d, <i>J</i> = 7.9 2H), 4.28 (s, 2H), 3.99 (s, 2H). MS (ESI): <i>m</i>/<i>z</i>: 198 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-(4,5-Dihydroxy-2-iodobenzyl)-2-hydroxyacetamide, (<b>52</b>)</h4><div class="NLM_p last">Pale yellow oil; yield 76% (221 mg, 0.68 mmol). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ = 7.20 (s, 1H), 6.77 (s, 1H), 4.30 (s, 2H), 4.02 (s, 2H). MS (ESI): <i>m</i>/<i>z</i>: 324 [M + H]<sup>+</sup>.</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Calcium Fluorimetry</h3><div class="NLM_p">SH-SY5Y-TRPV1 cells (kindly provided by Johanna Lilja and Anna Forsby (University of Stockholm, Stockholm, Sweden))<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> were cultured in 96-wells. Upon 90% confluence had been reached, cells were loaded with 5 Î¼M Fluo-4NW for 1 h at 37 Â°C. The Fluo-4NW fluorescence was measured through cycles (1.7 min each) of excitation at 485 nm and emission at 535 nm (POLARstar Omega BMG LABtech). Briefly, after measuring the basal fluorescence of the plate (four cycles), testing compounds were added to the plate, and the fluorescence was measured for additional 10 cycles; thereafter, 10 Î¼M capsaicin was added with a microinjector and the fluorescence was monitored for an additional 10 cycles. Under these conditions, testing agonists and antagonists were exposed to the cells for 25 min.</div><div class="NLM_p last">Ruthenium red (10 Î¼M) was used as a reference antagonist for the blockade of TRPV1 and to identify true channel mediated Ca<sup>2+</sup> influx. An agonistic effect was compared to the increase in fluorescence exerted by the capsaicin, and an antagonistic effect was compared to the extent of blockade produced by the reference ruthenium red. The EC<sub>50</sub> of agonistic compounds was obtained from the concentrationâresponse curves upon increasing the concentration of the compound. Similarly, the IC<sub>50</sub> of antagonists was determined from concentrationâresponse relationships derived from augmenting the concentration of the compound at a fixed concentration of capsaicin. This in vitro assay has a <i>Z</i>-factor of 0.85 in HTS format, which makes it highly suitable for screening applications.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Animals</h3><div class="NLM_p last">All procedures were approved by the Institutional Animal and Ethical Committee of the University Miguel HernÃ¡ndez de Elche, in accordance with the guidelines of the Economic European Community, the National Institutes of Health, and the Committee for Research and Ethical Issues of the International Association for the Study of Pain. Animals were kept in a controlled environment (21â23 Â°C, 12 h light/dark).</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> MicroElectrode Array Recordings</h3><div class="NLM_p">Neonatal dorsal root ganglia from Wistar rats (3â5 days old) were isolated and located into a Petri dish containing dulbeccoâs modified eagleâs medium (DMEM)-glutamax with 1% P/S (5000 U/mL). After removing roots, ganglia were digested with 0.25% (w/v) collagenase (type IA) in DMEM-glutamax with 1% P/S for 1 h (37 Â°C, 5% CO2). After digestion, DRGs were mechanically dissociated using a glass Pasteur pipet. Single cell suspension was passed through a 100 Î¼m cell strainer, and washed with DMEM Glutamax plus 10% phosphate buffer saline (FBS) and 1% P/S. Cells were seeded in a drop on microelectrode array chambers previously coated with poly <span class="smallcaps smallerCapital">l</span>-lysine (8.3 Î¼g/mL) and laminin (5 Î¼g/mL). After 2 h, medium was replaced with DMEM glutamax, 10% FBS and 1% P/S, supplemented with mouse 2.5S NGF 50 ng/mL and 1.25 Î¼g/mL cytosine arabinoside (37 Â°C, 5% CO2). All experiments were performed after 48 h cell seeding.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">Extracellular recordings were made using multiple electrode planar arrays of 60-electrode thin MEA chips, with 30 Î¼m diameter electrodes and 200 Î¼m interelectrode spacing with an integrated reference electrode (Multichannel Systems GmbH,). The electrical activity of primary sensory neurons was recorded by the MEA1060 System (Multi Channel Systems GmbH), and MC_Rack software version 4.3.0 at a sampling rate of 25 kHz.</div><div class="NLM_p last">TRPV1-mediated neuronal firing activity was evoked by two repetitive 15 s applications of 500 nM capsaicin, using continuous perfusion system (2 mL/min flux). Upon the first capsaicin application (P1), compound <b>36</b> at 10, 1, or 0.1 Î¼M, or capsazepine at 10 Î¼M or vehicle (DMSO 0.01% v/v) were applied together with capsaicin (P2). Finally, 40 mM KCl pulse was applied to ensure cell viability of the culture. Data analyzed using MC_RACK spike sorter and Neuroexplorer Software (Nex Technologies). An evoked spike was defined when the amplitude of the neuronal electrical activity overcame a threshold set at â15 Î¼V. The recorded signals were then processed to extract mean spike frequency. All measurements were performed at â¼25 Â°C. Ratio mean spike frequency between P2 and P1 was calculated and then normalized to vehicle-treated value. All data are expressed as mean Â± SEM, with <i>n</i> as the number of registered electrodes and <i>N</i> as the number of independent experiments. One-way ANOVA followed by BonferronÃ­s post hoc test measurements to compare treatments versus vehicle group. ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; **<i>p</i> < 0.05</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> In Vivo Assays</h3><div class="NLM_p">Experiments were performed in 8/10-week-old C57BL/6 male mice (Harlan, Netherlands) bred in the Animalario of the Universidad de Elche, housed six per cage with a bedding of sawdust and maintained on a 12 h darkâ light cycle with free access to food and water. Each animal was used only once. For intraplantar (i.pl.) injection animals were carefully immobilized in a small plastic tube leaving the hindpaw exposed for the injection. The corresponding compound was subcutaneously administered into the hindpaw. Intravenous (i.v.) injection was performed with the animals under slight Isoflurano anesthesia. Animals were placed in a small induction chamber where isoflurano was flowing mixed with oxigen. Then, animals were taking out and the drug was administered slowly into the lateral vein of the tail.</div><div class="NLM_p last">To induce inflammation, 30 Î¼L of CFA (1 mg/mL of <i>Mycobacterium tuberculosis</i> heat killed and dried, 0.85 mL paraffin oil and 0.15 mL mannide monooleate) was intraplantarly (i.pl.) administered into the plantar side of the right hind paw. Nociceptive responses were tested 24 h after injection.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Complete Freundâs Adjuvant (CFA)-Induced Thermal Hyperalgesia</h3><div class="NLM_p last">The effect of compound <b>36</b> against hyperalgesia associated with inflammation was investigated using the CFA model. Thermal hyperalgesia tests were conducted 24 h after injection. Mice were placed into transparent plastic cages, and after a 10 min habituation period compound <b>36</b> was either intravenous (i.v.) at doses from 1 to 10 mg/kg into the vein of the tail or intraplantarly (i.pl.) injected at doses from 10 to 100 Î¼gr. The latency required to elicit paw withdrawal in response to radiant heat applied to the plantar surface of a hind paw from underneath a glass floor with a high intensity infrared heat was measured with an electronic timer (Ugo Basile, Italy). The stimulus intensity was adjusted to yield a baseline paw withdrawal latency of 10â12 s in healthy animals. The average of two measurements per paw assessed within a 1 min interval was calculated in seconds. To avoid tissue damage, a cutoff of 20 s was employed.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Pruritus Induced Animal Models</h3><div class="NLM_p last">Mice were placed into transparent plastic cages, and after a 10 min habituation period they were intraplantarly injected with 125 Î¼g of histamine in 25 Î¼L of saline or with 200 Î¼g of chloroquine in 25 Î¼L of saline. Immediately after the injection, the animals were returned to the observation cages and the time spent in licking the injected paw during a 30 min period was recorded and measured manually with a chronometer. Animals receiving compound <b>36</b> (100 Î¼g) were administered with the drug 30 min before histamine or chloroquine injection.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Body Temperature</h3><div class="NLM_p last">Body temperature: body temperature was measured before intravenous injection, and at 30, 60, 90, and 120 min after injection using a rectal probe coupled to a digital thermometer.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Statistical Analysis of Data</h3><div class="NLM_p last">GraphPad Prism (Graph- Pad Software Inc., San Diego, CA) software were used for all statistical analyses. Two-way repeated measurements ANOVA was used for two factor analyses followed by Bonferroniâs multiple comparison test. Curve fitting was performed with Kaleidagraph. Statistical significance was usually considered ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; **<i>p</i> < 0.05</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">Metabolism</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Determination of the Metabolic Stability in Human HaCaT Homogenate (a), Human Plasma (b), Human Liver S9 (c), Recombinant Carboxylesterases (hCE1, hCE2) (d), and Human Keratinocites and Fibroblasts Homogenate (e)</h3><div class="NLM_p">(a) HaCaT cells were cultured in DMEM medium (Sigma-Aldrich, St. Louis, MO) supplemented with 10% fetal bovine serum, 2 mM glutamine, 10 units/mL penicillin, and 100 Î¼g/mL streptomycin. Cells were maintained in a humidified incubator supplied with 5% CO<sub>2</sub>/95% air at 37 Â°C and were subcultured as needed by detaching the cells with 0.25% trypsin and 5 mM ethylenediaminetetraacetic acid (EDTA). 10Ì7 cells were lysed in 20 mM Tris-HCl buffer pH 7.5 (supplemented with proteases inhibitors cocktail, Sigma). The absence of intact cells was monitored by trypan blue staining. Samples were centrifuged at 12000<i>g</i> for 10 min at 4 Â°C, and the supernatants were collected and quantified using Bradford (Biorad).</div><div class="NLM_p">The standard incubation mixture (250 Î¼L final volume) was carried out in a 50 mM TRIS (Tris[hydroxymethyl]aminomethane) buffer (pH 7.4) containing tween 80 surfactant (2.5 mg/mL) and substrate compounds (25 Î¼M). After pre-equilibration of the mixture, an appropriate volume of HaCaT homogenate suspension was added to give a final protein concentration of 0.4 mg/mL. The mixture was shaken for 0â60â240 min at 37 Â°C. Control incubations were carried out without HaCaT homogenate. Each incubation was performed in triplicate and stopped by addition of 250 Î¼L of ice-cold acetonitrile, vortexed and centrifuged at 13â¯000 r.p.m. for 10 min. An aliquot of 450 Î¼L of each supernatant was withdrawn and evaporated under reduced pressure (3h at 50 Â°C) and the residue was reconstituted in acetonitrile (100 Î¼L), vortexed, and centrifuged at 13â¯000 r.p.m. for 5 min.</div><div class="NLM_p">(b) Plasma samples were obtained following the centrifugation of whole blood and stored at -80 Â°C until analysis. The standard incubation mixture (70 Î¼L final volume) was carried out by dissolving the tested substrate compounds (100 Î¼M) in DMSO (5% final volume) in preincubated plasma at 37 Â°C. The mixture was shaken for 0â10â20 min at 37 Â°C. Control incubations were carried out without substrate. Each incubation was performed in triplicate and stopped by addition of 140 Î¼L of ice-cold acetonitrile, vortexed, and centrifuged at 13â¯000 r.p.m. for 10 min. An aliquot of 150 Î¼L of each supernatant was withdrawn and evaporated under reduced pressure (1 h at 50 Â°C), and the residue was reconstituted in acetonitrile (100 Î¼L), vortexed, and centrifuged at 13â¯000 r.p.m. for 5 min.</div><div class="NLM_p">(c) Human liver S9 fraction, (pooled mixed sex, 20 individual donors, protein concentration: 20 mg/mL) were purchased from Corning B.V. Life Sciences (Amsterdam, The Netherlands) and used throughout this study. The standard incubation mixture (150 Î¼L final volume) was carried out in a 50 mM TRIS (Tris[hydroxymethyl]aminomethane) buffer (pH 7.4) containing tween 80 surfactant (2.5 mg/mL), and 50 Î¼M substrate compounds. After pre-equilibration of the mixture, an appropriate volume of S9 suspension was added to give a final protein concentration of 1.0 mg/mL. The mixture was shaken for 0â15â30â60 min at 37 Â°C. Control incubations were carried out without S9. Each incubation was performed in triplicate and was stopped by addition of 150 Î¼L ice-cold acetonitrile, vortexed, and centrifuged at 13â¯000 r.p.m. for 10 min.</div><div class="NLM_p">(d) Primary adult epidermal keratinocytes (ATCC, PCS 200-011) were cultured in Dermal Cell Basal Media (ATCC, PCS 200â030) supplemented with Keratinocyte Growth kit components (Bovine Pituitary Extract (BPE), recombinant tumor growth factor alpha (rhTGFÎ±), <span class="smallcaps smallerCapital">l</span>-glutamine, hydrocortisone hemisuccinate, insulin, epinephrine, and apotransferrin, ATCC PCS 200-040), 10 units/mL penicillin and 100 Î¼g/mL streptomycin. Primary adult dermal fibroblasts (ATCC, PCS 200-012) were grown in Fibroblast Media supplemented with fibroblast growth kit-low serum (containing <span class="smallcaps smallerCapital">l</span>-glutamine, hydrocortisone, hemisuccinate, recombinant fibroblast growth factor beta (rhFGFÎ²), rh-insulin, ascorbic acid and fetal bovine serum, ATCC PCS-201-041), 10 units/mL penicillin, and 100 Î¼g/mL streptomycin. Cells were maintained in a humidified incubator supplied with 5% CO<sub>2</sub>/95% air at 37 Â°C and were subcultured as needed by detaching the cells with 0.25% trypsin and 5 mM EDTA. 10Ì7 cells were lysed in 20 mM Tris-HCl buffer pH 7.5 (supplemented with proteases inhibitors cocktail, Sigma). The absence of intact cells was monitored by trypan blue staining. Samples were centrifuged at 12000<i>g</i> for 10 min at 4 Â°C, and the supernatants were collected and quantified using Bradford (Biorad).</div><div class="NLM_p">The standard incubation mixture (100 Î¼L final volume) was carried out in a 50 mM TRIS (Tris[hydroxymethyl]aminomethane) buffer (pH 7.4) containing tween 80 surfactant (2.5 mg/mL), and substrate compounds (50 Î¼M). After pre-equilibration of the mixture, an appropriate volume of keratinocytes or fibroblasts homogenate suspension was added to give a final protein concentration of 0.4 mg/mL. The mixture was shaken for 0â120 min at 37 Â°C. Control incubations were carried out without homogenate. Each incubation was performed in triplicate and stopped by addition of 100 Î¼L of ice-cold acetonitrile, vortexed, and centrifuged at 13â¯000 r.p.m. for 10 min.</div><div class="NLM_p last">(e) Recombinant carboxylesterases 1 isoform b (hCE1) and 2 (hCE2) expressed in baculovirus infected BTI insect cells (protein concentration: 5 mg/mL, â¥ 500 units/mg protein) were purchased from Sigma-Aldrich (Milano, Italy) and used throughout this study. The standard incubation mixture (100 Î¼L final volume) was carried out in a 50 mM TRIS (Tris[hydroxymethyl]aminomethane) buffer (pH 7.4) containing tween 80 surfactant (2.5 mg/mL), and 50 Î¼M substrate compounds. After pre-equilibration of the mixture, an appropriate volume of hCE suspension was added to give a final protein concentration of 0.2 mg/mL for compounds <b>17</b> and <b>36</b> incubations and 1 mg/mL for compounds <b>34</b> and <b>46</b> incubations, respectively. The mixture was shaken at 37 Â°C for 0â10â20â30 min or 0â20â40â60 min for, respectively. Control incubations were carried out without hCE. Each incubation was performed in triplicate and was stopped by addition of 100 Î¼L of ice-cold acetonitrile, vortexed, and centrifuged at 13â¯000 r.p.m. for 10 min. For each incubation, the supernatant was analyzed by LC-UV systems. Metabolic stability was evaluated by monitoring the residual substrate area versus time. The rate constant <i>k</i> [min<sup>â1</sup>], derived for the substrate peak area versus time curve (single-exponential decay equation GraphPad Prism software, Inc., San Diego, CA USA) was used to calculate the in vitro half-life <i>t</i><sub>1/2</sub> (min), while the metabolic clearance expressed as Î¼L/min/mg was calculated using <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>.<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_m001.gif" alt="" id="_i99" /></img><span class="labelSpan">(1)</span></span></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00109" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00109" class="ext-link">10.1021/acs.jmedchem.8b00109</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Concentrationâresponse curves for selected agonists and antagonists in SH-SY5Y cells; metabolic stability in HaCaT homogenate, human plasma, liver S9, recombinant carboxylesterases (hCE1, hCE2), keratinocytes and fibroblasts homogenate; chemical stability study of compounds <b>17</b> and <b>36</b>; NMR spectra of compounds <b>17</b> and <b>36</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_001.csv">jm8b00109_si_001.csv (3.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf">jm8b00109_si_002.pdf (2.03 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00109" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Asia Fernandez-Carvajal</span> - <span class="hlFld-Affiliation affiliation">Instituto de BiologÃ­a
Molecular y Celular, Universitas Miguel
Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7716041e165911120519161913120d37021a1f591204"><span class="__cf_email__" data-cfemail="5f3e2c363e71393a2d313e313b3a251f2a3237713a2c">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracey Pirali</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3936-4787" title="Orcid link">http://orcid.org/0000-0003-3936-4787</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d5a1a7b4b6b0acfba5bca7b4b9bc95a0bbbca0a5bafbbca1"><span class="__cf_email__" data-cfemail="add9dfcccec8d483ddc4dfccc1c4edd8c3c4d8ddc283c4d9">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Serafini</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessia Griglio</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvio Aprile</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Seiti</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Travelli</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Franco Pattarino</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgio Grosa</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Sorba</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armando A. Genazzani</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, UniversitÃ  del Piemonte
Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara Gonzalez-Rodriguez</span> - <span class="hlFld-Affiliation affiliation">Instituto de BiologÃ­a
Molecular y Celular, Universitas Miguel
Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Butron</span> - <span class="hlFld-Affiliation affiliation">Instituto de BiologÃ­a
Molecular y Celular, Universitas Miguel
Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabel Devesa</span> - <span class="hlFld-Affiliation affiliation">AntalGenics, SL. Ed. Quorum III, Parque
CientÃ­fico UMH, Av de la Universidad
s/n, 03202 Elche, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Ferrer-Montiel</span> - <span class="hlFld-Affiliation affiliation">Instituto de BiologÃ­a
Molecular y Celular, Universitas Miguel
Hernandez, Av de la Universidad s/n, 03202 Elche, Spain</span></div></li></ul></li><li></li><li><span class="author-information-subsection-header">Funding</span><p>Funding from Compagnia di San Paolo (Grant No. C61J12000280007), Ministry of Economy and Competitiveness (SAF2015-66275-C02-01), and Generalitat Valenciana PROMETEO/2014/011.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A patent on some of the compounds has been filed and GID, AAG, TP, AFC, AVFM are listed as inventors. The patent is licensed to Antalgenics, of which GID is an employee and AFC and AVFM are shareholders.<br /></br></div></li></ul></div><div class="ack" id="ACK-d135e5619-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from Compagnia di San Paolo (Grant No. C61J12000280007) is gratefully acknowledged. We thank Johanna Lilja and Anna Forsby (University of Stockholm, Sweden) for kindly providing the TRPV1-SHSY-5Y neuroblastoma cells. We are grateful to Prof. Appendino and Prof. Minassi for their valuable advice and support during the project.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">BCTC</td><td class="NLM_def"><p class="first last">4-(3-chloro-2-pyridinyl)-<i>N</i>-[4-(1,1-dimethylethyl)phenyl]-1-piperazinecarboxamide</p></td></tr><tr><td class="NLM_term">BPE</td><td class="NLM_def"><p class="first last">bovine pituitary extract</p></td></tr><tr><td class="NLM_term">BuChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">CDCl<sub>3</sub></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">CD<sub>3</sub>OD</td><td class="NLM_def"><p class="first last">deuterated methanol</p></td></tr><tr><td class="NLM_term">CEs</td><td class="NLM_def"><p class="first last">carboxylesterases</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete Freundâs adjuvant</p></td></tr><tr><td class="NLM_term">CGRP</td><td class="NLM_def"><p class="first last">calcitonin gene related peptide</p></td></tr><tr><td class="NLM_term">CH<sub>2</sub>Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbeccoâs modified eagleâs medium</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO-<i>d</i><sub>6</sub></td><td class="NLM_def"><p class="first last">deuterated dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal effective concentration</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">phosphate buffer saline</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">HaCaT</td><td class="NLM_def"><p class="first last">cultured human keratinocyte cells</p></td></tr><tr><td class="NLM_term">hCEs</td><td class="NLM_def"><p class="first last">human carboxylesterases</p></td></tr><tr><td class="NLM_term">hCE1</td><td class="NLM_def"><p class="first last">human recombinant carboxylesterases isoform 1</p></td></tr><tr><td class="NLM_term">hCE2</td><td class="NLM_def"><p class="first last">human recombinant carboxylesterases isoform 2</p></td></tr><tr><td class="NLM_term">HPLC-UV</td><td class="NLM_def"><p class="first last">high performance liquid chromatography with UV detector</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximum inhibitory concentration</p></td></tr><tr><td class="NLM_term">i.pl.</td><td class="NLM_def"><p class="first last">intraplantar</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">infrared</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LC-UV</td><td class="NLM_def"><p class="first last">liquid chromatography with UV detector</p></td></tr><tr><td class="NLM_term">MCRs</td><td class="NLM_def"><p class="first last">multicomponent reactions</p></td></tr><tr><td class="NLM_term">MEA</td><td class="NLM_def"><p class="first last">multielectrode arrays</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">POCl<sub>3</sub></td><td class="NLM_def"><p class="first last">phosphorus oxychloride</p></td></tr><tr><td class="NLM_term">PON</td><td class="NLM_def"><p class="first last">paraoxonase</p></td></tr><tr><td class="NLM_term">rhFGFÎ²</td><td class="NLM_def"><p class="first last">recombinant fibroblast growth factor beta</p></td></tr><tr><td class="NLM_term">rhTGFÎ±</td><td class="NLM_def"><p class="first last">recombinant tumor growth factor alpha</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure activity relationship</p></td></tr><tr><td class="NLM_term">SH-SY5Y-TRPV1</td><td class="NLM_def"><p class="first last">human neuroblastoma cell line stably transfected with the rat TRPV1 cDNA</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TBDMS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">TBDMSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl chloride</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TRIS</td><td class="NLM_def"><p class="first last">tris(hydroxymethyl)aminomethane</p></td></tr><tr><td class="NLM_term">TRP</td><td class="NLM_def"><p class="first last">transient receptor potential</p></td></tr><tr><td class="NLM_term">TRPV1</td><td class="NLM_def"><p class="first last">transient receptor potential vanilloid type 1</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westaway, S. M.</span></span> <span> </span><span class="NLM_article-title">The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2589</span>â <span class="NLM_lpage">2596</span>, <span class="refDoi">Â DOI: 10.1021/jm060637e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060637e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2589-2596&author=S.+M.+Westaway&title=The+potential+of+transient+receptor+potential+vanilloid+type+1+channel+modulators+for+the+treatment+of+pain&doi=10.1021%2Fjm060637e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm060637e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060637e%26sid%3Dliteratum%253Aachs%26aulast%3DWestaway%26aufirst%3DS.%2BM.%26atitle%3DThe%2520potential%2520of%2520transient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520channel%2520modulators%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2589%26epage%3D2596%26doi%3D10.1021%2Fjm060637e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuziwara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denda, M.</span></span> <span> </span><span class="NLM_article-title">Functional vanillin receptors in cultured normal human epidermal keratinocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">124</span>â <span class="NLM_lpage">129</span>, <span class="refDoi">Â DOI: 10.1006/bbrc.2002.6393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1006%2Fbbrc.2002.6393" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2002&pages=124-129&author=K.+Inoueauthor=S.+Koizumiauthor=S.+Fuziwaraauthor=S.+Dendaauthor=K.+Inoueauthor=M.+Denda&title=Functional+vanillin+receptors+in+cultured+normal+human+epidermal+keratinocytes&doi=10.1006%2Fbbrc.2002.6393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2002.6393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2002.6393%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKoizumi%26aufirst%3DS.%26aulast%3DFuziwara%26aufirst%3DS.%26aulast%3DDenda%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DDenda%26aufirst%3DM.%26atitle%3DFunctional%2520vanillin%2520receptors%2520in%2520cultured%2520normal%2520human%2520epidermal%2520keratinocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D291%26spage%3D124%26epage%3D129%26doi%3D10.1006%2Fbbrc.2002.6393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szollosi, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biro, T.</span></span> <span> </span><span class="NLM_article-title">TRP channels in the skin</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">2568</span>â <span class="NLM_lpage">2581</span>, <span class="refDoi">Â DOI: 10.1111/bph.12569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1111%2Fbph.12569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=24372189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvV2isb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=2568-2581&author=B.+I.+Tothauthor=A.+Olahauthor=A.+G.+Szollosiauthor=T.+Biro&title=TRP+channels+in+the+skin&doi=10.1111%2Fbph.12569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TRP channels in the skin</span></div><div class="casAuthors">Toth, Balazs I.; Olah, Attila; Szoellosi, Attila Gabor; Biro, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2568-2581</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Emerging evidence suggests that transient receptor potential (TRP) ion channels not only act as 'polymodal cellular sensors' on sensory neurons but are also functionally expressed by a multitude of non-neuronal cell types.  This is esp. true in the skin, one of the largest organs of the body, where they appear to be critically involved in regulating various cutaneous functions both under physiol. and pathophysiol. conditions.  In this review, we focus on introducing the roles of several cutaneous TRP channels in the regulation of the skin barrier, skin cell proliferation and differentiation, and immune functions.  Moreover, we also describe the putative involvement of several TRP channels in the development of certain skin diseases and identify future TRP channel-targeted therapeutic opportunities.  Linked Articles : This article is part of a themed section on the pharmacol. of TRP channels.  To view the other articles in this section visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7lCuog2PFY7Vg90H21EOLACvtfcHk0lgTGcGQ1v0H2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvV2isb0%253D&md5=61596db81f2b065823cace10dc24c116</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12569%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DB.%2BI.%26aulast%3DOlah%26aufirst%3DA.%26aulast%3DSzollosi%26aufirst%3DA.%2BG.%26aulast%3DBiro%26aufirst%3DT.%26atitle%3DTRP%2520channels%2520in%2520the%2520skin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D2568%26epage%3D2581%26doi%3D10.1111%2Fbph.12569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">BirÃ², T.</span>; <span class="NLM_string-name">Paus, R.</span></span> <span> </span><span class="NLM_article-title">TRP channels in cutaneous biology in health and disease</span>. In  <i>TRP Channels in Health and Disease: Implications for Diagnosis and Therapy</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>, Ed.; <span class="NLM_publisher-name">Nova Science Publishers Inc</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">331</span>â <span class="NLM_lpage">361</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=331-361&author=T.+Bir%C3%B2&author=R.+Pausauthor=A.+Szallasi&title=TRP+Channels+in+Health+and+Disease%3A+Implications+for+Diagnosis+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBir%25C3%25B2%26aufirst%3DT.%26atitle%3DTRP%2520channels%2520in%2520cutaneous%2520biology%2520in%2520health%2520and%2520disease%26btitle%3DTRP%2520Channels%2520in%2520Health%2520and%2520Disease%253A%2520Implications%2520for%2520Diagnosis%2520and%2520Therapy%26aulast%3DSzallasi%26aufirst%3DA.%26pub%3DNova%2520Science%2520Publishers%2520Inc%26date%3D2011%26spage%3D331%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Caterina, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Z.</span></span> <span> </span><span class="NLM_article-title">TRP channels in skin biology and pathophysiology</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">77</span>â <span class="NLM_lpage">104</span>, <span class="refDoi">Â DOI: 10.3390/ph9040077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fph9040077" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=77-104&author=M.+J.+Caterinaauthor=Z.+Pang&title=TRP+channels+in+skin+biology+and+pathophysiology&doi=10.3390%2Fph9040077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3390%2Fph9040077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9040077%26sid%3Dliteratum%253Aachs%26aulast%3DCaterina%26aufirst%3DM.%2BJ.%26aulast%3DPang%26aufirst%3DZ.%26atitle%3DTRP%2520channels%2520in%2520skin%2520biology%2520and%2520pathophysiology%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D77%26epage%3D104%26doi%3D10.3390%2Fph9040077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gouin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LâHerondelle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebonvallet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Gall-Ianotto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BuhÃ©, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PlÃ©e-Gautier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CarrÃ¨, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefeuvre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misery, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGarrec, R.</span></span> <span> </span><span class="NLM_article-title">TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization</span>. <i>Protein Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">644</span>â <span class="NLM_lpage">661</span>, <span class="refDoi">Â DOI: 10.1007/s13238-017-0395-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1007%2Fs13238-017-0395-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=28364279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsV2ntbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=644-661&author=O.+Gouinauthor=K.+L%E2%80%99Herondelleauthor=N.+Lebonvalletauthor=C.+Le+Gall-Ianottoauthor=M.+Sakkaauthor=V.+Buh%C3%A9author=E.+Pl%C3%A9e-Gautierauthor=J.+L.+Carr%C3%A8author=L.+Lefeuvreauthor=L.+Miseryauthor=R.+LeGarrec&title=TRPV1+and+TRPA1+in+cutaneous+neurogenic+and+chronic+inflammation%3A+pro-inflammatory+response+induced+by+their+activation+and+their+sensitization&doi=10.1007%2Fs13238-017-0395-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization</span></div><div class="casAuthors">Gouin, Olivier; L'Herondelle, Killian; Lebonvallet, Nicolas; Le Gall-Ianotto, Christelle; Sakka, Mehdi; Buhe, Virginie; Plee-Gautier, Emmanuelle; Carre, Jean-Luc; Lefeuvre, Luc; Misery, Laurent; Le Garrec, Raphaele</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">644-661</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">Cutaneous neurogenic inflammation (CNI) is inflammation that is induced (or enhanced) in the skin by the release of neuropeptides from sensory nerve endings.  Clin. manifestations are mainly sensory and vascular disorders such as pruritus and erythema.  Transient receptor potential vanilloid 1 and ankyrin 1 (TRPV1 and TRPA1, resp.) are non-selective cation channels known to specifically participate in pain and CNI.  Both TRPV1 and TRPA1 are co-expressed in a large subset of sensory nerves, where they integrate numerous noxious stimuli.  It is now clear that the expression of both channels also extends far beyond the sensory nerves in the skin, occurring also in keratinocytes, mast cells, dendritic cells, and endothelial cells.  In these non-neuronal cells, TRPV1 and TRPA1 also act as nociceptive sensors and potentiate the inflammatory process.  This review discusses the role of TRPV1 and TRPA1 in the modulation of inflammatory genes that leads to or maintains CNI in sensory neurons and non-neuronal skin cells.  In addn., this review provides a summary of current research on the intracellular sensitization pathways of both TRP channels by other endogenous inflammatory mediators that promote the self-maintenance of CNI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUvZwJE9WRsbVg90H21EOLACvtfcHk0lj33ZM5B_wL2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsV2ntbY%253D&md5=5406a1a52afbee50b0291e821e9c79bf</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1007%2Fs13238-017-0395-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-017-0395-5%26sid%3Dliteratum%253Aachs%26aulast%3DGouin%26aufirst%3DO.%26aulast%3DL%25E2%2580%2599Herondelle%26aufirst%3DK.%26aulast%3DLebonvallet%26aufirst%3DN.%26aulast%3DLe%2BGall-Ianotto%26aufirst%3DC.%26aulast%3DSakka%26aufirst%3DM.%26aulast%3DBuh%25C3%25A9%26aufirst%3DV.%26aulast%3DPl%25C3%25A9e-Gautier%26aufirst%3DE.%26aulast%3DCarr%25C3%25A8%26aufirst%3DJ.%2BL.%26aulast%3DLefeuvre%26aufirst%3DL.%26aulast%3DMisery%26aufirst%3DL.%26aulast%3DLeGarrec%26aufirst%3DR.%26atitle%3DTRPV1%2520and%2520TRPA1%2520in%2520cutaneous%2520neurogenic%2520and%2520chronic%2520inflammation%253A%2520pro-inflammatory%2520response%2520induced%2520by%2520their%2520activation%2520and%2520their%2520sensitization%26jtitle%3DProtein%2520Cell%26date%3D2017%26volume%3D8%26spage%3D644%26epage%3D661%26doi%3D10.1007%2Fs13238-017-0395-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BirÃ², T.</span></span> <span> </span><span class="NLM_article-title">TRP channels and pruritus</span>. <i>Open Pain J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">62</span>â <span class="NLM_lpage">80</span>, <span class="refDoi">Â DOI: 10.2174/1876386301306010062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2174%2F1876386301306010062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=62-80&author=B.+I.+Tothauthor=T.+Bir%C3%B2&title=TRP+channels+and+pruritus&doi=10.2174%2F1876386301306010062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">TRP channels and pruritus</span></div><div class="casAuthors">Toth, Balazs I.; Biro, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Open Pain Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-80</span>CODEN:
                <span class="NLM_cas:coden">OPJPHI</span>;
        ISSN:<span class="NLM_cas:issn">1876-3863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Itch (pruritus) is one of the most often seen sensory phenomena in clin. practice.  Recent neurophysiol. findings proposed the existence of a novel pruriceptive system which includes a multitude of pruritogenic (itch-inducing) peripheral mediators, itch-selective pruriceptors, sensory afferent networks, spinal cord neurons, and certain central nervous system regions.  In this review, we first introduce major features of the pruriceptive system.  We then focus on defining the roles of transient receptor potential (TRP) ion channels in skin-coupled itch and provide compelling evidence that certain thermosensitive TRP channels (esp. TRPV1, TRPV3, TRPV4, and TRPA1) are indeed key players in pruritus pathogenesis.  Finally, we propose TRP-centered future exptl. directions towards the therapeutic targeting of TRP channels in the clin. management of itch.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJOArhBX-fJ7Vg90H21EOLACvtfcHk0lj33ZM5B_wL2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLnE&md5=4a1b34d5b9b4895f3e27cd7d627e56fb</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.2174%2F1876386301306010062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1876386301306010062%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DB.%2BI.%26aulast%3DBir%25C3%25B2%26aufirst%3DT.%26atitle%3DTRP%2520channels%2520and%2520pruritus%26jtitle%3DOpen%2520Pain%2520J.%26date%3D2013%26volume%3D6%26spage%3D62%26epage%3D80%26doi%3D10.2174%2F1876386301306010062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, P. M.</span></span> <span> </span><span class="NLM_article-title">Vanilloid (Capsaicin) receptors and mechanisms</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">159</span>â <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10353985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslChtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=159-212&author=A.+Szallasiauthor=P.+M.+Blumberg&title=Vanilloid+%28Capsaicin%29+receptors+and+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Vanilloid (capsaicin) receptors and mechanisms</span></div><div class="casAuthors">Szallasi, Arpad; Blumberg, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-211</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 560 refs.  Topics discussed include the targets and actions of capsaicin; direct evidence for a vanilloid (capsaicin) receptor (VR); anatomical localization and tissue specificity of VRs; evidence for multiple VRs; biochem. pharmacol. of VRs; requirements for ligand recognition by VRs; vanilloid mechanisms; diverse biol. actions of vanilloids; species-related differences in vanilloid actions; question on the existence of endogenous vanilloids; vanilloids in clin. practice; and the question on whether vanilloids are carcinogens, anticarcinogens or neither.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHzj_1onGyArVg90H21EOLACvtfcHk0lj33ZM5B_wL2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslChtr8%253D&md5=5d472de44d8ec7436ef3dba456f4dfe0</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DBlumberg%26aufirst%3DP.%2BM.%26atitle%3DVanilloid%2520%2528Capsaicin%2529%2520receptors%2520and%2520mechanisms%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26spage%3D159%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fattori, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, M. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossaneis, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho-Ribeiro, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verri, W. A.</span></span> <span> </span><span class="NLM_article-title">Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">844</span>â <span class="NLM_lpage">876</span>, <span class="refDoi">Â DOI: 10.3390/molecules21070844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fmolecules21070844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=27367653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OqtbzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=844-876&author=V.+Fattoriauthor=M.+S.+N.+Hohmannauthor=A.+C.+Rossaneisauthor=F.+A.+Pinho-Ribeiroauthor=W.+A.+Verri&title=Capsaicin%3A+current+understanding+of+its+mechanisms+and+therapy+of+pain+and+other+pre-clinical+and+clinical+uses&doi=10.3390%2Fmolecules21070844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin: current understanding of its mechanisms and therapy of pain and other pre clinical and clinical uses</span></div><div class="casAuthors">Fattori, Victor; Hohmann, Miriam S. N.; Rossaneis, Ana C.; Pinho-Ribeiro, Felipe A.; Verri, Waldiceu A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">844/1-844/33</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In this review, we discuss the importance of capsaicin to the current understanding of neuronal modulation of pain and explore the mechanisms of capsaicin-induced pain.  We will focus on the analgesic effects of capsaicin and its clin. applicability in treating pain.  Furthermore, we will draw attention to the rationale for other clin. therapeutic uses and implications of capsaicin in diseases such as obesity, diabetes, cardiovascular conditions, cancer, airway diseases, itch, gastric, and urol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKEU34UvVq7Vg90H21EOLACvtfcHk0lj33ZM5B_wL2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OqtbzK&md5=c9c4311e7e0e1b36ab7df8877dadd57f</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21070844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21070844%26sid%3Dliteratum%253Aachs%26aulast%3DFattori%26aufirst%3DV.%26aulast%3DHohmann%26aufirst%3DM.%2BS.%2BN.%26aulast%3DRossaneis%26aufirst%3DA.%2BC.%26aulast%3DPinho-Ribeiro%26aufirst%3DF.%2BA.%26aulast%3DVerri%26aufirst%3DW.%2BA.%26atitle%3DCapsaicin%253A%2520current%2520understanding%2520of%2520its%2520mechanisms%2520and%2520therapy%2520of%2520pain%2520and%2520other%2520pre-clinical%2520and%2520clinical%2520uses%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D844%26epage%3D876%26doi%3D10.3390%2Fmolecules21070844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, W.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>224</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">104</span>, <span class="refDoi">Â DOI: 10.1016/S0378-5173(01)00755-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2FS0378-5173%2801%2900755-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=11472818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlGgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2001&pages=89-104&author=Y.-Y.+Wangauthor=C.-T.+Hongauthor=W.-T.+Chiuauthor=J.-Y.+Fang&title=In+vitro+and+in+vivo+evaluations+of+topically+applied+capsaicin+and+nonivamide+from+hydrogels&doi=10.1016%2FS0378-5173%2801%2900755-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels</span></div><div class="casAuthors">Wang, Y.-Y.; Hong, C.-T.; Chiu, W.-T.; Fang, J.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">89-104</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was designed to investigate the in vitro and in vivo skin absorption of capsaicin and nonivamide from hydrogels.  Various commercialized creams of capsaicin were also compared with hydrogels.  Both skin stripping technique and Mexameter were applied to evaluate the level of capsaicin and nonivamide retained in stratum corneum (SC) and skin erythema in vivo.  The partition of drug between skin and the hydrogel matrix was considered to play an important role in the permeation process.  The in vitro permeation of capsaicin from hydrogels depends on the physicochem. nature and the concn. of the polymer used.  The incorporation of nonionic Pluronic F-127 polymer into hydrogels resulted in a retarded release of capsaicin.  On the other hand, the in vitro capsaicin permeation showed higher levels in cationic chitosan and anionic carboxymethyl-cellulose (CMC) hydrogels than cream bases.  The permeation of nonivamide was retarded at the late stage of in vitro application.  The inter-subject variation was more significant in the in vivo study than in vitro skin permeation expts.  The cream induced in vivo skin erythema depending on the drug concn., however, the dose-dependence was not obsd. in hydrogels.  Nonivamide-treated skin showed stronger erythema than capsaicin-treated skin.  The present study indicates that there is a moderate correlation between in vitro skin permeation and in vivo erythema responses of topically applied capsaicin and nonivamide.  The correlation between drug amt. in SC and skin erythema test in vivo was also obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67gRCf2ArwLVg90H21EOLACvtfcHk0lgyCZ-d3LiZbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlGgu7c%253D&md5=1e9ad4077d538ffc8bcc1aea13b99bff</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0378-5173%2801%2900755-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-5173%252801%252900755-4%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-Y.%26aulast%3DHong%26aufirst%3DC.-T.%26aulast%3DChiu%26aufirst%3DW.-T.%26aulast%3DFang%26aufirst%3DJ.-Y.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluations%2520of%2520topically%2520applied%2520capsaicin%2520and%2520nonivamide%2520from%2520hydrogels%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2001%26volume%3D224%26spage%3D89%26epage%3D104%26doi%3D10.1016%2FS0378-5173%2801%2900755-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">The two faces of capsaicin</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2809</span>â <span class="NLM_lpage">2814</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-10-3756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1158%2F0008-5472.CAN-10-3756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=21487045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWjsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2809-2814&author=A.+M.+Bodeauthor=Z.+Dong&title=The+two+faces+of+capsaicin&doi=10.1158%2F0008-5472.CAN-10-3756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Two Faces of Capsaicin</span></div><div class="casAuthors">Bode, Ann M.; Dong, Zigang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2809-2814</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is the principal pungent component in hot peppers, including red chili peppers, jalapen~os, and habaneros.  Consumed worldwide, capsaicin has a long and convoluted history of controversy about whether its consumption or topical application is entirely safe.  Conflicting epidemiol. data and basic research study results suggest that capsaicin can act as a carcinogen or as a cancer preventive agent.  Capsaicin is unique among naturally occurring irritant compds. because the initial neuronal excitation evoked is followed by a long-lasting refractory period, during which the previously excited neurons are no longer responsive to a broad range of stimuli.  This process is referred to as desensitization and has been exploited for its therapeutic potential.  Capsaicin-contg. creams have been in clin. use for many years to relieve a variety of painful conditions.  However, their effectiveness in pain relief is also highly debated and some adverse side effects have been reported.  We have found that chronic, long-term topical application of capsaicin increased skin carcinogenesis in mice treated with a tumor promoter.  These results might imply that caution should be exercised when using capsaicin-contg. topical applications in the presence of a tumor promoter, such as, for example, sunlight.  Cancer Res; 71(8); 2809-14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7KBpaS8G9PLVg90H21EOLACvtfcHk0lgyCZ-d3LiZbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWjsrw%253D&md5=bb7c1b853cf0adfd6ac4e478dafcda71</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3756%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DThe%2520two%2520faces%2520of%2520capsaicin%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2809%26epage%3D2814%26doi%3D10.1158%2F0008-5472.CAN-10-3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, D. M.</span></span> <span> </span><span class="NLM_article-title">Capsaicin 8% topical patch (Qutenza) - a review of the evidence</span>. <i>J. Pain Palliat. Care Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">32</span>â <span class="NLM_lpage">41</span>, <span class="refDoi">Â DOI: 10.3109/15360288.2010.547561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3109%2F15360288.2010.547561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=21426216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ovVCgsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=32-41&author=V.+M.+Jonesauthor=K.+A.+Mooreauthor=D.+M.+Peterson&title=Capsaicin+8%25+topical+patch+%28Qutenza%29+-+a+review+of+the+evidence&doi=10.3109%2F15360288.2010.547561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin 8% topical patch (Qutenza)--a review of the evidence</span></div><div class="casAuthors">Jones Virginia M; Moore Katrina A; Peterson David M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pain & palliative care pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Qutenza is a high-potency capsaicin (8%) topical patch, labeled for treating pain associated with postherpetic neuralgia (PHN).  Qutenza decreases pain sensation by reducing transient receptor potential vanilloid 1 (TRPV1) expression and decreasing the density of epidermal nerve fibers in the application area.  Systemic absorption from Qutenza is low.  Qutenza has not been directly compared to any other medications for the treating PHN.  Two pivotal clinical trials compared Qutenza to a control patch (0.04% capsaicin) in PHN.  The primary endpoint of both trials was the reduction in numeric pain rating scale (NPRS) score.  Qutenza reduced pain from baseline to weeks 2 to 8 (29.6% and 32% reductions) compared to control (19.9% and 24.4% reductions; P â¤ .01).  The improvement in NPRS scores persisted, with score reductions greater with Qutenza (29.9% and 32.3% reductions) compared to control (20.4% and 25% reductions; P â¤ .03) for the period 2 to 12 weeks.  Safety and efficacy of capsaicin 8% has been demonstrated in open-label trials for up to 48 weeks.  The most common adverse drug reactions occurring with capsaicin 8% are application site erythema (63%) and application site pain (42%).  Some patients experienced transient increases in blood pressure during Qutenza application.  Qutenza must be administered by a physician or under the close supervision of a physician.  Prior to application, pretreat the affected area with a topical anesthetic to reduce application site pain.  Some patients may require systemic analgesics during and after treatment for treatment-associated pain.  Applications of Qutenza can be repeated no sooner than once every 3 months, as needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaFFU2l-rPMJw7prLlxLOzfW6udTcc2eaSWzTTB_Aj67ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ovVCgsw%253D%253D&md5=679f0e450ce666ff2c011bad34c253ec</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3109%2F15360288.2010.547561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15360288.2010.547561%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DV.%2BM.%26aulast%3DMoore%26aufirst%3DK.%2BA.%26aulast%3DPeterson%26aufirst%3DD.%2BM.%26atitle%3DCapsaicin%25208%2525%2520topical%2520patch%2520%2528Qutenza%2529%2520-%2520a%2520review%2520of%2520the%2520evidence%26jtitle%3DJ.%2520Pain%2520Palliat.%2520Care%2520Pharmacother.%26date%3D2011%26volume%3D25%26spage%3D32%26epage%3D41%26doi%3D10.3109%2F15360288.2010.547561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. C.</span></span> <span> </span><span class="NLM_article-title">Resiniferatoxin: The evolution of the âmolecular scalpelâ for chronic pain relief</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">57</span>, <span class="refDoi">Â DOI: 10.3390/ph9030047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fph9030047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=47-57&author=D.+C.+Brown&title=Resiniferatoxin%3A+The+evolution+of+the+%E2%80%99molecular+scalpel%E2%80%99+for+chronic+pain+relief&doi=10.3390%2Fph9030047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fph9030047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9030047%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BC.%26atitle%3DResiniferatoxin%253A%2520The%2520evolution%2520of%2520the%2520%25E2%2580%2599molecular%2520scalpel%25E2%2580%2599%2520for%2520chronic%2520pain%2520relief%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D47%26epage%3D57%26doi%3D10.3390%2Fph9030047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, H. H.</span></span> <span> </span><span class="NLM_article-title">Activity-dependent targeting of TRPV1 with pore-permeating capsaicin analog</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">8497</span>â <span class="NLM_lpage">8502</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1018550108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1073%2Fpnas.1018550108" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=8497-8502&author=H.+Liauthor=S.+Wangauthor=A.+Y.+Chuangauthor=B.+E.+Cohenauthor=H.+H.+Chuang&title=Activity-dependent+targeting+of+TRPV1+with+pore-permeating+capsaicin+analog&doi=10.1073%2Fpnas.1018550108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1018550108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1018550108%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChuang%26aufirst%3DA.%2BY.%26aulast%3DCohen%26aufirst%3DB.%2BE.%26aulast%3DChuang%26aufirst%3DH.%2BH.%26atitle%3DActivity-dependent%2520targeting%2520of%2520TRPV1%2520with%2520pore-permeating%2520capsaicin%2520analog%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D8497%26epage%3D8502%26doi%3D10.1073%2Fpnas.1018550108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moshourab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauner, D.</span></span> <span> </span><span class="NLM_article-title">Photoswitchable fatty acids enable optical control of TRPV1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7118</span>â <span class="NLM_lpage">7128</span>, <span class="refDoi">Â DOI: 10.1038/ncomms8118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fncomms8118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=25997690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BC2Mfnt1Cquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7118-7128&author=J.+A.+Frankauthor=M.+Moroniauthor=R.+Moshourabauthor=M.+Sumserauthor=G.+R.+Lewinauthor=D.+Trauner&title=Photoswitchable+fatty+acids+enable+optical+control+of+TRPV1&doi=10.1038%2Fncomms8118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Photoswitchable fatty acids enable optical control of TRPV1</span></div><div class="casAuthors">Frank James Allen; Sumser Martin; Trauner Dirk; Moroni Mirko; Lewin Gary R; Moshourab Rabih</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7118</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fatty acids (FAs) are not only essential components of cellular energy storage and structure, but play crucial roles in signalling.  Here we present a toolkit of photoswitchable FA analogues (FAAzos) that incorporate an azobenzene photoswitch along the FA chain.  By modifying the FAAzos to resemble capsaicin, we prepare a series of photolipids targeting the Vanilloid Receptor 1 (TRPV1), a non-selective cation channel known for its role in nociception.  Several azo-capsaicin derivatives (AzCAs) emerge as photoswitchable agonists of TRPV1 that are relatively inactive in the dark and become active on irradiation with ultraviolet-A light.  This effect can be rapidly reversed by irradiation with blue light and permits the robust optical control of dorsal root ganglion neurons and C-fibre nociceptors with precision timing and kinetics not available with any other technique.  More generally, we expect that photolipids will find many applications in controlling biological pathways that rely on protein-lipid interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnB-unffqPQcyail4HZd-ifW6udTcc2ebDILKIEkRc1bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mfnt1Cquw%253D%253D&md5=34c274c1f24e547be3b7573eb2511f08</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncomms8118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8118%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DJ.%2BA.%26aulast%3DMoroni%26aufirst%3DM.%26aulast%3DMoshourab%26aufirst%3DR.%26aulast%3DSumser%26aufirst%3DM.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DTrauner%26aufirst%3DD.%26atitle%3DPhotoswitchable%2520fatty%2520acids%2520enable%2520optical%2520control%2520of%2520TRPV1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7118%26epage%3D7128%26doi%3D10.1038%2Fncomms8118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trevisani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, R.</span></span> <span> </span><span class="NLM_article-title">TRPV1 antagonists as analgesic agents</span>. <i>Open Pain J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">108</span>â <span class="NLM_lpage">118</span>, <span class="refDoi">Â DOI: 10.2174/1876386301306010108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2174%2F1876386301306010108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=108-118&author=M.+Trevisaniauthor=R.+Gatti&title=TRPV1+antagonists+as+analgesic+agents&doi=10.2174%2F1876386301306010108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 antagonists as analgesic agents</span></div><div class="casAuthors">Trevisani, Marcello; Gatti, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">Open Pain Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-118</span>CODEN:
                <span class="NLM_cas:coden">OPJPHI</span>;
        ISSN:<span class="NLM_cas:issn">1876-3863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The last decade (2001-2010), declared as the Decade of Pain Control and Research by the United States Congress, brought significantly advances in our understanding of pain biol.  Unfortunately, this has not translated into addnl. effective treatments of chronic pain conditions.  Chronic pain is a debilitating and complex clin. state usually assocd. with diabetic neuropathy, postherpetic neuralgia, low back pathol., fibromyalgia, and neurol. disorders.  Std. pain drugs, even narcotic opioid analgesic agents, often provide unsatisfactory pain relief while causing important side-effect such as sedation, tolerance, dependence, respiratory depression and constipation.  Furthermore, the effective management of chronic pain needs a multidisciplinary management approach and still represents one of the most urgent unmet medical need.  Recently, preclin. research has uncovered new mol. mechanisms underlying the generation and transduction of pain, many of which represent new targets for innovative pharmacol. interventions.  This review focuses on Transient Receptor Potential (TRP) Vanilloid Type 1 (TRPV1) channel as a target for treating chronic pain.  TRPV1 is a multifunctional ion channel involved in thermosensation (heat) and taste perception.  Importantly, TRPV1 also functions as a mol. integrator for a broad variety of seemingly unrelated noxious stimuli.  Indeed, TRPV1 is thought to be a major transducer of the thermal hyperalgesia that follows inflammation and/or tissue injury.  Desensitization to topical TRPV1 agonists (e.g. capsaicin creams and patches) has been in clin. use for decades to treat chronic painful conditions like diabetic neuropathy.  Most recently, a no. of potent, small mol. TRPV1 antagonists have been advanced into clin. trials for pain relief.  Perhaps not unexpectedly given the prominent role of TRPV1 in thermosensation, some of these antagonists showed worrisome adverse effects (hyperthermia and impaired noxious heat sensation) in humans, leading to their withdrawal from clin. trials.  However, recent reports of TRPV1 antagonists that do not affect core body temp. in preclin. species suggest a potential opportunity to reduce at least this important side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGmFhbqA4Cj7Vg90H21EOLACvtfcHk0li2jwbjfxVFjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLbN&md5=bfc5e776f62d16088483112982143959</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.2174%2F1876386301306010108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1876386301306010108%26sid%3Dliteratum%253Aachs%26aulast%3DTrevisani%26aufirst%3DM.%26aulast%3DGatti%26aufirst%3DR.%26atitle%3DTRPV1%2520antagonists%2520as%2520analgesic%2520agents%26jtitle%3DOpen%2520Pain%2520J.%26date%3D2013%26volume%3D6%26spage%3D108%26epage%3D118%26doi%3D10.2174%2F1876386301306010108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortright, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eid, S. R.</span></span> <span> </span><span class="NLM_article-title">The vanilloid receptor TRPV1:10 years from channel cloning to antagonist proof-of-concept</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">357</span>â <span class="NLM_lpage">372</span>, <span class="refDoi">Â DOI: 10.1038/nrd2280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fnrd2280" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=357-372&author=A.+Szallasiauthor=D.+N.+Cortrightauthor=C.+A.+Blumauthor=S.+R.+Eid&title=The+vanilloid+receptor+TRPV1%3A10+years+from+channel+cloning+to+antagonist+proof-of-concept&doi=10.1038%2Fnrd2280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2280%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DCortright%26aufirst%3DD.%2BN.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DEid%26aufirst%3DS.%2BR.%26atitle%3DThe%2520vanilloid%2520receptor%2520TRPV1%253A10%2520years%2520from%2520channel%2520cloning%2520to%2520antagonist%2520proof-of-concept%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D357%26epage%3D372%26doi%3D10.1038%2Fnrd2280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span> <span> </span><span class="NLM_article-title">Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2717</span>â <span class="NLM_lpage">2723</span>, <span class="refDoi">Â DOI: 10.1021/jm030560j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030560j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2717-2723&author=A.+Szallasiauthor=G.+Appendino&title=Vanilloid+receptor+TRPV1+antagonists+as+the+next+generation+of+painkillers.+Are+we+putting+the+cart+before+the+horse%3F&doi=10.1021%2Fjm030560j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm030560j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030560j%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DVanilloid%2520receptor%2520TRPV1%2520antagonists%2520as%2520the%2520next%2520generation%2520of%2520painkillers.%2520Are%2520we%2520putting%2520the%2520cart%2520before%2520the%2520horse%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2717%26epage%3D2723%26doi%3D10.1021%2Fjm030560j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span> <span> </span><span class="NLM_article-title">Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1576</span>â <span class="NLM_lpage">1579</span>, <span class="refDoi">Â DOI: 10.1038/jid.2011.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fjid.2011.87" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2011&pages=1576-1579&author=J.-W.+Yunauthor=F.+Seoauthor=F.+Jangauthor=F.+Kohauthor=S.+Baeauthor=C.+Parkauthor=P.+Lim&title=Antipruritic+effects+of+TRPV1+antagonist+in+murine+atopic+dermatitis+and+itching+models&doi=10.1038%2Fjid.2011.87"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1038%2Fjid.2011.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2011.87%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DJ.-W.%26aulast%3DSeo%26aufirst%3DF.%26aulast%3DJang%26aufirst%3DF.%26aulast%3DKoh%26aufirst%3DF.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26atitle%3DAntipruritic%2520effects%2520of%2520TRPV1%2520antagonist%2520in%2520murine%2520atopic%2520dermatitis%2520and%2520itching%2520models%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2011%26volume%3D131%26spage%3D1576%26epage%3D1579%26doi%3D10.1038%2Fjid.2011.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-H.</span></span> <span> </span><span class="NLM_article-title">Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin disease</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">393</span>â <span class="NLM_lpage">396</span>, <span class="refDoi">Â DOI: 10.1007/s12272-012-0321-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1007%2Fs12272-012-0321-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=22477184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVKgs7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=393-396&author=K.+M.+Limauthor=Y.-H.+Park&title=Development+of+PAC-14028%2C+a+novel+transient+receptor+potential+vanilloid+type+1+%28TRPV1%29+channel+antagonist+as+a+new+drug+for+refractory+skin+disease&doi=10.1007%2Fs12272-012-0321-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12eR"><div class="casContent"><span class="casTitleNuber">12e</span><div class="casTitle"><span class="NLM_cas:atitle">Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases</span></div><div class="casAuthors">Lim, Kyung-Min; Park, Young-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-396</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">The transient receptor potential vanilloid 1 (TRPV1) is a member of nonselective cation channels and was implicated in the progression of neurogenic inflammation and nociception.  Through the synthesis of over 2,000 new compds., a novel non-vanilloid TRPV1 antagonist PAC-14028 was discovered.  As well as ideal physicochem. and pharmacokinetic properties, PAC-14028 showed meaningful efficacies against diverse disease models that include visceral pain, inflammatory bowel disease, and inflammatory pain.  Of note, PAC-14028 effectively attenuates atopic dermatitis and pruritus without significant adverse effects, which is a substantial benefit over conventional pharmacotherapy.  This report introduces the potential of a novel TRPV1 antagonist PAC-14028 as a new drug for atopic dermatitis and pruritus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo9BrFnXwl8rVg90H21EOLACvtfcHk0lhk5Wa-up0G-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVKgs7o%253D&md5=9cbd36010540e589e62a7adba8f8bb93</span></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0321-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0321-6%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BM.%26aulast%3DPark%26aufirst%3DY.-H.%26atitle%3DDevelopment%2520of%2520PAC-14028%252C%2520a%2520novel%2520transient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520%2528TRPV1%2529%2520channel%2520antagonist%2520as%2520a%2520new%2520drug%2520for%2520refractory%2520skin%2520disease%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2012%26volume%3D35%26spage%3D393%26epage%3D396%26doi%3D10.1007%2Fs12272-012-0321-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tronino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offerta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostacolo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Caro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puglia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, P.</span></span> <span> </span><span class="NLM_article-title">Puglia, C.; Blasi, P. Nanoparticles prolong <i>N</i>-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">311</span>â <span class="NLM_lpage">317</span>, <span class="refDoi">Â DOI: 10.1016/j.colsurfb.2016.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.colsurfb.2016.01.058" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2016&pages=311-317&author=C.+Troninoauthor=A.+Offertaauthor=C.+Ostacoloauthor=R.+Russoauthor=C.+De+Caroauthor=A.+Calignanoauthor=C.+Pugliaauthor=P.+Blasi&title=Puglia%2C+C.%3B+Blasi%2C+P.+Nanoparticles+prolong+N-palmitoylethanolamide+anti-inflammatory+and+analgesic+effects+in+vivo&doi=10.1016%2Fj.colsurfb.2016.01.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2016.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2016.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DTronino%26aufirst%3DC.%26aulast%3DOfferta%26aufirst%3DA.%26aulast%3DOstacolo%26aufirst%3DC.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DDe%2BCaro%26aufirst%3DC.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPuglia%26aufirst%3DC.%26aulast%3DBlasi%26aufirst%3DP.%26atitle%3DPuglia%252C%2520C.%253B%2520Blasi%252C%2520P.%2520Nanoparticles%2520prolong%2520N-palmitoylethanolamide%2520anti-inflammatory%2520and%2520analgesic%2520effects%2520in%2520vivo%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2016%26volume%3D141%26spage%3D311%26epage%3D317%26doi%3D10.1016%2Fj.colsurfb.2016.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Banvolgyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palinkas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helyes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozsgai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szolcsanyi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinter, E.</span></span> <span> </span><span class="NLM_article-title">Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">86</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.jneuroim.2005.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.jneuroim.2005.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=16188326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BD2MrnvFKqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2005&pages=86-96&author=A.+Banvolgyiauthor=L.+Palinkasauthor=T.+Berkiauthor=N.+Clarkauthor=A.+D.+Grantauthor=Z.+Helyesauthor=G.+Pozsgaiauthor=J.+Szolcsanyiauthor=S.+D.+Brainauthor=E.+Pinter&title=Evidence+for+a+novel+protective+role+of+the+vanilloid+TRPV1+receptor+in+a+cutaneous+contact+allergic+dermatitis+model&doi=10.1016%2Fj.jneuroim.2005.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12gR"><div class="casContent"><span class="casTitleNuber">12g</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model</span></div><div class="casAuthors">Banvolgyi Agnes; Palinkas Laszlo; Berki Timea; Clark Natalie; Grant Andrew D; Helyes Zsuzsanna; Pozsgai Gabor; Szolcsanyi Janos; Brain Susan D; Pinter Erika</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroimmunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">86-96</span>
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    </div><div class="casAbstract">The purpose of this study was to examine the involvement of the transient receptor potential vanilloid receptor 1 (TRPV1) in inflammatory processes observed in murine allergic contact dermatitis (ACD).  Oxazolone-induced ACD evoked a significant ear swelling after 24-72 h.  It was augmented in TRPV1 knockout mice at all time points and supported by histological analysis and measure of TNF-alpha.  However, tissue swelling and cytokine generation was significantly reduced in both neurokinin 1 receptor and calcitonin gene-related peptide (CGRP) knockout mice.  A protective involvement of the TRPV1 receptor was identified of contact dermatitis distinct from mechanisms involving the major pro-inflammatory neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUYRLAtoCrkzAEfvC7EH1LfW6udTcc2eaypP93k-sMVbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrnvFKqug%253D%253D&md5=4d87ceee05f8e55444dc0bb3e9fc6c5d</span></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2005.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2005.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DBanvolgyi%26aufirst%3DA.%26aulast%3DPalinkas%26aufirst%3DL.%26aulast%3DBerki%26aufirst%3DT.%26aulast%3DClark%26aufirst%3DN.%26aulast%3DGrant%26aufirst%3DA.%2BD.%26aulast%3DHelyes%26aufirst%3DZ.%26aulast%3DPozsgai%26aufirst%3DG.%26aulast%3DSzolcsanyi%26aufirst%3DJ.%26aulast%3DBrain%26aufirst%3DS.%2BD.%26aulast%3DPinter%26aufirst%3DE.%26atitle%3DEvidence%2520for%2520a%2520novel%2520protective%2520role%2520of%2520the%2520vanilloid%2520TRPV1%2520receptor%2520in%2520a%2520cutaneous%2520contact%2520allergic%2520dermatitis%2520model%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2005%26volume%3D169%26spage%3D86%26epage%3D96%26doi%3D10.1016%2Fj.jneuroim.2005.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Transient receptor potential vanilloid type 1 antagonists: a patent review (2011â2014)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">291</span>â <span class="NLM_lpage">318</span>, <span class="refDoi">Â DOI: 10.1517/13543776.2015.1008449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1517%2F13543776.2015.1008449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=25666693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit12ltb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=291-318&author=Y.+Leeauthor=S.+Hongauthor=M.+Cuiauthor=P.+K.+Sharmaauthor=J.+Leeauthor=S.+Choi&title=Transient+receptor+potential+vanilloid+type+1+antagonists%3A+a+patent+review+%282011%E2%80%932014%29&doi=10.1517%2F13543776.2015.1008449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014)</span></div><div class="casAuthors">Lee, Yoonji; Hong, Sunhye; Cui, Minghua; Sharma, Pankaz K.; Lee, Jeewoo; Choi, Sun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-318</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Transient receptor potential vanilloid type 1 (TRPV1) is a nonselective cation channel that can be activated by noxious heat, low pH and vanilloid compds. such as capsaicin.  Since TRPV1 acts as an integrator of painful stimuli, TRPV1 antagonists can be used as promising therapeutics for new types of analgesics.  Areas covered: This review article covers the patents that claim TRPV1 antagonists and were published during 2011 - 2014.  The patent evaluation is organized according to the applicant companies, and the representative chem. entities with important in vitro and in vivo data are summarized.  Expert opinion: Many pharmaceutical companies showed promising results in the discovery of potent small mol. TRPV1 antagonists, and recently, a no. of small mol. TRPV1 antagonists have been advanced into clin. trials.  Unfortunately, several candidate mols. showed crit. side effects such as hyperthermia and impaired noxious heat sensation in humans, leading to their withdrawal from clin. trials.  Some TRPV1 antagonists patented in recent years (2011 - 2014) overcame these undesirable side effects, making the development of TRPV1 antagonists much more promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtjpXsyQalxbVg90H21EOLACvtfcHk0lhyUUuhPC20_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit12ltb8%253D&md5=6150e80eeacea466be516a03367829ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1517%2F13543776.2015.1008449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2015.1008449%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DP.%2BK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DTransient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520antagonists%253A%2520a%2520patent%2520review%2520%25282011%25E2%2580%25932014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26spage%3D291%26epage%3D318%26doi%3D10.1517%2F13543776.2015.1008449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gavva, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surapaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akrami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesslak, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palluconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanovsky, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davar, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">202</span>â <span class="NLM_lpage">210</span>, <span class="refDoi">Â DOI: 10.1016/j.pain.2008.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.pain.2008.01.024" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2008&pages=202-210&author=N.+R.+Gavvaauthor=J.+J.+Treanorauthor=A.+Garamiauthor=L.+Fangauthor=S.+Surapaneniauthor=A.+Akramiauthor=F.+Alvarezauthor=A.+Bakauthor=M.+Darlingauthor=A.+Goreauthor=G.+R.+Jangauthor=J.+P.+Kesslakauthor=L.+Niauthor=M.+H.+Normanauthor=G.+Palluconiauthor=M.+J.+Roseauthor=M.+Salfiauthor=E.+Tanauthor=A.+A.+Romanovskyauthor=C.+Banfieldauthor=G.+Davar&title=Pharmacological+blockade+of+the+vanilloid+receptor+TRPV1+elicits+marked+hyperthermia+in+humans&doi=10.1016%2Fj.pain.2008.01.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2008.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2008.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DGavva%26aufirst%3DN.%2BR.%26aulast%3DTreanor%26aufirst%3DJ.%2BJ.%26aulast%3DGarami%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DSurapaneni%26aufirst%3DS.%26aulast%3DAkrami%26aufirst%3DA.%26aulast%3DAlvarez%26aufirst%3DF.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DDarling%26aufirst%3DM.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DJang%26aufirst%3DG.%2BR.%26aulast%3DKesslak%26aufirst%3DJ.%2BP.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DPalluconi%26aufirst%3DG.%26aulast%3DRose%26aufirst%3DM.%2BJ.%26aulast%3DSalfi%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DRomanovsky%26aufirst%3DA.%2BA.%26aulast%3DBanfield%26aufirst%3DC.%26aulast%3DDavar%26aufirst%3DG.%26atitle%3DPharmacological%2520blockade%2520of%2520the%2520vanilloid%2520receptor%2520TRPV1%2520elicits%2520marked%2520hyperthermia%2520in%2520humans%26jtitle%3DPain%26date%3D2008%26volume%3D136%26spage%3D202%26epage%3D210%26doi%3D10.1016%2Fj.pain.2008.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zykova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carper, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langfald, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">779</span>â <span class="NLM_lpage">785</span>, <span class="refDoi">Â DOI: 10.1093/carcin/bgr037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1093%2Fcarcin%2Fbgr037" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=779-785&author=S.+Liauthor=A.+M.+Bodeauthor=F.+Zhuauthor=K.+Liuauthor=J.+Zhangauthor=M.+O.+Kimauthor=K.+Reddyauthor=T.+Zykovaauthor=W.-Y.+Maauthor=A.+L.+Carperauthor=A.+K.+Langfaldauthor=Z.+Dong&title=TRPV1-antagonist+AMG9810+promotes+mouse+skin+tumorigenesis+through+EGFR%2FAkt+signaling&doi=10.1093%2Fcarcin%2Fbgr037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgr037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgr037%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BO.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DZykova%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DW.-Y.%26aulast%3DCarper%26aufirst%3DA.%2BL.%26aulast%3DLangfald%26aufirst%3DA.%2BK.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DTRPV1-antagonist%2520AMG9810%2520promotes%2520mouse%2520skin%2520tumorigenesis%2520through%2520EGFR%252FAkt%2520signaling%26jtitle%3DCarcinogenesis%26date%3D2011%26volume%3D32%26spage%3D779%26epage%3D785%26doi%3D10.1093%2Fcarcin%2Fbgr037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatfield, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidgeon-Hart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, I.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagg, R.</span></span> <span> </span><span class="NLM_article-title">Do TRPV1 antagonists increase the risk for skin tumourigenesis? A collaborative in vitro and in vivo assessment</span>. <i>Cell Biol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">143</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1007/s10565-017-9407-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1007%2Fs10565-017-9407-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=28815372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCntb%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=143-162&author=M.+Parkauthor=A.+A.+Naidooauthor=A.+Burnsauthor=J.+K.+Choiauthor=K.+M.+Gatfieldauthor=M.+Vidgeon-Hartauthor=I.-H.+Baeauthor=C.+S.+Leeauthor=G.+Choiauthor=A.+J.+Powellauthor=Y.-H.+Parkauthor=R.+Fagg&title=Do+TRPV1+antagonists+increase+the+risk+for+skin+tumourigenesis%3F+A+collaborative+in+vitro+and+in+vivo+assessment&doi=10.1007%2Fs10565-017-9407-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Do TRPV1 antagonists increase the risk for skin tumourigenesis? A collaborative in vitro and in vivo assessment</span></div><div class="casAuthors">Park, Miyoung; Naidoo, Anita A.; Burns, Angie; Choi, Jin Kyu; Gatfield, Kelly M.; Vidgeon-Hart, Martin; Bae, Il-Hong; Lee, Chang Seok; Choi, Gyeyoung; Powell, Andrew J.; Park, Young-Ho; Fagg, Rajni</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-162</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A recent hypothesis suggesting that the pharmacol. target TRPV1 (transient receptor potential vanilloid subfamily, member 1) may function as a tumor suppressor, which potentially impacts the development of TRPV1 antagonist therapeutics for a range of conditions.  However, little is known about the long-term physiol. effects of TRPV1 blockade in the skin.  In vitro and in vivo studies suggested that the potent TRPV1 competitive antagonist AMG-9810 promoted proliferation in N/TERT1 cells (telomerase-immortalised primary human keratinocytes 1) and tumor development in mouse skin that was mediated through EGFR/Akt/mTOR signalling.  We attempted to reproduce the reported in vitro and in vivo findings to further explore this hypothesis to understand the underlying mechanism and the risk assocd. with TRPV1 antagonism in the skin.  In vitro proliferation studies using multiple methods and topical application with AMG-9810 and structurally similar TRPV1 antagonists such as SB-705498 and PAC-14028 were performed.  Although we confirmed expression of TRPV1 in primary human epidermal keratinocytes (HEKn) and spontaneously immortalised human keratinocytes (HaCaT), we were unable to demonstrate cell proliferation in either cell type or any clear evidence of increased expression of proteins in the EGFR/Akt/mTOR signalling pathway with these mols.  We were also unable to demonstrate skin tumor promotion or underlying mol. mechanisms involved in the EGFR/Akt/mTOR signalling pathway in a single-dose and two-stage carcinogenesis mouse study treated with TRPV1 antagonists.  In conclusion, our data suggest that inhibiting the pharmacol. function of TRPV1 in skin by specific antagonists has not been considered to be indicative of skin tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-VatNsWSUzLVg90H21EOLACvtfcHk0lg2uxTyUocwuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCntb%252FM&md5=845a361fdb410f12889272cd80abd77a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs10565-017-9407-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10565-017-9407-8%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%26aulast%3DNaidoo%26aufirst%3DA.%2BA.%26aulast%3DBurns%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DGatfield%26aufirst%3DK.%2BM.%26aulast%3DVidgeon-Hart%26aufirst%3DM.%26aulast%3DBae%26aufirst%3DI.-H.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChoi%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DA.%2BJ.%26aulast%3DPark%26aufirst%3DY.-H.%26aulast%3DFagg%26aufirst%3DR.%26atitle%3DDo%2520TRPV1%2520antagonists%2520increase%2520the%2520risk%2520for%2520skin%2520tumourigenesis%253F%2520A%2520collaborative%2520in%2520vitro%2520and%2520in%2520vivo%2520assessment%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2018%26volume%3D34%26spage%3D143%26epage%3D162%26doi%3D10.1007%2Fs10565-017-9407-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">Soft drug design: general principles and recent applications</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">58</span>â <span class="NLM_lpage">101</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10608921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=58-101&author=N.+Bodorauthor=P.+Buchwald&title=Soft+drug+design%3A+general+principles+and+recent+applications&doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drug design: general principles and recent applications</span></div><div class="casAuthors">Bodor, Nicholas; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-101</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 208 refs.  Soft drug design represents a new approach aimed to design safer drugs with an increased therapeutic index by integrating metab. considerations into the drug design process.  Soft drugs are new therapeutic agents that undergo predictable metab. to inactive metabolites after exerting their therapeutic effect.  Hence, they are obtained by building into the mol., in addn. to the activity, the most desired way in which the mol. is to be deactivated and detoxified.  In an attempt to systematize and summarize the related work done in a no. of labs., including ours, the present review presents an overview of the general soft drug design principles and provides a variety of specific examples to illustrate the concepts.  A no. of already marketed drugs, such as esmolol, remifentanil, or loteprednol etabonate, resulted from the successful application of such design principles.  Many other promising drug candidates are currently under investigation in a variety of fields including possible soft antimicrobials, anticholinergics, corticosteroids, Î²-blockers, analgetics, ACE inhibitors, antiarrhythmics, and others.  Whenever possible, pharmacokinetic and pharmacodynamic properties are briefly summarized and compared to those of other compds. used in the same field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphV1vhXwTl8LVg90H21EOLACvtfcHk0lg2uxTyUocwuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D&md5=e0ca493ba31d001e62a759be0fc4bcc8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200001%252920%253A1%253C58%253A%253AAID-MED3%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBodor%26aufirst%3DN.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSoft%2520drug%2520design%253A%2520general%2520principles%2520and%2520recent%2520applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D58%26epage%3D101%26doi%3D10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DÃ¶mling, A.</span></span> <span> </span><span class="NLM_article-title">Recent developments in isocyanide based multicomponent reactions in applied chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">17</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1021/cr0505728</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0505728" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FhslyntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=17-89&author=A.+D%C3%B6mling&title=Recent+developments+in+isocyanide+based+multicomponent+reactions+in+applied+chemistry&doi=10.1021%2Fcr0505728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in isocyanide based multicomponent reactions in applied chemistry</span></div><div class="casAuthors">Domling Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-89</span>
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtCMEx7SbgjiM8MEzWGjS9fW6udTcc2ebsD_jcV0J4Pbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FhslyntA%253D%253D&md5=33b233fa9ca718d7e0e6db6fee49e5fd</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fcr0505728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0505728%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25B6mling%26aufirst%3DA.%26atitle%3DRecent%2520developments%2520in%2520isocyanide%2520based%2520multicomponent%2520reactions%2520in%2520applied%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D17%26epage%3D89%26doi%3D10.1021%2Fcr0505728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Domling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of multicomponent reactions</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">3083</span>â <span class="NLM_lpage">3135</span>, <span class="refDoi">Â DOI: 10.1021/cr100233r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100233r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ehsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=3083-3135&author=A.+Domlingauthor=W.+Wangauthor=K.+Wang&title=Chemistry+and+biology+of+multicomponent+reactions&doi=10.1021%2Fcr100233r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and Biology Of Multicomponent Reactions</span></div><div class="casAuthors">Domling, Alexander; Wang, Wei; Wang, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3083-3135</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors discuss the usefulness of multicomponent reactions (MCR) in medicinal chem. for drug discovery purposes.  An advantage of MCR chem. is the very large chem. space, probably the largest available chem. space for drug discovery and medicinal chem. purposes.  This also poses very high demands for the right choice of the discovery strategy, for example, high throughput screening or structure-based design.  A promising and complementary strategy which leverages the strength of MCR chem. is the use of computation screening and genetic algorithms.  In addn., MCRs can be of great value in natural product total synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwcvlT6_uy4rVg90H21EOLACvtfcHk0liExXUU1dbnow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ehsbg%253D&md5=09577e3204db313fdb16807df21ab724</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fcr100233r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100233r%26sid%3Dliteratum%253Aachs%26aulast%3DDomling%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DChemistry%2520and%2520biology%2520of%2520multicomponent%2520reactions%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D3083%26epage%3D3135%26doi%3D10.1021%2Fcr100233r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Wang, M.</span></span> <i>Multicomponent Reactions in Organic Synthesis</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co.</span>: <span class="NLM_publisher-loc">Weinheim</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Zhu&author=Q.+Wang&author=M.+Wang&title=Multicomponent+Reactions+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26btitle%3DMulticomponent%2520Reactions%2520in%2520Organic%2520Synthesis%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, V.</span></span> <span> </span><span class="NLM_article-title">Multi-component reactions: emerging chemistry in drug discovery âfrom xylocain to crixivanâ</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">80</span>, <span class="refDoi">Â DOI: 10.2174/0929867033368600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2174%2F0929867033368600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=12570721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVSrtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=51-80&author=C.+Hulmeauthor=V.+Gore&title=Multi-component+reactions%3A+emerging+chemistry+in+drug+discovery+%E2%80%99from+xylocain+to+crixivan%E2%80%99&doi=10.2174%2F0929867033368600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-component reactions: emerging chemistry in drug discovery from xylocain to crixivan</span></div><div class="casAuthors">Hulme, Christopher; Gore, Vijay</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-80</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  With the recent emergence of combinatorial chem. and high-speed parallel synthesis for drug discovery applications, the multi-component reaction (MCR) has seen a resurgence of interest.  Easily automated one-pot reactions, such as the Ugi and Passerini reactions, are powerful tools for producing diverse arrays of compds., often in one step and high yield.  Despite this synthetic potential, the Ugi reaction is limited by producing products that are flexible and peptide-like, often being classified as "non drug-like".  This review details developments of new, highly atom-economic MCR derived chem. methods, which enable the fast and efficient prodn. of chem. libraries comprised of a variety of biol. relevant templates.  Representative examples will also be given demonstrating the successful impact of MCR combinatorial methods at different stages of the lead discovery, lead optimization and pre-clin. process development arenas.  This will include applications spanning biol. tools, natural products and natural product-like diversity, traditional small mol. and "biotech" therapeutics resp.  In particular, this review will focus on applications of isocyanide based MCR (IMCR) reactions.  A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe0RqQebnFkrVg90H21EOLACvtfcHk0liExXUU1dbnow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVSrtA%253D%253D&md5=4a38e495aa941010cd026d2ace1004d5</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.2174%2F0929867033368600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033368600%26sid%3Dliteratum%253Aachs%26aulast%3DHulme%26aufirst%3DC.%26aulast%3DGore%26aufirst%3DV.%26atitle%3DMulti-component%2520reactions%253A%2520emerging%2520chemistry%2520in%2520drug%2520discovery%2520%25E2%2580%2599from%2520xylocain%2520to%2520crixivan%25E2%2580%2599%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D51%26epage%3D80%26doi%3D10.2174%2F0929867033368600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ruijter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orru, R. V.</span></span> <span> </span><span class="NLM_article-title">Multicomponent reactions - opportunities for the pharmaceutical industry</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e15</span>â <span class="NLM_lpage">e20</span>, <span class="refDoi">Â DOI: 10.1016/j.ddtec.2012.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.ddtec.2012.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=24050225" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=e15-e20&author=E.+Ruijterauthor=R.+V.+Orru&title=Multicomponent+reactions+-+opportunities+for+the+pharmaceutical+industry&doi=10.1016%2Fj.ddtec.2012.10.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2012.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2012.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DRuijter%26aufirst%3DE.%26aulast%3DOrru%26aufirst%3DR.%2BV.%26atitle%3DMulticomponent%2520reactions%2520-%2520opportunities%2520for%2520the%2520pharmaceutical%2520industry%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2013%26volume%3D10%26spage%3De15%26epage%3De20%26doi%3D10.1016%2Fj.ddtec.2012.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Passerini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isonitrili, I.</span></span> <span> </span><span class="NLM_article-title">Composti del pâisonitrileazobenzene con acetone e acidoacetico</span>. <i>Gazz. Chim. Ital.</i> <span class="NLM_year" style="font-weight: bold;">1921</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">126</span>â <span class="NLM_lpage">129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1921&pages=126-129&author=M.+Passeriniauthor=I.+Isonitrili&title=Composti+del+p%E2%80%93isonitrileazobenzene+con+acetone+e+acidoacetico"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasserini%26aufirst%3DM.%26aulast%3DIsonitrili%26aufirst%3DI.%26atitle%3DComposti%2520del%2520p%25E2%2580%2593isonitrileazobenzene%2520con%2520acetone%2520e%2520acidoacetico%26jtitle%3DGazz.%2520Chim.%2520Ital.%26date%3D1921%26volume%3D51%26spage%3D126%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, L.</span>; <span class="NLM_string-name">Riva, R.</span></span> <span> </span><span class="NLM_article-title">The Passerini reaction</span>. In  <i>Organic Reactions</i>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2005</span>; Vol.  <span class="NLM_volume">65</span>, pp  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1002%2F0471264180.or065.01" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=1-140&author=L.+Banfi&author=R.+Riva&title=Organic+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or065.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471264180.or065.01%26sid%3Dliteratum%253Aachs%26aulast%3DBanfi%26aufirst%3DL.%26atitle%3DThe%2520Passerini%2520reaction%26btitle%3DOrganic%2520Reactions%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2005%26volume%3D65%26spage%3D1%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarov-Yarovoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span> <span> </span><span class="NLM_article-title">Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">518</span>â <span class="NLM_lpage">524</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fnchembio.1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=26053297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ygsbrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=518-524&author=F.+Yangauthor=W.+Chengauthor=W.+Yangauthor=P.+Yuauthor=Z.+Songauthor=V.+Yarov-Yarovoyauthor=J.+Zhengauthor=X.+Xiao&title=Structural+mechanism+underlying+capsaicin+binding+and+activation+of+the+TRPV1+ion+channel&doi=10.1038%2Fnchembio.1835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel</span></div><div class="casAuthors">Yang, Fan; Xiao, Xian; Cheng, Wei; Yang, Wei; Yu, Peilin; Song, Zhenzhen; Yarov-Yarovoy, Vladimir; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">518-524</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Capsaicin (CAP) adds spiciness to foods by activating TRPV1 channel with exquisite potency and selectivity.  Although a capsaicin-bound channel structure was previously resolved by cryo-EM at 4.2- to 4.5-Ã resoln., capsaicin was registered as a small electron d., reflecting neither its chem. structure nor specific ligand-channel interactions - important details required for mechanistic understanding.  We obtained the missing at.-level details by iterative computation and confirmed them by systematic site-specific functional tests.  We obsd. that the bound capsaicin takes a 'tail-up, head-down' configuration.  The vanillyl and amide groups form specific interactions to anchor its bound position, while the aliph. tail may sample a range of conformations, making it invisible in cryo-EM images.  Capsaicin stabilizes TRPV1's open (O) state by 'pull-and-contact' interactions between the vanillyl group and the S4-S5 linker.  Our study provides a structural mechanism for the agonistic function of capsaicin and its analogs, and demonstrates an effective approach to obtain at.-level information from cryo-EM structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjPDL4IyhjWrVg90H21EOLACvtfcHk0liExXUU1dbnow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ygsbrN&md5=3febf24841cb0c3e91b8449de45c4563</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1835%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DYarov-Yarovoy%26aufirst%3DV.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DX.%26atitle%3DStructural%2520mechanism%2520underlying%2520capsaicin%2520binding%2520and%2520activation%2520of%2520the%2520TRPV1%2520ion%2520channel%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D518%26epage%3D524%26doi%3D10.1038%2Fnchembio.1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foged, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, C.</span></span> <span> </span><span class="NLM_article-title">Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1124/mol.59.1.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fmol.59.1.9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=9-15&author=P.+Wahlauthor=C.+Fogedauthor=S.+Tullinauthor=C.+Thomsen&title=Iodo-resiniferatoxin%2C+a+new+potent+vanilloid+receptor+antagonist&doi=10.1124%2Fmol.59.1.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.1.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.1.9%26sid%3Dliteratum%253Aachs%26aulast%3DWahl%26aufirst%3DP.%26aulast%3DFoged%26aufirst%3DC.%26aulast%3DTullin%26aufirst%3DS.%26aulast%3DThomsen%26aufirst%3DC.%26atitle%3DIodo-resiniferatoxin%252C%2520a%2520new%2520potent%2520vanilloid%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D9%26epage%3D15%26doi%3D10.1124%2Fmol.59.1.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daddario, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriello, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">The taming of capsaicin. Reversal of the vanilloid activity of N-Acylvanillamines by aromatic iodination</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4663</span>â <span class="NLM_lpage">4669</span>, <span class="refDoi">Â DOI: 10.1021/jm050139q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050139q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFSmtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4663-4669&author=G.+Appendinoauthor=N.+Daddarioauthor=A.+Minassiauthor=A.+S.+Morielloauthor=L.+De+Petrocellisauthor=V.+Di+Marzo&title=The+taming+of+capsaicin.+Reversal+of+the+vanilloid+activity+of+N-Acylvanillamines+by+aromatic+iodination&doi=10.1021%2Fjm050139q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Taming of Capsaicin. Reversal of the Vanilloid Activity of N-Acylvanillamines by Aromatic Iodination</span></div><div class="casAuthors">Appendino, Giovanni; Daddario, Nives; Minassi, Alberto; Moriello, Aniello Schiano; De Petrocellis, Luciano; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4663-4669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arom. iodination ortho to the phenolic hydroxyl reverts the activity of the ultrapotent vanilloid agonist resiniferatoxin (RTX), generating the ultrapotent antagonist 5'-iodoRTX.  To better understand the role of iodine in this remarkable switch of activity, a systematic investigation on the halogenation of vanillamides, a class of compds. structurally simpler than resiniferonoids, was carried out.  The results showed that (a) the antagonistic activity depends on the site of halogenation and is maximal at C-6', (b) iodine is more efficient than chlorine and bromine at reverting the agonistic activity, and (c) iodine-carbon exchange decreases antagonist activity.  Iodine-induced reversal of vanilloid activity was also obsd. in vanillamides more powerful than capsaicin, but a poor correlation was found between agonistic and antagonistic potencies, suggesting that differences exist in the way vanillamides and their 6'-iodo derivs. bind to TRPV1.''.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_TtNSCuRwyrVg90H21EOLACvtfcHk0lj6pBqo_83big"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFSmtbY%253D&md5=9def27ca7df975b545a8d23858d3c3c1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm050139q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050139q%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26aulast%3DDaddario%26aufirst%3DN.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DMoriello%26aufirst%3DA.%2BS.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DThe%2520taming%2520of%2520capsaicin.%2520Reversal%2520of%2520the%2520vanilloid%2520activity%2520of%2520N-Acylvanillamines%2520by%2520aromatic%2520iodination%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4663%26epage%3D4669%26doi%3D10.1021%2Fjm050139q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">N-acylanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3739</span>â <span class="NLM_lpage">3745</span>, <span class="refDoi">Â DOI: 10.1021/jm020844o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020844o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3739-3745&author=G.+Appendinoauthor=A.+Minassiauthor=A.+S.+Morelloauthor=L.+De+Petrocellisauthor=V.+Di+Marzo&title=N-acylanillamides%3A+development+of+an+expeditious+synthesis+and+discovery+of+new+acyl+templates+for+powerful+activation+of+the+vanilloid+receptor&doi=10.1021%2Fjm020844o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm020844o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020844o%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DMorello%26aufirst%3DA.%2BS.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DN-acylanillamides%253A%2520development%2520of%2520an%2520expeditious%2520synthesis%2520and%2520discovery%2520of%2520new%2520acyl%2520templates%2520for%2520powerful%2520activation%2520of%2520the%2520vanilloid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3739%26epage%3D3745%26doi%3D10.1021%2Fjm020844o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevisani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daddario, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriello, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzieri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geppetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Development of the first ultra-potent âcapsaicinoidâ agonist transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential</span>. <i>J. Pharm. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">561</span>â <span class="NLM_lpage">570</span>, <span class="refDoi">Â DOI: 10.1124/jpet.104.074864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fjpet.104.074864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=15356216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCnsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=561-570&author=G.+Appendinoauthor=L.+De+Petrocellisauthor=M.+Trevisaniauthor=A.+Minassiauthor=N.+Daddarioauthor=A.+S.+Morielloauthor=D.+Gazzieriauthor=A.+Ligrestiauthor=B.+Campiauthor=G.+Fontanaauthor=C.+Pinnaauthor=P.+Geppettiauthor=V.+Di+Marzo&title=Development+of+the+first+ultra-potent+%E2%80%9Ccapsaicinoid%E2%80%9D+agonist+transient+receptor+potential+vanilloid+type+1+%28TRPV1%29+channels+and+its+therapeutic+potential&doi=10.1124%2Fjpet.104.074864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential</span></div><div class="casAuthors">Appendino, Giovanni; De Petrocellis, Luciano; Trevisani, Marcello; Minassi, Alberto; Daddario, Nives; Moriello, Aniello Schiano; Gazzieri, David; Ligresti, Alessia; Campi, Barbara; Fontana, Gabriele; Pinna, Christian; Geppetti, Pierangelo; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">561-570</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Olvanil (N-9-Z-octadecenoyl-vanillamide) is an agonist of transient receptor potential vanilloid type 1 (TRPV1) channels that lack the pungency of capsaicin and was developed as an oral analgesic.  Vanillamides are unmatched in terms of structural simplicity, straightforward synthesis, and safety compared with the more powerful TRPV1 agonists, like the structurally complex phorboid compd. resiniferatoxin.  The authors have modified the fatty acyl chain of olvanil to obtain ultra-potent analogs.  The insertion of a hydroxyl group at C-12 yielded a compd. named rinvanil, after ricinoleic acid, significantly less potent than olvanil (EC50 = 6 vs. 0.7 nM), but more versatile in terms of structural modifications because of the presence of an addnl. functional group.  Acetylation and phenylacetylation of rinvanil reestablished and dramatically enhanced, resp., its potency at hTRPV1.  With a two-digit picomolar EC50 (90 pM), phenylacetylrinvanil (PhAR, IDN5890) is the most potent vanillamide ever described with potency comparable with that of resiniferatoxin (EC50, 11 pM).  Benzoyl- and phenylpropionylrinvanil were as potent and less potent than PhAR, resp., whereas configurational inversion to ent-PhAR and cyclopropanation (but not hydrogenation or epoxidn.) of the double bond were tolerated.  Finally, iodination of the arom. hydroxyl caused a dramatic switch in functional activity, generating compds. that behaved as TRPV1 antagonists rather than agonists.  Since the potency of PhAR was maintained in rat dorsal root ganglion neurons and, particularly, in the rat urinary bladder, this compd. was investigated in an in vivo rat model of urinary incontinence and proved as effective as resiniferatoxin at reducing bladder detrusor overactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyHSRYmqtTE7Vg90H21EOLACvtfcHk0lj6pBqo_83big"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCnsb8%253D&md5=eb0a31cb066693c6a88d0a7cb1cdd353</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.074864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.074864%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DTrevisani%26aufirst%3DM.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDaddario%26aufirst%3DN.%26aulast%3DMoriello%26aufirst%3DA.%2BS.%26aulast%3DGazzieri%26aufirst%3DD.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DCampi%26aufirst%3DB.%26aulast%3DFontana%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DC.%26aulast%3DGeppetti%26aufirst%3DP.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DDevelopment%2520of%2520the%2520first%2520ultra-potent%2520%25E2%2580%259Ccapsaicinoid%25E2%2580%259D%2520agonist%2520transient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520%2528TRPV1%2529%2520channels%2520and%2520its%2520therapeutic%2520potential%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D561%26epage%3D570%26doi%3D10.1124%2Fjpet.104.074864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigglesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J.</span></span> <span> </span><span class="NLM_article-title">Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic â³A-regionâ³</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2362</span>â <span class="NLM_lpage">2372</span>, <span class="refDoi">Â DOI: 10.1021/jm00068a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2362-2372&author=C.+S.+J.+Walpoleauthor=R.+Wrigglesworthauthor=S.+Bevanauthor=E.+A.+Campbellauthor=A.+Drayauthor=I.+F.+Jamesauthor=M.+N.+Perkinsauthor=D.+J.+Reidauthor=J.+Winter&title=Analogs+of+capsaicin+with+agonist+activity+as+novel+analgesic+agents%3B+structure-activity+studies.+1.+The+aromatic+%E2%80%B3A-region%E2%80%B3&doi=10.1021%2Fjm00068a014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a014%26sid%3Dliteratum%253Aachs%26aulast%3DWalpole%26aufirst%3DC.%2BS.%2BJ.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DBevan%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DE.%2BA.%26aulast%3DDray%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DI.%2BF.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DReid%26aufirst%3DD.%2BJ.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DAnalogs%2520of%2520capsaicin%2520with%2520agonist%2520activity%2520as%2520novel%2520analgesic%2520agents%253B%2520structure-activity%2520studies.%25201.%2520The%2520aromatic%2520%25E2%2580%25B3A-region%25E2%2580%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2362%26epage%3D2372%26doi%3D10.1021%2Fjm00068a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griglio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirali, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">The use of 2-hydroxymethyl benzoic acid as an effective water surrogate in the Passerini reaction: A straightforward access to Î±-hydroxyamides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4786</span>â <span class="NLM_lpage">4789</span>, <span class="refDoi">Â DOI: 10.1016/j.tetlet.2017.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.tetlet.2017.11.021" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=4786-4789&author=M.+Serafiniauthor=A.+Griglioauthor=E.+Obertoauthor=T.+Piraliauthor=G.+C.+Tron&title=The+use+of+2-hydroxymethyl+benzoic+acid+as+an+effective+water+surrogate+in+the+Passerini+reaction%3A+A+straightforward+access+to+%CE%B1-hydroxyamides&doi=10.1016%2Fj.tetlet.2017.11.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2017.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2017.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DSerafini%26aufirst%3DM.%26aulast%3DGriglio%26aufirst%3DA.%26aulast%3DOberto%26aufirst%3DE.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DThe%2520use%2520of%25202-hydroxymethyl%2520benzoic%2520acid%2520as%2520an%2520effective%2520water%2520surrogate%2520in%2520the%2520Passerini%2520reaction%253A%2520A%2520straightforward%2520access%2520to%2520%25CE%25B1-hydroxyamides%26jtitle%3DTetrahedron%2520Lett.%26date%3D2017%26volume%3D58%26spage%3D4786%26epage%3D4789%26doi%3D10.1016%2Fj.tetlet.2017.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La Spisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mossetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">An efficient synthesis of symmetric and unsymmetric bis-(Î²-aminoamides) via Ugi multicomponent reaction</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6044</span>â <span class="NLM_lpage">6047</span>, <span class="refDoi">Â DOI: 10.1021/ol302935y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol302935y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=6044-6047&author=F.+La+Spisaauthor=A.+Feoauthor=R.+Mossettiauthor=G.+C.+Tron&title=An+efficient+synthesis+of+symmetric+and+unsymmetric+bis-%28%CE%B2-aminoamides%29+via+Ugi+multicomponent+reaction&doi=10.1021%2Fol302935y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Synthesis of Symmetric and Unsymmetric Bis-(Î²-aminoamides) via Ugi Multicomponent Reaction</span></div><div class="casAuthors">La Spisa, Fabio; Feo, Alberto; Mossetti, Riccardo; Tron, Gian Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6044-6047</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A library of sym. and unsym. bis-(Î²-aminoamides) has been prepd. starting from sym. secondary diamines by using a double Ugi four-component reaction.  A sacrificial Mumm rearrangement, thanks to the use of 2-(hydroxymethyl)benzoic acid, is necessary to suppress the competing split-Ugi reaction, increasing the yield and simplifying the purifn. step.  The scope, the reaction conditions, and the role of water in trapping the nitrilium intermediate are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4qI64fofl7Vg90H21EOLACvtfcHk0lgZPB6-k7RwSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73I&md5=34920b54a116d0ef186f248a1f37f569</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fol302935y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol302935y%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BSpisa%26aufirst%3DF.%26aulast%3DFeo%26aufirst%3DA.%26aulast%3DMossetti%26aufirst%3DR.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DAn%2520efficient%2520synthesis%2520of%2520symmetric%2520and%2520unsymmetric%2520bis-%2528%25CE%25B2-aminoamides%2529%2520via%2520Ugi%2520multicomponent%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D6044%26epage%3D6047%26doi%3D10.1021%2Fol302935y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Giustiniano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">An efficient synthesis of 1-arylindazole-3-carboxamides using nitrile imines, isocyanides and 2-hydroxymethylbenzoic acid, followed by a chemoselective BuchwaldâHartwig intramolecular cyclization</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">34913</span>â <span class="NLM_lpage">34920</span>, <span class="refDoi">Â DOI: 10.1039/C6RA01442A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1039%2FC6RA01442A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1OqtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=34913-34920&author=M.+Giustinianoauthor=V.+Mercalliauthor=E.+Novellinoauthor=G.+C.+Tron&title=An+efficient+synthesis+of+1-arylindazole-3-carboxamides+using+nitrile+imines%2C+isocyanides+and+2-hydroxymethylbenzoic+acid%2C+followed+by+a+chemoselective+Buchwald%E2%80%93Hartwig+intramolecular+cyclization&doi=10.1039%2FC6RA01442A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient synthesis of 1-arylindazole-3-carboxamides using nitrile imines, isocyanides and 2-hydroxymethylbenzoic acid, followed by a chemoselective Buchwald-Hartwig intramolecular cyclization</span></div><div class="casAuthors">Giustiniano, M.; Mercalli, V.; Novellino, E.; Tron, G. C.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">34913-34920</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A convergent and efficient two-step synthesis of pharmaceutically relevant 1-arylindazole-3-carboxamides was reported.  These mols. were obtained in good to excellent yields (up to 98%) starting from a strategic reaction between isocyanides, 2-iodo-N-arylbenzohydrazonoyl chlorides and 2-hydroxymethylbenzoic acid followed by a chemoselective Buchwald-Hartwig intramol. cyclization.  This novel strategy provided an addnl. indazole synthesis to those already reported in literature both in the type of substrate as well as the substitution pattern obtainable in the products.  Furthermore benzylisocyanide was herein reported for the first time as a convertible isocyanide providing an expeditious access to N-arylindazole-3-carbonitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Bx0aJX-gfrVg90H21EOLACvtfcHk0lgZPB6-k7RwSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1OqtLY%253D&md5=8b80974cabe0a9620ac39a6c0a056a20</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1039%2FC6RA01442A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA01442A%26sid%3Dliteratum%253Aachs%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DMercalli%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DAn%2520efficient%2520synthesis%2520of%25201-arylindazole-3-carboxamides%2520using%2520nitrile%2520imines%252C%2520isocyanides%2520and%25202-hydroxymethylbenzoic%2520acid%252C%2520followed%2520by%2520a%2520chemoselective%2520Buchwald%25E2%2580%2593Hartwig%2520intramolecular%2520cyclization%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D34913%26epage%3D34920%26doi%3D10.1039%2FC6RA01442A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couvreur, P.</span></span> <span> </span><span class="NLM_article-title">Squalenoylation: a novel technology for anticancer and antibiotic drugs with enhanced activity</span>. In  <i>Nanosciences and Nanotechnology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourtioz, J. M.</span>, <span class="NLM_string-name">Lahmani, M.</span>, <span class="NLM_string-name">Dupas-Haeberlin, C.</span>, <span class="NLM_string-name">Hesto, P.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">253</span>â <span class="NLM_lpage">272</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=253-272&author=P.+Couvreurauthor=J.+M.+Lourtioz&author=M.+Lahmani&author=C.+Dupas-Haeberlin&author=P.+Hesto&title=Nanosciences+and+Nanotechnology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCouvreur%26aufirst%3DP.%26atitle%3DSqualenoylation%253A%2520a%2520novel%2520technology%2520for%2520anticancer%2520and%2520antibiotic%2520drugs%2520with%2520enhanced%2520activity%26btitle%3DNanosciences%2520and%2520Nanotechnology%26aulast%3DLourtioz%26aufirst%3DJ.%2BM.%26pub%3DSpringer%26date%3D2015%26spage%3D253%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">The evaluation of the metabolic pathway was focused on hydrolytic behavior, as glucuronide or sulfate conjugates were not detected when the compounds were incubated in the presence of microsomal or cytosol liver fractions, confirming their resistance toward phase II metabolic enzymes (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadgrove, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jay, M.</span></span> <span> </span><span class="NLM_article-title">Biotransformation capacity of carboxylesterase in skin and keratinocytes for the penta-ethyl ester prodrug of DTPA</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1313</span>â <span class="NLM_lpage">1318</span>, <span class="refDoi">Â DOI: 10.1124/dmd.116.069377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fdmd.116.069377" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1313-1318&author=J.+Fuauthor=M.+Sadgroveauthor=L.+Marsonauthor=M.+Jay&title=Biotransformation+capacity+of+carboxylesterase+in+skin+and+keratinocytes+for+the+penta-ethyl+ester+prodrug+of+DTPA&doi=10.1124%2Fdmd.116.069377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.069377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.069377%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DSadgrove%26aufirst%3DM.%26aulast%3DMarson%26aufirst%3DL.%26aulast%3DJay%26aufirst%3DM.%26atitle%3DBiotransformation%2520capacity%2520of%2520carboxylesterase%2520in%2520skin%2520and%2520keratinocytes%2520for%2520the%2520penta-ethyl%2520ester%2520prodrug%2520of%2520DTPA%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D1313%26epage%3D1318%26doi%3D10.1124%2Fdmd.116.069377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, C. K.</span></span> <span> </span><span class="NLM_article-title">Biotransformation of drugs in human skin</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">253</span>, <span class="refDoi">Â DOI: 10.1124/dmd.108.024794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fdmd.108.024794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=19005027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=247-253&author=C.+K.+Svensson&title=Biotransformation+of+drugs+in+human+skin&doi=10.1124%2Fdmd.108.024794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of drugs in human skin</span></div><div class="casAuthors">Svensson, Craig K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Although it is the largest organ of the human body, skin is often not considered in discussions of drug metab.  However, there is growing evidence that most common drug-metabolizing enzymes are expressed in the skin.  Evidence for expression of cytochromes P 450, flavin monooxygenases, glutathione-S-transferases, N-acetyltransferases, and sulfotransferases in human skin and skin cells are presented.  Addnl. discussion is focused on the evidence of actual metab. of drugs.  Finally, the potential clin. implications of metab. within the skin are discussed briefly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GNsGESefO7Vg90H21EOLACvtfcHk0li0ZdLuodRF-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D&md5=c7bb178e9cfcd22a11dee43b9c396ff8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024794%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DC.%2BK.%26atitle%3DBiotransformation%2520of%2520drugs%2520in%2520human%2520skin%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D247%26epage%3D253%26doi%3D10.1124%2Fdmd.108.024794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J- -H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Stereoselective characteristics and mechanisms of epidermal carboxylesterase metabolism observed in HaCaT keratinocytes</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">532</span>â <span class="NLM_lpage">536</span>, <span class="refDoi">Â DOI: 10.1248/bpb.30.532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1248%2Fbpb.30.532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=17329851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVSntb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=532-536&author=Q.-G.+Zhuauthor=J-+-H.+Huauthor=J.-Y.+Liuauthor=S.-W.+Luauthor=Y.-X.+Liuauthor=J.+Wang&title=Stereoselective+characteristics+and+mechanisms+of+epidermal+carboxylesterase+metabolism+observed+in+HaCaT+keratinocytes&doi=10.1248%2Fbpb.30.532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective characteristics and mechanisms of epidermal carboxylesterase metabolism observed in HaCaT keratinocytes</span></div><div class="casAuthors">Zhu, Quan-Gang; Hu, Jin-Hong; Liu, Ji-Yong; Lu, Song-Wei; Liu, Yan-Xia; Wang, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">532-536</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">There is increasing evidence that epidermal carboxylesterase may be involved in the stereoselective hydrolysis of prodrugs in percutaneous absorption.  The present study was designed to evaluate the stereoselective characteristics and mechanisms of ketoprofen Et ester hydrolysis by epidermal carboxylesterase expressed in HaCaT keratinocytes.  Ketoprofen Et ester was mainly hydrolyzed to R-ketoprofen by carboxylesterase of human HaCaT keratinocytes.  Human carboxylesterase-1 (hCE-1) and human carboxylesterase-2 (hCE-2) were intensively detected in L02 hepatocytes, hCE-2 was also intensively detected in HaCaT keratinocytes, but hCE-1 was not detected in HaCaT keratinocytes.  HCE-2 is thus an abundant carboxylesterase in HaCaT keratinocytes which may be responsible for stereoselective hydrolysis of ketoprofen Et ester.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOWzy6SiCLm7Vg90H21EOLACvtfcHk0li0ZdLuodRF-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVSntb8%253D&md5=6f27c6606a23f6a8f2d498eb81577c30</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.532%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DQ.-G.%26aulast%3DHu%26aufirst%3DJ-%2B-H.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DLu%26aufirst%3DS.-W.%26aulast%3DLiu%26aufirst%3DY.-X.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DStereoselective%2520characteristics%2520and%2520mechanisms%2520of%2520epidermal%2520carboxylesterase%2520metabolism%2520observed%2520in%2520HaCaT%2520keratinocytes%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D532%26epage%3D536%26doi%3D10.1248%2Fbpb.30.532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Eijl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶tz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. J.</span></span> <span> </span><span class="NLM_article-title">Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e41721</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0041721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1371%2Fjournal.pone.0041721" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e41721&author=S.+Van+Eijlauthor=Z.+Zhuauthor=J.+Cupittauthor=M.+Gierulaauthor=C.+G%C3%B6tzauthor=E.+Fritscheauthor=R.+J.+Edwards&title=Elucidation+of+xenobiotic+metabolism+pathways+in+human+skin+and+human+skin+models+by+proteomic+profiling&doi=10.1371%2Fjournal.pone.0041721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0041721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0041721%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BEijl%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCupitt%26aufirst%3DJ.%26aulast%3DGierula%26aufirst%3DM.%26aulast%3DG%25C3%25B6tz%26aufirst%3DC.%26aulast%3DFritsche%26aufirst%3DE.%26aulast%3DEdwards%26aufirst%3DR.%2BJ.%26atitle%3DElucidation%2520of%2520xenobiotic%2520metabolism%2520pathways%2520in%2520human%2520skin%2520and%2520human%2520skin%2520models%2520by%2520proteomic%2520profiling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De41721%26doi%3D10.1371%2Fjournal.pone.0041721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span> <span> </span><span class="NLM_article-title">Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">412</span>â <span class="NLM_lpage">431</span>, <span class="refDoi">Â DOI: 10.3390/molecules13020412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fmolecules13020412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=18305428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=412-431&author=M.+Hosokawa&title=Structure+and+catalytic+properties+of+carboxylesterase+isozymes+involved+in+metabolic+activation+of+prodrugs&doi=10.3390%2Fmolecules13020412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs</span></div><div class="casAuthors">Hosokawa, Masakiyo</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">412-431</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Mammalian carboxylesterases (CESs) comprise a multigene family whose gene products play important roles in biotransformation of ester- or amide-type prodrugs.  They are members of an Î±,Î²-hydrolase-fold family and are found in various mammals.  It has been suggested that CESs can be classified into 5 major groups denominated CES1-CES5, according to the homol. of the amino acid sequence, and the majority of CESs that have been identified belong to the CES1 or CES2 family.  The substrate specificities of CES1 and CES2 are significantly different.  The CES1 isoenzyme mainly hydrolyzes a substrate with a small alc. group and large acyl group, but its wide active site pocket sometimes allows it to act on structurally distinct compds. of either a large or small alc. moiety.  In contrast, the CES2 isoenzyme recognizes a substrate with a large alc. group and small acyl group, and its substrate specificity may be restricted by the capability of acyl-enzyme conjugate formation due to the presence of conformational interference in the active pocket.  Since pharmacokinetic and pharmacol. data for prodrugs obtained from preclin. expts. using various animals are generally used as refs. for human studies, it is important to clarify the biochem. properties of CES isoenzymes.  Further experimentation for an understanding of detailed substrate specificity of prodrugs for CES isoenzymes and its hydrolyzates will help researchers to design the ideal prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouTX8xLu6R1rVg90H21EOLACvtfcHk0limaIVsU_aTLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D&md5=2737ed528ff2b616b7d256ad01b5c1d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13020412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13020412%26sid%3Dliteratum%253Aachs%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DStructure%2520and%2520catalytic%2520properties%2520of%2520carboxylesterase%2520isozymes%2520involved%2520in%2520metabolic%2520activation%2520of%2520prodrugs%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D412%26epage%3D431%26doi%3D10.3390%2Fmolecules13020412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">The hydrolytic chemical stability of <b>17</b> and <b>36</b> was checked by storing aliquots of solid compounds at different temperature and humidity conditions (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a>). The two esters did not suffer from degradation due to prolonged temperature and humidity exposure (40 Â°C for 2 months, 60 Â°C for 15 days, and 80% relative humidity). Only compound <b>36</b> underwent a mild hydrolysis after storage in methanolâwater 95:5 solution for 15 days (85% residual substrate after exposure). Overall, the results suggested a good stability of the ester function.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonic-Kocijan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhac, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span> <span> </span><span class="NLM_article-title">TRPV1 channel-mediated bilateral allodynia induced by unilateral masseter muscle inflammation in rats</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">9</span>â <span class="NLM_lpage">68</span>, <span class="refDoi">Â DOI: 10.1186/1744-8069-9-68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1186%2F1744-8069-9-68" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=9-68&author=S.+Simonic-Kocijanauthor=X.+Zhaoauthor=W.+Liuauthor=Y.+Wuauthor=I.+Uhacauthor=K.+Wang&title=TRPV1+channel-mediated+bilateral+allodynia+induced+by+unilateral+masseter+muscle+inflammation+in+rats&doi=10.1186%2F1744-8069-9-68"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-9-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-9-68%26sid%3Dliteratum%253Aachs%26aulast%3DSimonic-Kocijan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DUhac%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DTRPV1%2520channel-mediated%2520bilateral%2520allodynia%2520induced%2520by%2520unilateral%2520masseter%2520muscle%2520inflammation%2520in%2520rats%26jtitle%3DMol.%2520Pain%26date%3D2013%26volume%3D30%26spage%3D9%26epage%3D68%26doi%3D10.1186%2F1744-8069-9-68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoon, M. A.</span></span> <span> </span><span class="NLM_article-title">Why we scratch an itch: the molecules, cells and circuits of itch</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">175</span>â <span class="NLM_lpage">182</span>, <span class="refDoi">Â DOI: 10.1038/nn.3619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fnn.3619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=24473265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=175-182&author=D.+M.+Bautistaauthor=S.+R.+Wilsonauthor=M.+A.+Hoon&title=Why+we+scratch+an+itch%3A+the+molecules%2C+cells+and+circuits+of+itch&doi=10.1038%2Fnn.3619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Why we scratch an itch: the molecules, cells and circuits of itch</span></div><div class="casAuthors">Bautista, Diana M.; Wilson, Sarah R.; Hoon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Itch is described as an irritating sensation that triggers a desire to scratch.  However, this definition hardly seems fitting for the millions of people who suffer from intractable itch.  Indeed, the Buddhist philosopher Nagarjuna more aptly stated, "There is pleasure when an itch is scratched.  But to be without an itch is more pleasurable still." Chronic itch is widespread and very difficult to treat.  In this review we focus on the mols., cells and circuits in the peripheral and central nervous systems that drive acute and chronic itch transmission.  Understanding the itch circuitry is crit. to developing new therapies for this intractable disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocL800rrv887Vg90H21EOLACvtfcHk0limaIVsU_aTLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsrc%253D&md5=62d6635c23d76fe004f600a40987adb9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnn.3619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3619%26sid%3Dliteratum%253Aachs%26aulast%3DBautista%26aufirst%3DD.%2BM.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DHoon%26aufirst%3DM.%2BA.%26atitle%3DWhy%2520we%2520scratch%2520an%2520itch%253A%2520the%2520molecules%252C%2520cells%2520and%2520circuits%2520of%2520itch%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D175%26epage%3D182%26doi%3D10.1038%2Fnn.3619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, G. I.</span>; <span class="NLM_string-name">Genazzani, A. A.</span>; <span class="NLM_string-name">Pirali, T.</span>; <span class="NLM_string-name">Fernandez-Carvajal, A.</span>; <span class="NLM_string-name">Ferrer-Montiel, A. V.</span></span> TRPV1Modulator Compounds. <span class="NLM_patent">EP17382266.9</span>, May 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Devesa%2C+G.+I.%3B+Genazzani%2C+A.+A.%3B+Pirali%2C+T.%3B+Fernandez-Carvajal%2C+A.%3B+Ferrer-Montiel%2C+A.+V.+TRPV1Modulator+Compounds.+EP17382266.9%2C+May+11%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDevesa%26aufirst%3DG.%2BI.%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koganti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bley, K.</span></span> <span> </span><span class="NLM_article-title">In vitro hepatic and skin metabolism of capsaicin</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">670</span>â <span class="NLM_lpage">675</span>, <span class="refDoi">Â DOI: 10.1124/dmd.107.019240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fdmd.107.019240" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=670-675&author=S.+Chandaauthor=M.+Bashirauthor=S.+Babbarauthor=A.+Kogantiauthor=K.+Bley&title=In+vitro+hepatic+and+skin+metabolism+of+capsaicin&doi=10.1124%2Fdmd.107.019240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.019240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.019240%26sid%3Dliteratum%253Aachs%26aulast%3DChanda%26aufirst%3DS.%26aulast%3DBashir%26aufirst%3DM.%26aulast%3DBabbar%26aufirst%3DS.%26aulast%3DKoganti%26aufirst%3DA.%26aulast%3DBley%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520hepatic%2520and%2520skin%2520metabolism%2520of%2520capsaicin%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D670%26epage%3D675%26doi%3D10.1124%2Fdmd.107.019240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of analogues of BCTC incorporating a pyrrolidinyl linker and biological evaluation as Transient Receptor Potential Vanilloid 1 antagonists</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">306</span>â <span class="NLM_lpage">311</span>, <span class="refDoi">Â DOI: 10.1111/cbdd.12661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1111%2Fcbdd.12661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=26360809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7vO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2016&pages=306-311&author=L.+Yanauthor=J.+Wangauthor=M.+Panauthor=Q.+Qiuauthor=W.+Huangauthor=H.+Qian&title=Synthesis+of+analogues+of+BCTC+incorporating+a+pyrrolidinyl+linker+and+biological+evaluation+as+Transient+Receptor+Potential+Vanilloid+1+antagonists&doi=10.1111%2Fcbdd.12661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists</span></div><div class="casAuthors">Yan, Lin; Wang, Jingjie; Pan, Miaobo; Qiu, Qianqian; Huang, Wenlong; Qian, Hai</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">306-311</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A series of novel pyrrolidinyl linker TRPV1 antagonists were prepd. in an effort to lower the hyperthermic side-effects of first-generation antagonist BCTC.  These compds. were studied for antagonism of hTRPV1 activation by capsaicin and acid in vitro.  Preliminary results suggested the four compds. had favorable TRPV1 antagonism activity.  In further studies in vivo, (S)-1-(4-(3-chloropyridin-2-yl)piperazine-1-carbonyl)-N-(4-(tert-butyl)phenyl)pyrrolidine-2-carboxamide comparable to BCTC, showed potent analgesic activity in capsaicin-induced and heat-induced pain models.  In addn., (S)-1-(4-(3-chloropyridin-2-yl)piperazine-1-carbonyl)-N-(4-(tert-butyl)phenyl)pyrrolidine-2-carboxamide indicated a reduced risk of body temp. elevation.  All of these demonstrated that (S)-1-(4-(3-chloropyridin-2-yl)piperazine-1-carbonyl)-N-(4-(tert-butyl)phenyl)pyrrolidine-2-carboxamide can be considered as a safe candidate for the further development of analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryAO-LFq0pRbVg90H21EOLACvtfcHk0limaIVsU_aTLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7vO&md5=52a09fb21dc6d0e4e4ffacfde606b04f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12661%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520analogues%2520of%2520BCTC%2520incorporating%2520a%2520pyrrolidinyl%2520linker%2520and%2520biological%2520evaluation%2520as%2520Transient%2520Receptor%2520Potential%2520Vanilloid%25201%2520antagonists%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2016%26volume%3D87%26spage%3D306%26epage%3D311%26doi%3D10.1111%2Fcbdd.12661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="note"><p class="first last">The synthesis of <b>36</b> is made of five synthetic steps, with an overall yield of 45%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ceruti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balliano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerst, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuber, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">208</span>, <span class="refDoi">Â DOI: 10.1016/0223-5234(87)90050-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2F0223-5234%2887%2990050-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1987&pages=199-208&author=M.+Cerutiauthor=G.+Ballianoauthor=F.+Violaauthor=L.+Cattelauthor=N.+Gerstauthor=F.+Schuber&title=Synthesis+and+biological+activity+of+azasqualenes%2C+bis-azasqualenes+and+derivatives&doi=10.1016%2F0223-5234%2887%2990050-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2F0223-5234%2887%2990050-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0223-5234%252887%252990050-X%26sid%3Dliteratum%253Aachs%26aulast%3DCeruti%26aufirst%3DM.%26aulast%3DBalliano%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DF.%26aulast%3DCattel%26aufirst%3DL.%26aulast%3DGerst%26aufirst%3DN.%26aulast%3DSchuber%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520azasqualenes%252C%2520bis-azasqualenes%2520and%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1987%26volume%3D22%26spage%3D199%26epage%3D208%26doi%3D10.1016%2F0223-5234%2887%2990050-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceruti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fresta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolino, D.</span></span> <span> </span><span class="NLM_article-title">Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2535</span>â <span class="NLM_lpage">2546</span>, <span class="refDoi">Â DOI: 10.2147/IJN.S28114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2147%2FIJN.S28114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=22679366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVyrtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2535-2546&author=D.+Coscoauthor=F.+Roccoauthor=M.+Cerutiauthor=M.+Vonoauthor=M.+Frestaauthor=D.+Paolino&title=Self-assembled+squalenoyl-cytarabine+nanostructures+as+a+potent+nanomedicine+for+treatment+of+leukemic+diseases&doi=10.2147%2FIJN.S28114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases</span></div><div class="casAuthors">Cosco, Donato; Rocco, Flavio; Ceruti, Maurizio; Vono, Margherita; Fresta, Massimo; Paolino, Donatella</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2535-2546</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: In this investigation, the antileukemic activity of a new nanomedicine based on the conjugation of 1,1',2-tris-nor-squalenic acid with cytarabine (Ara-C) was evaluated.  Methods: Squalenoyl-Ara-C conjugate (Sq-Ara-C) self-assembled nanosystems were obtained by the nanopptn. method and characterized in vitro and in vivo.  Results: This new nanomedicine, which had a mean diam. of approx. 150 nm, improved the in vitro antitumoral activity of Ara-C in different cancer cell lines (L1210, K562 and MCF-7).  Sq-Ara-C nanomedicine allowed redn. of the IC50 value with respect to the free drug and was also active against drug-resistant leukemic cells (L1210R).  A noticeable increase in the survival rate of mice with aggressive metastatic L1210R leukemia was obsd. after treatment with Sq-Ara-C (50 mg/kg) as compared with the free active compd. (100 mg/kg).  Finally, evaluation of the biodistribution and pharmacokinetic profiles of the drug demonstrated that these nanoaggregates preferentially localized to the liver and spleen and protected the drug from physiol. metab.  Conclusion: Squalenoylation of cytarabine offers several pharmacol. benefits both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpID6Zw1uy097Vg90H21EOLACvtfcHk0ljhXR4Woob5Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVyrtbg%253D&md5=f6ce7980cd80d24423774dad04d9f089</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.2147%2FIJN.S28114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S28114%26sid%3Dliteratum%253Aachs%26aulast%3DCosco%26aufirst%3DD.%26aulast%3DRocco%26aufirst%3DF.%26aulast%3DCeruti%26aufirst%3DM.%26aulast%3DVono%26aufirst%3DM.%26aulast%3DFresta%26aufirst%3DM.%26aulast%3DPaolino%26aufirst%3DD.%26atitle%3DSelf-assembled%2520squalenoyl-cytarabine%2520nanostructures%2520as%2520a%2520potent%2520nanomedicine%2520for%2520treatment%2520of%2520leukemic%2520diseases%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D2535%26epage%3D2546%26doi%3D10.2147%2FIJN.S28114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, E.</span>; <span class="NLM_string-name">Mclellan, A.</span>; <span class="NLM_string-name">Reed, M. A.</span>; <span class="NLM_string-name">Sun, S.</span>; <span class="NLM_string-name">Weaver, D.</span></span> <span> </span><span class="NLM_article-title">Terpenoid Analogues and Uses Thereof for Treating Neurological Conditions</span>. U.S. Patent <span class="NLM_patent">WO 2012034232A1</span>, March 22, 2012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lu%2C+E.%3B+Mclellan%2C+A.%3B+Reed%2C+M.+A.%3B+Sun%2C+S.%3B+Weaver%2C+D.+Terpenoid+Analogues+and+Uses+Thereof+for+Treating+Neurological+Conditions.+U.S.+Patent+WO+2012034232A1%2C+March+22%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DE.%26atitle%3DTerpenoid%2520Analogues%2520and%2520Uses%2520Thereof%2520for%2520Treating%2520Neurological%2520Conditions" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lilja, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laulund, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsby, A.</span></span> <span> </span><span class="NLM_article-title">Insulin and insulin-like growth factor type-I up-regulate the vanilloid receptor-1 (TRPV1) in stably TRPV1-expressing SH-SY5Y neuroblastoma cells</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1413</span>â <span class="NLM_lpage">1419</span>, <span class="refDoi">Â DOI: 10.1002/jnr.21255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1002%2Fjnr.21255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=17385724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVWltbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=1413-1419&author=J.+Liljaauthor=F.+Laulundauthor=A.+Forsby&title=Insulin+and+insulin-like+growth+factor+type-I+up-regulate+the+vanilloid+receptor-1+%28TRPV1%29+in+stably+TRPV1-expressing+SH-SY5Y+neuroblastoma+cells&doi=10.1002%2Fjnr.21255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin and insulin-like growth factor type-I Up-regulate the vanilloid receptor-1 (TRPV1) in stably TRPV1-expressing SH-SY5Y neuroblastoma cells</span></div><div class="casAuthors">Lilja, Johanna; Laulund, Frida; Forsby, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1413-1419</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The capsaicin receptor, transient receptor potential, vanilloid type 1 (TRPV1), is a Ca2+-permeable ion channel activated by noxious stimuli eliciting pain.  Several reports have shown modulation of TRPV1 activity and expression by neuronal growth factors.  Here, we study the long-term effects on TRPV1 expression mediated by insulin-like growth factor type-I (IGF-I) and insulin in a stably TRPV1-expressing SH-SY5Y neuroblastoma cell line.  We show that, after 72 h of 10 nM IGF-I or insulin exposure, the TRPV1 protein level was up-regulated 2.5-and 2-fold, resp.  By blocking phosphatidylinositol-3-kinase [PI(3)K] or mitogen-activated protein kinase (MAPK) signaling, we concluded that the increase in total TRPV1 protein content induced by IGF-I was controlled by PI(3)K signaling, whereas insulin seemed to regulate TRPV1 protein expression via both PI(3)K and MAPK pathways.  Inhibiting protein kinase C (PKC) blocked the effects of both IGF-I and insulin.  Furthermore, the concns. causing a 50% Ca2+ increase (EC50) after insulin and IGF-I treatments were significantly lowered compared with untreated cells.  We conclude that IGF-I and insulin enhance TRPV1 protein expression and activity, and impaired pain sensation might result from distorted TRPV1 regulation in the peripheral nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAUho0Yqj3UbVg90H21EOLACvtfcHk0ljhXR4Woob5Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVWltbg%253D&md5=b7f8eb003102d97cf13ea7e5b9d1bae4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21255%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DJ.%26aulast%3DLaulund%26aufirst%3DF.%26aulast%3DForsby%26aufirst%3DA.%26atitle%3DInsulin%2520and%2520insulin-like%2520growth%2520factor%2520type-I%2520up-regulate%2520the%2520vanilloid%2520receptor-1%2520%2528TRPV1%2529%2520in%2520stably%2520TRPV1-expressing%2520SH-SY5Y%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2007%26volume%3D85%26spage%3D1413%26epage%3D1419%26doi%3D10.1002%2Fjnr.21255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FerrÃ¡ndiz-Huertas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathivanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LujÃ¡n, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span> <span> </span><span class="NLM_article-title">Î±CGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">18345</span>â <span class="NLM_lpage">18350</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1420252111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1073%2Fpnas.1420252111" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=18345-18350&author=I.+Devesaauthor=C.+Ferr%C3%A1ndiz-Huertasauthor=S.+Mathivananauthor=C.+Wolfauthor=R.+Luj%C3%A1nauthor=J.+P.+Changeuxauthor=A.+Ferrer-Montiel&title=%CE%B1CGRP+is+essential+for+algesic+exocytotic+mobilization+of+TRPV1+channels+in+peptidergic+nociceptors&doi=10.1073%2Fpnas.1420252111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420252111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420252111%26sid%3Dliteratum%253Aachs%26aulast%3DDevesa%26aufirst%3DI.%26aulast%3DFerr%25C3%25A1ndiz-Huertas%26aufirst%3DC.%26aulast%3DMathivanan%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DC.%26aulast%3DLuj%25C3%25A1n%26aufirst%3DR.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26atitle%3D%25CE%25B1CGRP%2520is%2520essential%2520for%2520algesic%2520exocytotic%2520mobilization%2520of%2520TRPV1%2520channels%2520in%2520peptidergic%2520nociceptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D18345%26epage%3D18350%26doi%3D10.1073%2Fpnas.1420252111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e','cit12f','cit12g'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27'],'ref28':[],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':[],'ref41':['cit41a','cit41b'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Beatrice Riva, Alessia Griglio, Marta Serafini, Celia Cordero-Sanchez, Silvio Aprile, Rosanna Di Paola, Enrico Gugliandolo, Dalia Alansary, Isabella Biocotino, Dmitry Lim, Giorgio Grosa, Ubaldina Galli, Barbara Niemeyer, Giovanni Sorba, Pier Luigi Canonico, Salvatore Cuzzocrea, Armando A. Genazzani, <span class="NLM_string-name hlFld-ContribAuthor">Tracey Pirali</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9756-9783. <a href="https://doi.org/10.1021/acs.jmedchem.8b01512" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01512%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrtriazoles%25252C%252Ba%252BNovel%252BClass%252Bof%252BStore-Operated%252BCalcium%252BEntry%252BModulators%25253A%252BDiscovery%25252C%252BBiological%252BProfiling%25252C%252Band%252Bin%252BVivo%252BProof-of-Concept%252BEfficacy%252Bin%252BAcute%252BPancreatitis%26aulast%3DRiva%26aufirst%3DBeatrice%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28092018%26date%3D30102018%26date%3D22102018%26volume%3D61%26issue%3D21%26spage%3D9756%26epage%3D9783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Nikolaeva-Koleva</span>, <span class="hlFld-ContribAuthor ">Laura  Butron</span>, <span class="hlFld-ContribAuthor ">Sara  GonzÃ¡lez-RodrÃ­guez</span>, <span class="hlFld-ContribAuthor ">Isabel  Devesa</span>, <span class="hlFld-ContribAuthor ">Pierluigi  Valente</span>, <span class="hlFld-ContribAuthor ">Marta  Serafini</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Tracey  Pirali</span>, <span class="hlFld-ContribAuthor ">Gregorio FernÃ¡ndez  Ballester</span>, <span class="hlFld-ContribAuthor ">Asia  FernÃ¡ndez-Carvajal</span>, <span class="hlFld-ContribAuthor ">Antonio  Ferrer-Montiel</span>. </span><span class="cited-content_cbyCitation_article-title">A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-80725-z" title="DOI URL">https://doi.org/10.1038/s41598-020-80725-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-80725-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-80725-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bcapsaicinoid-based%252Bsoft%252Bdrug%25252C%252BAG1529%25252C%252Bfor%252Battenuating%252BTRPV1-mediated%252Bhistaminergic%252Band%252Binflammatory%252Bsensory%252Bneuron%252Bexcitability%26aulast%3DNikolaeva-Koleva%26aufirst%3DMagdalena%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amanda Spring  de Almeida</span>, <span class="hlFld-ContribAuthor ">Laura de Barros  Bernardes</span>, <span class="hlFld-ContribAuthor ">Gabriela  Trevisan</span>. </span><span class="cited-content_cbyCitation_article-title">TRP channels in cancer pain. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2021,</strong> <em>904 </em>, 174185. <a href="https://doi.org/10.1016/j.ejphar.2021.174185" title="DOI URL">https://doi.org/10.1016/j.ejphar.2021.174185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2021.174185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2021.174185%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DTRP%252Bchannels%252Bin%252Bcancer%252Bpain%26aulast%3Dde%2BAlmeida%26aufirst%3DAmanda%2BSpring%26date%3D2021%26volume%3D904%26spage%3D174185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuâjuan  Feng</span>, <span class="hlFld-ContribAuthor ">YuâLin  Ren</span>, <span class="hlFld-ContribAuthor ">LiâMing  Zhao</span>, <span class="hlFld-ContribAuthor ">GuoâQiang  Xue</span>, <span class="hlFld-ContribAuthor ">WenâHao  Yu</span>, <span class="hlFld-ContribAuthor ">JiaâQi  Yang</span>, <span class="hlFld-ContribAuthor ">JunâWei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Novel
              Î±âAcyloxycarboxamideâBased
              Derivatives as
              câMet
              Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>39 </em>
                                    (8)
                                     , 2241-2250. <a href="https://doi.org/10.1002/cjoc.202100106" title="DOI URL">https://doi.org/10.1002/cjoc.202100106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202100106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202100106%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B%2525CE%2525B1%2525E2%252580%252590Acyloxycarboxamide%2525E2%252580%252590Based%252BDerivatives%252Bas%252Bc%2525E2%252580%252590Met%252BInhibitors%26aulast%3DFeng%26aufirst%3DYu%25E2%2580%2590juan%26date%3D2021%26date%3D2021%26volume%3D39%26issue%3D8%26spage%3D2241%26epage%3D2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengkang  Gao</span>, <span class="hlFld-ContribAuthor ">Yusui  Wang</span>, <span class="hlFld-ContribAuthor ">Lanqi  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenrui  Qiao</span>, <span class="hlFld-ContribAuthor ">Lin  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of transient receptor potential vanilloid type 1 modulators (2014âpresent). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (2)
                                     , 169-187. <a href="https://doi.org/10.1080/13543776.2021.1854225" title="DOI URL">https://doi.org/10.1080/13543776.2021.1854225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1854225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1854225%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Btransient%252Breceptor%252Bpotential%252Bvanilloid%252Btype%252B1%252Bmodulators%252B%2525282014%2525E2%252580%252593present%252529%26aulast%3DGao%26aufirst%3DMengkang%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D2%26spage%3D169%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mircea  Iftinca</span>, <span class="hlFld-ContribAuthor ">Manon  Defaye</span>, <span class="hlFld-ContribAuthor ">Christophe  Altier</span>. </span><span class="cited-content_cbyCitation_article-title">TRPV1-Targeted Drugs in Development for Human Pain Conditions. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2021,</strong> <em>81 </em>
                                    (1)
                                     , 7-27. <a href="https://doi.org/10.1007/s40265-020-01429-2" title="DOI URL">https://doi.org/10.1007/s40265-020-01429-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-020-01429-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-020-01429-2%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DTRPV1-Targeted%252BDrugs%252Bin%252BDevelopment%252Bfor%252BHuman%252BPain%252BConditions%26aulast%3DIftinca%26aufirst%3DMircea%26date%3D2021%26date%3D2020%26volume%3D81%26issue%3D1%26spage%3D7%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcus O. W.  Grimm</span>, <span class="hlFld-ContribAuthor ">Tamara  BlÃ¼mel</span>, <span class="hlFld-ContribAuthor ">Anna A.  Lauer</span>, <span class="hlFld-ContribAuthor ">Daniel  Janitschke</span>, <span class="hlFld-ContribAuthor ">Christoph  Stahlmann</span>, <span class="hlFld-ContribAuthor ">Janine  Mett</span>, <span class="hlFld-ContribAuthor ">Viola J.  Haupenthal</span>, <span class="hlFld-ContribAuthor ">Anna-Maria  Miederer</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Niemeyer</span>, <span class="hlFld-ContribAuthor ">Heike S.  Grimm</span>, <span class="hlFld-ContribAuthor ">Tobias  Hartmann</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of capsaicinoids on APP processing in Alzheimerâs disease in SH-SY5Y cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-66009-6" title="DOI URL">https://doi.org/10.1038/s41598-020-66009-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-66009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-66009-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DThe%252Bimpact%252Bof%252Bcapsaicinoids%252Bon%252BAPP%252Bprocessing%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bin%252BSH-SY5Y%252Bcells%26aulast%3DGrimm%26aufirst%3DMarcus%2BO.%2BW.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asia  FernÃ¡ndez-Carvajal</span>, <span class="hlFld-ContribAuthor ">Rosario  GonzÃ¡lez-MuÃ±iz</span>, <span class="hlFld-ContribAuthor ">Gregorio  FernÃ¡ndez-Ballester</span>, <span class="hlFld-ContribAuthor ">Antonio  Ferrer-Montiel</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2020,</strong> <em>29 </em>
                                    (11)
                                     , 1209-1222. <a href="https://doi.org/10.1080/13543784.2020.1825680" title="DOI URL">https://doi.org/10.1080/13543784.2020.1825680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2020.1825680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2020.1825680%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bdrugs%252Bin%252Bearly%252Bphase%252Bclinical%252Btrials%252Btargeting%252Bthermotransient%252Breceptor%252Bpotential%252B%252528thermoTRP%252529%252Bchannels%26aulast%3DFern%25C3%25A1ndez-Carvajal%26aufirst%3DAsia%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D11%26spage%3D1209%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregorio  FernÃ¡ndez-Ballester</span>, <span class="hlFld-ContribAuthor ">Asia  FernÃ¡ndez-Carvajal</span>, <span class="hlFld-ContribAuthor ">Antonio  Ferrer-Montiel</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting thermoTRP ion channels:
              in silico
              preclinical approaches and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2020,</strong> <em>24 </em>
                                    (11)
                                     , 1079-1097. <a href="https://doi.org/10.1080/14728222.2020.1820987" title="DOI URL">https://doi.org/10.1080/14728222.2020.1820987</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2020.1820987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2020.1820987%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252BthermoTRP%252Bion%252Bchannels%25253A%252Bin%252Bsilico%252Bpreclinical%252Bapproaches%252Band%252Bopportunities%26aulast%3DFern%25C3%25A1ndez-Ballester%26aufirst%3DGregorio%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D11%26spage%3D1079%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linwei  Zeng</span>, <span class="hlFld-ContribAuthor ">Yuxin  Lin</span>, <span class="hlFld-ContribAuthor ">Sunliang  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Indoleâ
              N
              âCarboxylic Acids and Indoleâ
              N
              âCarboxamides in Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â An Asian Journal</span><span> <strong>2020,</strong> <em>15 </em>
                                    (7)
                                     , 973-985. <a href="https://doi.org/10.1002/asia.201901806" title="DOI URL">https://doi.org/10.1002/asia.201901806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201901806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201901806%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DIndole%2525E2%252580%252590%252BN%252B%2525E2%252580%252590Carboxylic%252BAcids%252Band%252BIndole%2525E2%252580%252590%252BN%252B%2525E2%252580%252590Carboxamides%252Bin%252BOrganic%252BSynthesis%26aulast%3DZeng%26aufirst%3DLinwei%26date%3D2020%26volume%3D15%26issue%3D7%26spage%3D973%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvio  Aprile</span>, <span class="hlFld-ContribAuthor ">Marta  Serafini</span>, <span class="hlFld-ContribAuthor ">Tracey  Pirali</span>. </span><span class="cited-content_cbyCitation_article-title">Soft drugs for dermatological applications: recent trends. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2234-2246. <a href="https://doi.org/10.1016/j.drudis.2019.08.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DSoft%252Bdrugs%252Bfor%252Bdermatological%252Bapplications%25253A%252Brecent%252Btrends%26aulast%3DAprile%26aufirst%3DSilvio%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2234%26epage%3D2246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Serafini</span>, <span class="hlFld-ContribAuthor ">Enza  Torre</span>, <span class="hlFld-ContribAuthor ">Silvio  Aprile</span>, <span class="hlFld-ContribAuthor ">Alberto  Massarotti</span>, <span class="hlFld-ContribAuthor ">Silvia  Fallarini</span>, <span class="hlFld-ContribAuthor ">Tracey  Pirali</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (10)
                                     , 1874. <a href="https://doi.org/10.3390/molecules24101874" title="DOI URL">https://doi.org/10.3390/molecules24101874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24101874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24101874%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BDocking%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BNovel%252BClass%252Bof%252BImidazothiazoles%252Bas%252BIDO1%252BInhibitors%26aulast%3DSerafini%26aufirst%3DMarta%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D10%26spage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Xie</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammatory mediators causing cutaneous chronic itch in some diseases via transient receptor potential channel subfamily V member 1 and subfamily A member 1. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Dermatology</span><span> <strong>2019,</strong> <em>46 </em>
                                    (3)
                                     , 177-185. <a href="https://doi.org/10.1111/1346-8138.14749" title="DOI URL">https://doi.org/10.1111/1346-8138.14749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1346-8138.14749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1346-8138.14749%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Dermatology%26atitle%3DInflammatory%252Bmediators%252Bcausing%252Bcutaneous%252Bchronic%252Bitch%252Bin%252Bsome%252Bdiseases%252Bvia%252Btransient%252Breceptor%252Bpotential%252Bchannel%252Bsubfamily%252BV%252Bmember%252B1%252Band%252Bsubfamily%252BA%252Bmember%252B1%26aulast%3DXie%26aufirst%3DBo%26date%3D2019%26date%3D2018%26volume%3D46%26issue%3D3%26spage%3D177%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leticia  MartÃ­nez-Ortega</span>, <span class="hlFld-ContribAuthor ">Amalia  Mira</span>, <span class="hlFld-ContribAuthor ">Asia  Fernandez-Carvajal</span>, <span class="hlFld-ContribAuthor ">C. Reyes  Mateo</span>, <span class="hlFld-ContribAuthor ">Ricardo  Mallavia</span>, <span class="hlFld-ContribAuthor ">Alberto  Falco</span>. </span><span class="cited-content_cbyCitation_article-title">Development of A New Delivery System Based on Drug-Loadable Electrospun Nanofibers for Psoriasis Treatment. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2019,</strong> <em>11 </em>
                                    (1)
                                     , 14. <a href="https://doi.org/10.3390/pharmaceutics11010014" title="DOI URL">https://doi.org/10.3390/pharmaceutics11010014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics11010014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics11010014%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DDevelopment%252Bof%252BA%252BNew%252BDelivery%252BSystem%252BBased%252Bon%252BDrug-Loadable%252BElectrospun%252BNanofibers%252Bfor%252BPsoriasis%252BTreatment%26aulast%3DMart%25C3%25ADnez-Ortega%26aufirst%3DLeticia%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D1%26spage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharwatie  Ramsaywack</span>, <span class="hlFld-ContribAuthor ">Allyson  Bos</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Vogels</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Gray</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Westcott</span>. </span><span class="cited-content_cbyCitation_article-title">Preliminary investigations into the synthesis and antimicrobial activities of boron-containing capsaicinoids. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Chemistry</span><span> <strong>2018,</strong> <em>96 </em>
                                    (12)
                                     , 1065-1070. <a href="https://doi.org/10.1139/cjc-2018-0193" title="DOI URL">https://doi.org/10.1139/cjc-2018-0193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/cjc-2018-0193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fcjc-2018-0193%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Chemistry%26atitle%3DPreliminary%252Binvestigations%252Binto%252Bthe%252Bsynthesis%252Band%252Bantimicrobial%252Bactivities%252Bof%252Bboron-containing%252Bcapsaicinoids%26aulast%3DRamsaywack%26aufirst%3DSharwatie%26date%3D2018%26volume%3D96%26issue%3D12%26spage%3D1065%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Topical Agonists and Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Soft Analogues of Capsaicin</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the Vanillyl Isocyanides <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (1) Na<sub>2</sub>CO<sub>3</sub>, THF; (2) methyl formate, THF, 35 Â°C, 16 h, 96%. (b) imidazole, TBDMSCl, DMAP, dry DMF, rt, 2 h, 54%. (c) POCl<sub>3</sub>, TEA, dry CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 1 h, 84â87%. (d) CF<sub>3</sub>COOAg, I<sub>2</sub>, CHCl<sub>3</sub>, rt, 1 h, 84%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the First Series of Agonists (<b>7</b>â<b>25</b>) and Antagonists (<b>26</b>â<b>44</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 37% aqueous CH<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 40 Â°C, 20 h. (b) TBAF 1 M in THF, CH<sub>3</sub>COOH, THF, 0 Â°C, 30 min, 24â99%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of the 3,4-Dyhydroxybenzyl Isocyanides <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) imidazole, TBDMSCl, dry CH<sub>2</sub>Cl<sub>2</sub>, rt, 22 h, 76%. (b) ethyl formate, 52 Â°C, 28 h, 97%. (c) POCl<sub>3</sub>, TEA, dry CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 2 h, 65â87%. (d) CF<sub>3</sub>COOAg, I<sub>2</sub>, CHCl<sub>3</sub>, rt, 4 h, 66%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of the Second Series of Agonists and Antagonists <b>45</b>â<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 37% aqueous CH<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 40 Â°C, 4 h. (b) TBAF 1 M in THF, CH<sub>3</sub>COOH, THF, 0 Â°C, 3 h, 39â63%.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Metabolites <b>49</b>â<b>52</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH, H<sub>2</sub>O, THF, rt, 5 h, 47â82%. (b) 2-hydroxymethyl benzoic acid, 37% aqueous CH<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 40 Â°C, 16 h. (c) TBAF 1 M in THF, CH<sub>3</sub>COOH, THF, 0 Â°C, 3 h, 70â76%.</p></p></figure><figure data-id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Percentage of TRPV1 evoked activity of compounds <b>7</b>â<b>10</b>, <b>12</b>â<b>14</b>, and <b>16</b>â<b>19</b> plotted against its number of acyl carbons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of compound <b>36</b> on TRPV1-mediated neuronal excitability. (A) Representative MEA recording showing TRPV1-mediated neuronal spiking upon two repetitive 15-s applications of 500 nM capsaicin (P1, P2). Compound <b>36</b> at 10, 1, or 0.1 Î¼M, or vehicle or capsazepine at 10 Î¼M, applied together with second pulse of capsaicin. Finally, 40 mM KCl to ensure cell viability and excitability. (B) Concentration response effects of compound <b>36</b> on TRPV1-mediated neuronal excitability. Mean spike frequency ratio (P2/P1) (were normalized (%) to that of vehicle-treated cells (black bar), capsazepine is representated by a white bar. Statistical analysis was one-way ANOVA followed by BonferronÃ­s post-test; ****<i>p</i> < 0.0001. Data are expressed as mean Â± SEM, <i>N</i> = 3 independent nociceptor primary cultures, <i>n</i> > 100 total registered electrodes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of intraplantar administration of compound <b>36</b> on CFA-induced thermal hyperalgesia. (A) CFA injected paw (ipsilateral); (B) contralateral paw. Compound <b>36</b> was injected at the doses indicated; vehicle was used as a control. Compound <b>36</b> and vehicle were administered in the ipsilateral paw. First thermal measurement was performed upon compound/vehicle administration. Data expressed as mean Â± SEM, <i>n</i> = 5 mice per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni est by multiple comparison. ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; **<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of intravenous injection on CFA-induced thermal hyperalgesia. (A) CFA injected paw (ipsilateral); (B) contralateral paw. Compound <b>36</b> was injected at the doses indicated; vehicle was used as a control. Animals with an inflammation received vehicle intravenously and were used as control. First thermal measurement was performed upon compound/vehicle administration. Data expressed as mean Â± SEM, <i>n</i> = 5 animals per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison. ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; **<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>36</b> on histaminergic pruritus. The transient effect induced by histamine was observed during 30 min having the peak at 10â15 min interval after injection. White bars denote animals administered with vehicle; black bars, denote animals instillated with compound <b>36</b>. The licking time was measured in the 5 min interval denoted in the <i>x</i>-axis. Data expressed as mean Â± SEM, <i>n</i> = 6 animals per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>36</b> on non-histaminergic pruritus. The transient effect induced by chloroquine was observed during 25 min having the peak at 5â10 min interval after injection. White bars denote animals administered with vehicle; black bars, denote animals instillated with compound <b>36</b>. The licking time was measured in the 5 min interval denoted in the <i>x</i>-axis. Data expressed as mean Â± SEM, <i>n</i> = 6 mice per group. Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison ****<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/medium/jm-2018-00109d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0008.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compounds after IV administration on body temperature in mice. BCTC at 3 mg/kg, compound <b>36</b> at 10 mg/kg and vehicle (1% DMSO in saline). Data are expressed as mean Â± SEM (<i>n</i> = 5 mice). Statistical analysis was two-way ANOVA followed by post hoc Bonferroni test by multiple comparison test compared with the vehicle-treated group, *<i>p</i> < 0.05; ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00109/20180517/images/large/jm-2018-00109d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00109&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westaway, S. M.</span></span> <span> </span><span class="NLM_article-title">The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2589</span>â <span class="NLM_lpage">2596</span>, <span class="refDoi">Â DOI: 10.1021/jm060637e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060637e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2589-2596&author=S.+M.+Westaway&title=The+potential+of+transient+receptor+potential+vanilloid+type+1+channel+modulators+for+the+treatment+of+pain&doi=10.1021%2Fjm060637e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm060637e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060637e%26sid%3Dliteratum%253Aachs%26aulast%3DWestaway%26aufirst%3DS.%2BM.%26atitle%3DThe%2520potential%2520of%2520transient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520channel%2520modulators%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2589%26epage%3D2596%26doi%3D10.1021%2Fjm060637e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuziwara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denda, M.</span></span> <span> </span><span class="NLM_article-title">Functional vanillin receptors in cultured normal human epidermal keratinocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">124</span>â <span class="NLM_lpage">129</span>, <span class="refDoi">Â DOI: 10.1006/bbrc.2002.6393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1006%2Fbbrc.2002.6393" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2002&pages=124-129&author=K.+Inoueauthor=S.+Koizumiauthor=S.+Fuziwaraauthor=S.+Dendaauthor=K.+Inoueauthor=M.+Denda&title=Functional+vanillin+receptors+in+cultured+normal+human+epidermal+keratinocytes&doi=10.1006%2Fbbrc.2002.6393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2002.6393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2002.6393%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKoizumi%26aufirst%3DS.%26aulast%3DFuziwara%26aufirst%3DS.%26aulast%3DDenda%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DDenda%26aufirst%3DM.%26atitle%3DFunctional%2520vanillin%2520receptors%2520in%2520cultured%2520normal%2520human%2520epidermal%2520keratinocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D291%26spage%3D124%26epage%3D129%26doi%3D10.1006%2Fbbrc.2002.6393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szollosi, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biro, T.</span></span> <span> </span><span class="NLM_article-title">TRP channels in the skin</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">2568</span>â <span class="NLM_lpage">2581</span>, <span class="refDoi">Â DOI: 10.1111/bph.12569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1111%2Fbph.12569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=24372189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvV2isb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=2568-2581&author=B.+I.+Tothauthor=A.+Olahauthor=A.+G.+Szollosiauthor=T.+Biro&title=TRP+channels+in+the+skin&doi=10.1111%2Fbph.12569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TRP channels in the skin</span></div><div class="casAuthors">Toth, Balazs I.; Olah, Attila; Szoellosi, Attila Gabor; Biro, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2568-2581</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Emerging evidence suggests that transient receptor potential (TRP) ion channels not only act as 'polymodal cellular sensors' on sensory neurons but are also functionally expressed by a multitude of non-neuronal cell types.  This is esp. true in the skin, one of the largest organs of the body, where they appear to be critically involved in regulating various cutaneous functions both under physiol. and pathophysiol. conditions.  In this review, we focus on introducing the roles of several cutaneous TRP channels in the regulation of the skin barrier, skin cell proliferation and differentiation, and immune functions.  Moreover, we also describe the putative involvement of several TRP channels in the development of certain skin diseases and identify future TRP channel-targeted therapeutic opportunities.  Linked Articles : This article is part of a themed section on the pharmacol. of TRP channels.  To view the other articles in this section visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7lCuog2PFY7Vg90H21EOLACvtfcHk0ljVCcVL2vY7vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvV2isb0%253D&md5=61596db81f2b065823cace10dc24c116</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12569%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DB.%2BI.%26aulast%3DOlah%26aufirst%3DA.%26aulast%3DSzollosi%26aufirst%3DA.%2BG.%26aulast%3DBiro%26aufirst%3DT.%26atitle%3DTRP%2520channels%2520in%2520the%2520skin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D2568%26epage%3D2581%26doi%3D10.1111%2Fbph.12569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">BirÃ², T.</span>; <span class="NLM_string-name">Paus, R.</span></span> <span> </span><span class="NLM_article-title">TRP channels in cutaneous biology in health and disease</span>. In  <i>TRP Channels in Health and Disease: Implications for Diagnosis and Therapy</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>, Ed.; <span class="NLM_publisher-name">Nova Science Publishers Inc</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">331</span>â <span class="NLM_lpage">361</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=331-361&author=T.+Bir%C3%B2&author=R.+Pausauthor=A.+Szallasi&title=TRP+Channels+in+Health+and+Disease%3A+Implications+for+Diagnosis+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBir%25C3%25B2%26aufirst%3DT.%26atitle%3DTRP%2520channels%2520in%2520cutaneous%2520biology%2520in%2520health%2520and%2520disease%26btitle%3DTRP%2520Channels%2520in%2520Health%2520and%2520Disease%253A%2520Implications%2520for%2520Diagnosis%2520and%2520Therapy%26aulast%3DSzallasi%26aufirst%3DA.%26pub%3DNova%2520Science%2520Publishers%2520Inc%26date%3D2011%26spage%3D331%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Caterina, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Z.</span></span> <span> </span><span class="NLM_article-title">TRP channels in skin biology and pathophysiology</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">77</span>â <span class="NLM_lpage">104</span>, <span class="refDoi">Â DOI: 10.3390/ph9040077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fph9040077" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=77-104&author=M.+J.+Caterinaauthor=Z.+Pang&title=TRP+channels+in+skin+biology+and+pathophysiology&doi=10.3390%2Fph9040077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3390%2Fph9040077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9040077%26sid%3Dliteratum%253Aachs%26aulast%3DCaterina%26aufirst%3DM.%2BJ.%26aulast%3DPang%26aufirst%3DZ.%26atitle%3DTRP%2520channels%2520in%2520skin%2520biology%2520and%2520pathophysiology%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D77%26epage%3D104%26doi%3D10.3390%2Fph9040077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gouin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LâHerondelle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebonvallet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Gall-Ianotto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BuhÃ©, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PlÃ©e-Gautier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CarrÃ¨, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefeuvre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misery, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGarrec, R.</span></span> <span> </span><span class="NLM_article-title">TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization</span>. <i>Protein Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">644</span>â <span class="NLM_lpage">661</span>, <span class="refDoi">Â DOI: 10.1007/s13238-017-0395-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1007%2Fs13238-017-0395-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=28364279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsV2ntbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=644-661&author=O.+Gouinauthor=K.+L%E2%80%99Herondelleauthor=N.+Lebonvalletauthor=C.+Le+Gall-Ianottoauthor=M.+Sakkaauthor=V.+Buh%C3%A9author=E.+Pl%C3%A9e-Gautierauthor=J.+L.+Carr%C3%A8author=L.+Lefeuvreauthor=L.+Miseryauthor=R.+LeGarrec&title=TRPV1+and+TRPA1+in+cutaneous+neurogenic+and+chronic+inflammation%3A+pro-inflammatory+response+induced+by+their+activation+and+their+sensitization&doi=10.1007%2Fs13238-017-0395-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization</span></div><div class="casAuthors">Gouin, Olivier; L'Herondelle, Killian; Lebonvallet, Nicolas; Le Gall-Ianotto, Christelle; Sakka, Mehdi; Buhe, Virginie; Plee-Gautier, Emmanuelle; Carre, Jean-Luc; Lefeuvre, Luc; Misery, Laurent; Le Garrec, Raphaele</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">644-661</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">Cutaneous neurogenic inflammation (CNI) is inflammation that is induced (or enhanced) in the skin by the release of neuropeptides from sensory nerve endings.  Clin. manifestations are mainly sensory and vascular disorders such as pruritus and erythema.  Transient receptor potential vanilloid 1 and ankyrin 1 (TRPV1 and TRPA1, resp.) are non-selective cation channels known to specifically participate in pain and CNI.  Both TRPV1 and TRPA1 are co-expressed in a large subset of sensory nerves, where they integrate numerous noxious stimuli.  It is now clear that the expression of both channels also extends far beyond the sensory nerves in the skin, occurring also in keratinocytes, mast cells, dendritic cells, and endothelial cells.  In these non-neuronal cells, TRPV1 and TRPA1 also act as nociceptive sensors and potentiate the inflammatory process.  This review discusses the role of TRPV1 and TRPA1 in the modulation of inflammatory genes that leads to or maintains CNI in sensory neurons and non-neuronal skin cells.  In addn., this review provides a summary of current research on the intracellular sensitization pathways of both TRP channels by other endogenous inflammatory mediators that promote the self-maintenance of CNI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUvZwJE9WRsbVg90H21EOLACvtfcHk0ljVCcVL2vY7vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsV2ntbY%253D&md5=5406a1a52afbee50b0291e821e9c79bf</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1007%2Fs13238-017-0395-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-017-0395-5%26sid%3Dliteratum%253Aachs%26aulast%3DGouin%26aufirst%3DO.%26aulast%3DL%25E2%2580%2599Herondelle%26aufirst%3DK.%26aulast%3DLebonvallet%26aufirst%3DN.%26aulast%3DLe%2BGall-Ianotto%26aufirst%3DC.%26aulast%3DSakka%26aufirst%3DM.%26aulast%3DBuh%25C3%25A9%26aufirst%3DV.%26aulast%3DPl%25C3%25A9e-Gautier%26aufirst%3DE.%26aulast%3DCarr%25C3%25A8%26aufirst%3DJ.%2BL.%26aulast%3DLefeuvre%26aufirst%3DL.%26aulast%3DMisery%26aufirst%3DL.%26aulast%3DLeGarrec%26aufirst%3DR.%26atitle%3DTRPV1%2520and%2520TRPA1%2520in%2520cutaneous%2520neurogenic%2520and%2520chronic%2520inflammation%253A%2520pro-inflammatory%2520response%2520induced%2520by%2520their%2520activation%2520and%2520their%2520sensitization%26jtitle%3DProtein%2520Cell%26date%3D2017%26volume%3D8%26spage%3D644%26epage%3D661%26doi%3D10.1007%2Fs13238-017-0395-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BirÃ², T.</span></span> <span> </span><span class="NLM_article-title">TRP channels and pruritus</span>. <i>Open Pain J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">62</span>â <span class="NLM_lpage">80</span>, <span class="refDoi">Â DOI: 10.2174/1876386301306010062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2174%2F1876386301306010062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=62-80&author=B.+I.+Tothauthor=T.+Bir%C3%B2&title=TRP+channels+and+pruritus&doi=10.2174%2F1876386301306010062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">TRP channels and pruritus</span></div><div class="casAuthors">Toth, Balazs I.; Biro, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Open Pain Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-80</span>CODEN:
                <span class="NLM_cas:coden">OPJPHI</span>;
        ISSN:<span class="NLM_cas:issn">1876-3863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Itch (pruritus) is one of the most often seen sensory phenomena in clin. practice.  Recent neurophysiol. findings proposed the existence of a novel pruriceptive system which includes a multitude of pruritogenic (itch-inducing) peripheral mediators, itch-selective pruriceptors, sensory afferent networks, spinal cord neurons, and certain central nervous system regions.  In this review, we first introduce major features of the pruriceptive system.  We then focus on defining the roles of transient receptor potential (TRP) ion channels in skin-coupled itch and provide compelling evidence that certain thermosensitive TRP channels (esp. TRPV1, TRPV3, TRPV4, and TRPA1) are indeed key players in pruritus pathogenesis.  Finally, we propose TRP-centered future exptl. directions towards the therapeutic targeting of TRP channels in the clin. management of itch.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJOArhBX-fJ7Vg90H21EOLACvtfcHk0lgPIp_OSPMmRQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLnE&md5=4a1b34d5b9b4895f3e27cd7d627e56fb</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.2174%2F1876386301306010062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1876386301306010062%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DB.%2BI.%26aulast%3DBir%25C3%25B2%26aufirst%3DT.%26atitle%3DTRP%2520channels%2520and%2520pruritus%26jtitle%3DOpen%2520Pain%2520J.%26date%3D2013%26volume%3D6%26spage%3D62%26epage%3D80%26doi%3D10.2174%2F1876386301306010062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, P. M.</span></span> <span> </span><span class="NLM_article-title">Vanilloid (Capsaicin) receptors and mechanisms</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">159</span>â <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10353985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslChtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=159-212&author=A.+Szallasiauthor=P.+M.+Blumberg&title=Vanilloid+%28Capsaicin%29+receptors+and+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Vanilloid (capsaicin) receptors and mechanisms</span></div><div class="casAuthors">Szallasi, Arpad; Blumberg, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-211</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 560 refs.  Topics discussed include the targets and actions of capsaicin; direct evidence for a vanilloid (capsaicin) receptor (VR); anatomical localization and tissue specificity of VRs; evidence for multiple VRs; biochem. pharmacol. of VRs; requirements for ligand recognition by VRs; vanilloid mechanisms; diverse biol. actions of vanilloids; species-related differences in vanilloid actions; question on the existence of endogenous vanilloids; vanilloids in clin. practice; and the question on whether vanilloids are carcinogens, anticarcinogens or neither.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHzj_1onGyArVg90H21EOLACvtfcHk0lgPIp_OSPMmRQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslChtr8%253D&md5=5d472de44d8ec7436ef3dba456f4dfe0</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DBlumberg%26aufirst%3DP.%2BM.%26atitle%3DVanilloid%2520%2528Capsaicin%2529%2520receptors%2520and%2520mechanisms%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26spage%3D159%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fattori, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, M. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossaneis, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho-Ribeiro, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verri, W. A.</span></span> <span> </span><span class="NLM_article-title">Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">844</span>â <span class="NLM_lpage">876</span>, <span class="refDoi">Â DOI: 10.3390/molecules21070844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fmolecules21070844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=27367653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OqtbzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=844-876&author=V.+Fattoriauthor=M.+S.+N.+Hohmannauthor=A.+C.+Rossaneisauthor=F.+A.+Pinho-Ribeiroauthor=W.+A.+Verri&title=Capsaicin%3A+current+understanding+of+its+mechanisms+and+therapy+of+pain+and+other+pre-clinical+and+clinical+uses&doi=10.3390%2Fmolecules21070844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin: current understanding of its mechanisms and therapy of pain and other pre clinical and clinical uses</span></div><div class="casAuthors">Fattori, Victor; Hohmann, Miriam S. N.; Rossaneis, Ana C.; Pinho-Ribeiro, Felipe A.; Verri, Waldiceu A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">844/1-844/33</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In this review, we discuss the importance of capsaicin to the current understanding of neuronal modulation of pain and explore the mechanisms of capsaicin-induced pain.  We will focus on the analgesic effects of capsaicin and its clin. applicability in treating pain.  Furthermore, we will draw attention to the rationale for other clin. therapeutic uses and implications of capsaicin in diseases such as obesity, diabetes, cardiovascular conditions, cancer, airway diseases, itch, gastric, and urol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKEU34UvVq7Vg90H21EOLACvtfcHk0lgPIp_OSPMmRQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OqtbzK&md5=c9c4311e7e0e1b36ab7df8877dadd57f</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21070844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21070844%26sid%3Dliteratum%253Aachs%26aulast%3DFattori%26aufirst%3DV.%26aulast%3DHohmann%26aufirst%3DM.%2BS.%2BN.%26aulast%3DRossaneis%26aufirst%3DA.%2BC.%26aulast%3DPinho-Ribeiro%26aufirst%3DF.%2BA.%26aulast%3DVerri%26aufirst%3DW.%2BA.%26atitle%3DCapsaicin%253A%2520current%2520understanding%2520of%2520its%2520mechanisms%2520and%2520therapy%2520of%2520pain%2520and%2520other%2520pre-clinical%2520and%2520clinical%2520uses%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D844%26epage%3D876%26doi%3D10.3390%2Fmolecules21070844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, W.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>224</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">104</span>, <span class="refDoi">Â DOI: 10.1016/S0378-5173(01)00755-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2FS0378-5173%2801%2900755-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=11472818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlGgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2001&pages=89-104&author=Y.-Y.+Wangauthor=C.-T.+Hongauthor=W.-T.+Chiuauthor=J.-Y.+Fang&title=In+vitro+and+in+vivo+evaluations+of+topically+applied+capsaicin+and+nonivamide+from+hydrogels&doi=10.1016%2FS0378-5173%2801%2900755-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels</span></div><div class="casAuthors">Wang, Y.-Y.; Hong, C.-T.; Chiu, W.-T.; Fang, J.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">89-104</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was designed to investigate the in vitro and in vivo skin absorption of capsaicin and nonivamide from hydrogels.  Various commercialized creams of capsaicin were also compared with hydrogels.  Both skin stripping technique and Mexameter were applied to evaluate the level of capsaicin and nonivamide retained in stratum corneum (SC) and skin erythema in vivo.  The partition of drug between skin and the hydrogel matrix was considered to play an important role in the permeation process.  The in vitro permeation of capsaicin from hydrogels depends on the physicochem. nature and the concn. of the polymer used.  The incorporation of nonionic Pluronic F-127 polymer into hydrogels resulted in a retarded release of capsaicin.  On the other hand, the in vitro capsaicin permeation showed higher levels in cationic chitosan and anionic carboxymethyl-cellulose (CMC) hydrogels than cream bases.  The permeation of nonivamide was retarded at the late stage of in vitro application.  The inter-subject variation was more significant in the in vivo study than in vitro skin permeation expts.  The cream induced in vivo skin erythema depending on the drug concn., however, the dose-dependence was not obsd. in hydrogels.  Nonivamide-treated skin showed stronger erythema than capsaicin-treated skin.  The present study indicates that there is a moderate correlation between in vitro skin permeation and in vivo erythema responses of topically applied capsaicin and nonivamide.  The correlation between drug amt. in SC and skin erythema test in vivo was also obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67gRCf2ArwLVg90H21EOLACvtfcHk0lhVV-c-qZj1-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlGgu7c%253D&md5=1e9ad4077d538ffc8bcc1aea13b99bff</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0378-5173%2801%2900755-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-5173%252801%252900755-4%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-Y.%26aulast%3DHong%26aufirst%3DC.-T.%26aulast%3DChiu%26aufirst%3DW.-T.%26aulast%3DFang%26aufirst%3DJ.-Y.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluations%2520of%2520topically%2520applied%2520capsaicin%2520and%2520nonivamide%2520from%2520hydrogels%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2001%26volume%3D224%26spage%3D89%26epage%3D104%26doi%3D10.1016%2FS0378-5173%2801%2900755-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">The two faces of capsaicin</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2809</span>â <span class="NLM_lpage">2814</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-10-3756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1158%2F0008-5472.CAN-10-3756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=21487045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWjsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2809-2814&author=A.+M.+Bodeauthor=Z.+Dong&title=The+two+faces+of+capsaicin&doi=10.1158%2F0008-5472.CAN-10-3756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Two Faces of Capsaicin</span></div><div class="casAuthors">Bode, Ann M.; Dong, Zigang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2809-2814</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is the principal pungent component in hot peppers, including red chili peppers, jalapen~os, and habaneros.  Consumed worldwide, capsaicin has a long and convoluted history of controversy about whether its consumption or topical application is entirely safe.  Conflicting epidemiol. data and basic research study results suggest that capsaicin can act as a carcinogen or as a cancer preventive agent.  Capsaicin is unique among naturally occurring irritant compds. because the initial neuronal excitation evoked is followed by a long-lasting refractory period, during which the previously excited neurons are no longer responsive to a broad range of stimuli.  This process is referred to as desensitization and has been exploited for its therapeutic potential.  Capsaicin-contg. creams have been in clin. use for many years to relieve a variety of painful conditions.  However, their effectiveness in pain relief is also highly debated and some adverse side effects have been reported.  We have found that chronic, long-term topical application of capsaicin increased skin carcinogenesis in mice treated with a tumor promoter.  These results might imply that caution should be exercised when using capsaicin-contg. topical applications in the presence of a tumor promoter, such as, for example, sunlight.  Cancer Res; 71(8); 2809-14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7KBpaS8G9PLVg90H21EOLACvtfcHk0lhVV-c-qZj1-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWjsrw%253D&md5=bb7c1b853cf0adfd6ac4e478dafcda71</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3756%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DThe%2520two%2520faces%2520of%2520capsaicin%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2809%26epage%3D2814%26doi%3D10.1158%2F0008-5472.CAN-10-3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, D. M.</span></span> <span> </span><span class="NLM_article-title">Capsaicin 8% topical patch (Qutenza) - a review of the evidence</span>. <i>J. Pain Palliat. Care Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">32</span>â <span class="NLM_lpage">41</span>, <span class="refDoi">Â DOI: 10.3109/15360288.2010.547561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3109%2F15360288.2010.547561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=21426216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ovVCgsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=32-41&author=V.+M.+Jonesauthor=K.+A.+Mooreauthor=D.+M.+Peterson&title=Capsaicin+8%25+topical+patch+%28Qutenza%29+-+a+review+of+the+evidence&doi=10.3109%2F15360288.2010.547561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin 8% topical patch (Qutenza)--a review of the evidence</span></div><div class="casAuthors">Jones Virginia M; Moore Katrina A; Peterson David M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pain & palliative care pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Qutenza is a high-potency capsaicin (8%) topical patch, labeled for treating pain associated with postherpetic neuralgia (PHN).  Qutenza decreases pain sensation by reducing transient receptor potential vanilloid 1 (TRPV1) expression and decreasing the density of epidermal nerve fibers in the application area.  Systemic absorption from Qutenza is low.  Qutenza has not been directly compared to any other medications for the treating PHN.  Two pivotal clinical trials compared Qutenza to a control patch (0.04% capsaicin) in PHN.  The primary endpoint of both trials was the reduction in numeric pain rating scale (NPRS) score.  Qutenza reduced pain from baseline to weeks 2 to 8 (29.6% and 32% reductions) compared to control (19.9% and 24.4% reductions; P â¤ .01).  The improvement in NPRS scores persisted, with score reductions greater with Qutenza (29.9% and 32.3% reductions) compared to control (20.4% and 25% reductions; P â¤ .03) for the period 2 to 12 weeks.  Safety and efficacy of capsaicin 8% has been demonstrated in open-label trials for up to 48 weeks.  The most common adverse drug reactions occurring with capsaicin 8% are application site erythema (63%) and application site pain (42%).  Some patients experienced transient increases in blood pressure during Qutenza application.  Qutenza must be administered by a physician or under the close supervision of a physician.  Prior to application, pretreat the affected area with a topical anesthetic to reduce application site pain.  Some patients may require systemic analgesics during and after treatment for treatment-associated pain.  Applications of Qutenza can be repeated no sooner than once every 3 months, as needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaFFU2l-rPMJw7prLlxLOzfW6udTcc2eZW8ydIfVzL0bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ovVCgsw%253D%253D&md5=679f0e450ce666ff2c011bad34c253ec</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3109%2F15360288.2010.547561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15360288.2010.547561%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DV.%2BM.%26aulast%3DMoore%26aufirst%3DK.%2BA.%26aulast%3DPeterson%26aufirst%3DD.%2BM.%26atitle%3DCapsaicin%25208%2525%2520topical%2520patch%2520%2528Qutenza%2529%2520-%2520a%2520review%2520of%2520the%2520evidence%26jtitle%3DJ.%2520Pain%2520Palliat.%2520Care%2520Pharmacother.%26date%3D2011%26volume%3D25%26spage%3D32%26epage%3D41%26doi%3D10.3109%2F15360288.2010.547561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. C.</span></span> <span> </span><span class="NLM_article-title">Resiniferatoxin: The evolution of the âmolecular scalpelâ for chronic pain relief</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">57</span>, <span class="refDoi">Â DOI: 10.3390/ph9030047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fph9030047" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=47-57&author=D.+C.+Brown&title=Resiniferatoxin%3A+The+evolution+of+the+%E2%80%99molecular+scalpel%E2%80%99+for+chronic+pain+relief&doi=10.3390%2Fph9030047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fph9030047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9030047%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BC.%26atitle%3DResiniferatoxin%253A%2520The%2520evolution%2520of%2520the%2520%25E2%2580%2599molecular%2520scalpel%25E2%2580%2599%2520for%2520chronic%2520pain%2520relief%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D47%26epage%3D57%26doi%3D10.3390%2Fph9030047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, H. H.</span></span> <span> </span><span class="NLM_article-title">Activity-dependent targeting of TRPV1 with pore-permeating capsaicin analog</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">8497</span>â <span class="NLM_lpage">8502</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1018550108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1073%2Fpnas.1018550108" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=8497-8502&author=H.+Liauthor=S.+Wangauthor=A.+Y.+Chuangauthor=B.+E.+Cohenauthor=H.+H.+Chuang&title=Activity-dependent+targeting+of+TRPV1+with+pore-permeating+capsaicin+analog&doi=10.1073%2Fpnas.1018550108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1018550108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1018550108%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChuang%26aufirst%3DA.%2BY.%26aulast%3DCohen%26aufirst%3DB.%2BE.%26aulast%3DChuang%26aufirst%3DH.%2BH.%26atitle%3DActivity-dependent%2520targeting%2520of%2520TRPV1%2520with%2520pore-permeating%2520capsaicin%2520analog%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D8497%26epage%3D8502%26doi%3D10.1073%2Fpnas.1018550108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moshourab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauner, D.</span></span> <span> </span><span class="NLM_article-title">Photoswitchable fatty acids enable optical control of TRPV1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7118</span>â <span class="NLM_lpage">7128</span>, <span class="refDoi">Â DOI: 10.1038/ncomms8118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fncomms8118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=25997690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BC2Mfnt1Cquw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7118-7128&author=J.+A.+Frankauthor=M.+Moroniauthor=R.+Moshourabauthor=M.+Sumserauthor=G.+R.+Lewinauthor=D.+Trauner&title=Photoswitchable+fatty+acids+enable+optical+control+of+TRPV1&doi=10.1038%2Fncomms8118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Photoswitchable fatty acids enable optical control of TRPV1</span></div><div class="casAuthors">Frank James Allen; Sumser Martin; Trauner Dirk; Moroni Mirko; Lewin Gary R; Moshourab Rabih</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7118</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fatty acids (FAs) are not only essential components of cellular energy storage and structure, but play crucial roles in signalling.  Here we present a toolkit of photoswitchable FA analogues (FAAzos) that incorporate an azobenzene photoswitch along the FA chain.  By modifying the FAAzos to resemble capsaicin, we prepare a series of photolipids targeting the Vanilloid Receptor 1 (TRPV1), a non-selective cation channel known for its role in nociception.  Several azo-capsaicin derivatives (AzCAs) emerge as photoswitchable agonists of TRPV1 that are relatively inactive in the dark and become active on irradiation with ultraviolet-A light.  This effect can be rapidly reversed by irradiation with blue light and permits the robust optical control of dorsal root ganglion neurons and C-fibre nociceptors with precision timing and kinetics not available with any other technique.  More generally, we expect that photolipids will find many applications in controlling biological pathways that rely on protein-lipid interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnB-unffqPQcyail4HZd-ifW6udTcc2eYDXIZoIQKqmLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mfnt1Cquw%253D%253D&md5=34c274c1f24e547be3b7573eb2511f08</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncomms8118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8118%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DJ.%2BA.%26aulast%3DMoroni%26aufirst%3DM.%26aulast%3DMoshourab%26aufirst%3DR.%26aulast%3DSumser%26aufirst%3DM.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DTrauner%26aufirst%3DD.%26atitle%3DPhotoswitchable%2520fatty%2520acids%2520enable%2520optical%2520control%2520of%2520TRPV1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7118%26epage%3D7128%26doi%3D10.1038%2Fncomms8118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trevisani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, R.</span></span> <span> </span><span class="NLM_article-title">TRPV1 antagonists as analgesic agents</span>. <i>Open Pain J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">108</span>â <span class="NLM_lpage">118</span>, <span class="refDoi">Â DOI: 10.2174/1876386301306010108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2174%2F1876386301306010108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=108-118&author=M.+Trevisaniauthor=R.+Gatti&title=TRPV1+antagonists+as+analgesic+agents&doi=10.2174%2F1876386301306010108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 antagonists as analgesic agents</span></div><div class="casAuthors">Trevisani, Marcello; Gatti, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">Open Pain Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-118</span>CODEN:
                <span class="NLM_cas:coden">OPJPHI</span>;
        ISSN:<span class="NLM_cas:issn">1876-3863</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The last decade (2001-2010), declared as the Decade of Pain Control and Research by the United States Congress, brought significantly advances in our understanding of pain biol.  Unfortunately, this has not translated into addnl. effective treatments of chronic pain conditions.  Chronic pain is a debilitating and complex clin. state usually assocd. with diabetic neuropathy, postherpetic neuralgia, low back pathol., fibromyalgia, and neurol. disorders.  Std. pain drugs, even narcotic opioid analgesic agents, often provide unsatisfactory pain relief while causing important side-effect such as sedation, tolerance, dependence, respiratory depression and constipation.  Furthermore, the effective management of chronic pain needs a multidisciplinary management approach and still represents one of the most urgent unmet medical need.  Recently, preclin. research has uncovered new mol. mechanisms underlying the generation and transduction of pain, many of which represent new targets for innovative pharmacol. interventions.  This review focuses on Transient Receptor Potential (TRP) Vanilloid Type 1 (TRPV1) channel as a target for treating chronic pain.  TRPV1 is a multifunctional ion channel involved in thermosensation (heat) and taste perception.  Importantly, TRPV1 also functions as a mol. integrator for a broad variety of seemingly unrelated noxious stimuli.  Indeed, TRPV1 is thought to be a major transducer of the thermal hyperalgesia that follows inflammation and/or tissue injury.  Desensitization to topical TRPV1 agonists (e.g. capsaicin creams and patches) has been in clin. use for decades to treat chronic painful conditions like diabetic neuropathy.  Most recently, a no. of potent, small mol. TRPV1 antagonists have been advanced into clin. trials for pain relief.  Perhaps not unexpectedly given the prominent role of TRPV1 in thermosensation, some of these antagonists showed worrisome adverse effects (hyperthermia and impaired noxious heat sensation) in humans, leading to their withdrawal from clin. trials.  However, recent reports of TRPV1 antagonists that do not affect core body temp. in preclin. species suggest a potential opportunity to reduce at least this important side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGmFhbqA4Cj7Vg90H21EOLACvtfcHk0liy2LI2TGG3eA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKktLbN&md5=bfc5e776f62d16088483112982143959</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.2174%2F1876386301306010108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1876386301306010108%26sid%3Dliteratum%253Aachs%26aulast%3DTrevisani%26aufirst%3DM.%26aulast%3DGatti%26aufirst%3DR.%26atitle%3DTRPV1%2520antagonists%2520as%2520analgesic%2520agents%26jtitle%3DOpen%2520Pain%2520J.%26date%3D2013%26volume%3D6%26spage%3D108%26epage%3D118%26doi%3D10.2174%2F1876386301306010108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortright, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eid, S. R.</span></span> <span> </span><span class="NLM_article-title">The vanilloid receptor TRPV1:10 years from channel cloning to antagonist proof-of-concept</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">357</span>â <span class="NLM_lpage">372</span>, <span class="refDoi">Â DOI: 10.1038/nrd2280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fnrd2280" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=357-372&author=A.+Szallasiauthor=D.+N.+Cortrightauthor=C.+A.+Blumauthor=S.+R.+Eid&title=The+vanilloid+receptor+TRPV1%3A10+years+from+channel+cloning+to+antagonist+proof-of-concept&doi=10.1038%2Fnrd2280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2280%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DCortright%26aufirst%3DD.%2BN.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DEid%26aufirst%3DS.%2BR.%26atitle%3DThe%2520vanilloid%2520receptor%2520TRPV1%253A10%2520years%2520from%2520channel%2520cloning%2520to%2520antagonist%2520proof-of-concept%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D357%26epage%3D372%26doi%3D10.1038%2Fnrd2280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span> <span> </span><span class="NLM_article-title">Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2717</span>â <span class="NLM_lpage">2723</span>, <span class="refDoi">Â DOI: 10.1021/jm030560j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030560j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2717-2723&author=A.+Szallasiauthor=G.+Appendino&title=Vanilloid+receptor+TRPV1+antagonists+as+the+next+generation+of+painkillers.+Are+we+putting+the+cart+before+the+horse%3F&doi=10.1021%2Fjm030560j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm030560j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030560j%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DVanilloid%2520receptor%2520TRPV1%2520antagonists%2520as%2520the%2520next%2520generation%2520of%2520painkillers.%2520Are%2520we%2520putting%2520the%2520cart%2520before%2520the%2520horse%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2717%26epage%3D2723%26doi%3D10.1021%2Fjm030560j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span> <span> </span><span class="NLM_article-title">Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1576</span>â <span class="NLM_lpage">1579</span>, <span class="refDoi">Â DOI: 10.1038/jid.2011.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fjid.2011.87" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2011&pages=1576-1579&author=J.-W.+Yunauthor=F.+Seoauthor=F.+Jangauthor=F.+Kohauthor=S.+Baeauthor=C.+Parkauthor=P.+Lim&title=Antipruritic+effects+of+TRPV1+antagonist+in+murine+atopic+dermatitis+and+itching+models&doi=10.1038%2Fjid.2011.87"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1038%2Fjid.2011.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2011.87%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DJ.-W.%26aulast%3DSeo%26aufirst%3DF.%26aulast%3DJang%26aufirst%3DF.%26aulast%3DKoh%26aufirst%3DF.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26atitle%3DAntipruritic%2520effects%2520of%2520TRPV1%2520antagonist%2520in%2520murine%2520atopic%2520dermatitis%2520and%2520itching%2520models%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2011%26volume%3D131%26spage%3D1576%26epage%3D1579%26doi%3D10.1038%2Fjid.2011.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-H.</span></span> <span> </span><span class="NLM_article-title">Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin disease</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">393</span>â <span class="NLM_lpage">396</span>, <span class="refDoi">Â DOI: 10.1007/s12272-012-0321-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1007%2Fs12272-012-0321-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=22477184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVKgs7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=393-396&author=K.+M.+Limauthor=Y.-H.+Park&title=Development+of+PAC-14028%2C+a+novel+transient+receptor+potential+vanilloid+type+1+%28TRPV1%29+channel+antagonist+as+a+new+drug+for+refractory+skin+disease&doi=10.1007%2Fs12272-012-0321-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12eR"><div class="casContent"><span class="casTitleNuber">12e</span><div class="casTitle"><span class="NLM_cas:atitle">Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases</span></div><div class="casAuthors">Lim, Kyung-Min; Park, Young-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-396</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">The transient receptor potential vanilloid 1 (TRPV1) is a member of nonselective cation channels and was implicated in the progression of neurogenic inflammation and nociception.  Through the synthesis of over 2,000 new compds., a novel non-vanilloid TRPV1 antagonist PAC-14028 was discovered.  As well as ideal physicochem. and pharmacokinetic properties, PAC-14028 showed meaningful efficacies against diverse disease models that include visceral pain, inflammatory bowel disease, and inflammatory pain.  Of note, PAC-14028 effectively attenuates atopic dermatitis and pruritus without significant adverse effects, which is a substantial benefit over conventional pharmacotherapy.  This report introduces the potential of a novel TRPV1 antagonist PAC-14028 as a new drug for atopic dermatitis and pruritus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo9BrFnXwl8rVg90H21EOLACvtfcHk0lh0PBLNQT25yg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVKgs7o%253D&md5=9cbd36010540e589e62a7adba8f8bb93</span></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0321-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0321-6%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BM.%26aulast%3DPark%26aufirst%3DY.-H.%26atitle%3DDevelopment%2520of%2520PAC-14028%252C%2520a%2520novel%2520transient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520%2528TRPV1%2529%2520channel%2520antagonist%2520as%2520a%2520new%2520drug%2520for%2520refractory%2520skin%2520disease%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2012%26volume%3D35%26spage%3D393%26epage%3D396%26doi%3D10.1007%2Fs12272-012-0321-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tronino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offerta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostacolo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Caro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puglia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasi, P.</span></span> <span> </span><span class="NLM_article-title">Puglia, C.; Blasi, P. Nanoparticles prolong <i>N</i>-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">311</span>â <span class="NLM_lpage">317</span>, <span class="refDoi">Â DOI: 10.1016/j.colsurfb.2016.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.colsurfb.2016.01.058" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2016&pages=311-317&author=C.+Troninoauthor=A.+Offertaauthor=C.+Ostacoloauthor=R.+Russoauthor=C.+De+Caroauthor=A.+Calignanoauthor=C.+Pugliaauthor=P.+Blasi&title=Puglia%2C+C.%3B+Blasi%2C+P.+Nanoparticles+prolong+N-palmitoylethanolamide+anti-inflammatory+and+analgesic+effects+in+vivo&doi=10.1016%2Fj.colsurfb.2016.01.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2016.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2016.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DTronino%26aufirst%3DC.%26aulast%3DOfferta%26aufirst%3DA.%26aulast%3DOstacolo%26aufirst%3DC.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DDe%2BCaro%26aufirst%3DC.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPuglia%26aufirst%3DC.%26aulast%3DBlasi%26aufirst%3DP.%26atitle%3DPuglia%252C%2520C.%253B%2520Blasi%252C%2520P.%2520Nanoparticles%2520prolong%2520N-palmitoylethanolamide%2520anti-inflammatory%2520and%2520analgesic%2520effects%2520in%2520vivo%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2016%26volume%3D141%26spage%3D311%26epage%3D317%26doi%3D10.1016%2Fj.colsurfb.2016.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Banvolgyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palinkas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helyes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozsgai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szolcsanyi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinter, E.</span></span> <span> </span><span class="NLM_article-title">Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">86</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.jneuroim.2005.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.jneuroim.2005.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=16188326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BD2MrnvFKqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2005&pages=86-96&author=A.+Banvolgyiauthor=L.+Palinkasauthor=T.+Berkiauthor=N.+Clarkauthor=A.+D.+Grantauthor=Z.+Helyesauthor=G.+Pozsgaiauthor=J.+Szolcsanyiauthor=S.+D.+Brainauthor=E.+Pinter&title=Evidence+for+a+novel+protective+role+of+the+vanilloid+TRPV1+receptor+in+a+cutaneous+contact+allergic+dermatitis+model&doi=10.1016%2Fj.jneuroim.2005.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12gR"><div class="casContent"><span class="casTitleNuber">12g</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model</span></div><div class="casAuthors">Banvolgyi Agnes; Palinkas Laszlo; Berki Timea; Clark Natalie; Grant Andrew D; Helyes Zsuzsanna; Pozsgai Gabor; Szolcsanyi Janos; Brain Susan D; Pinter Erika</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroimmunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">86-96</span>
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    </div><div class="casAbstract">The purpose of this study was to examine the involvement of the transient receptor potential vanilloid receptor 1 (TRPV1) in inflammatory processes observed in murine allergic contact dermatitis (ACD).  Oxazolone-induced ACD evoked a significant ear swelling after 24-72 h.  It was augmented in TRPV1 knockout mice at all time points and supported by histological analysis and measure of TNF-alpha.  However, tissue swelling and cytokine generation was significantly reduced in both neurokinin 1 receptor and calcitonin gene-related peptide (CGRP) knockout mice.  A protective involvement of the TRPV1 receptor was identified of contact dermatitis distinct from mechanisms involving the major pro-inflammatory neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUYRLAtoCrkzAEfvC7EH1LfW6udTcc2ebj4kkRuZ9vubntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrnvFKqug%253D%253D&md5=4d87ceee05f8e55444dc0bb3e9fc6c5d</span></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2005.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2005.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DBanvolgyi%26aufirst%3DA.%26aulast%3DPalinkas%26aufirst%3DL.%26aulast%3DBerki%26aufirst%3DT.%26aulast%3DClark%26aufirst%3DN.%26aulast%3DGrant%26aufirst%3DA.%2BD.%26aulast%3DHelyes%26aufirst%3DZ.%26aulast%3DPozsgai%26aufirst%3DG.%26aulast%3DSzolcsanyi%26aufirst%3DJ.%26aulast%3DBrain%26aufirst%3DS.%2BD.%26aulast%3DPinter%26aufirst%3DE.%26atitle%3DEvidence%2520for%2520a%2520novel%2520protective%2520role%2520of%2520the%2520vanilloid%2520TRPV1%2520receptor%2520in%2520a%2520cutaneous%2520contact%2520allergic%2520dermatitis%2520model%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2005%26volume%3D169%26spage%3D86%26epage%3D96%26doi%3D10.1016%2Fj.jneuroim.2005.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Transient receptor potential vanilloid type 1 antagonists: a patent review (2011â2014)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">291</span>â <span class="NLM_lpage">318</span>, <span class="refDoi">Â DOI: 10.1517/13543776.2015.1008449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1517%2F13543776.2015.1008449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=25666693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit12ltb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=291-318&author=Y.+Leeauthor=S.+Hongauthor=M.+Cuiauthor=P.+K.+Sharmaauthor=J.+Leeauthor=S.+Choi&title=Transient+receptor+potential+vanilloid+type+1+antagonists%3A+a+patent+review+%282011%E2%80%932014%29&doi=10.1517%2F13543776.2015.1008449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014)</span></div><div class="casAuthors">Lee, Yoonji; Hong, Sunhye; Cui, Minghua; Sharma, Pankaz K.; Lee, Jeewoo; Choi, Sun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-318</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Transient receptor potential vanilloid type 1 (TRPV1) is a nonselective cation channel that can be activated by noxious heat, low pH and vanilloid compds. such as capsaicin.  Since TRPV1 acts as an integrator of painful stimuli, TRPV1 antagonists can be used as promising therapeutics for new types of analgesics.  Areas covered: This review article covers the patents that claim TRPV1 antagonists and were published during 2011 - 2014.  The patent evaluation is organized according to the applicant companies, and the representative chem. entities with important in vitro and in vivo data are summarized.  Expert opinion: Many pharmaceutical companies showed promising results in the discovery of potent small mol. TRPV1 antagonists, and recently, a no. of small mol. TRPV1 antagonists have been advanced into clin. trials.  Unfortunately, several candidate mols. showed crit. side effects such as hyperthermia and impaired noxious heat sensation in humans, leading to their withdrawal from clin. trials.  Some TRPV1 antagonists patented in recent years (2011 - 2014) overcame these undesirable side effects, making the development of TRPV1 antagonists much more promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtjpXsyQalxbVg90H21EOLACvtfcHk0lh0PBLNQT25yg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit12ltb8%253D&md5=6150e80eeacea466be516a03367829ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1517%2F13543776.2015.1008449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2015.1008449%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DP.%2BK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DTransient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520antagonists%253A%2520a%2520patent%2520review%2520%25282011%25E2%2580%25932014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26spage%3D291%26epage%3D318%26doi%3D10.1517%2F13543776.2015.1008449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gavva, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surapaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akrami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesslak, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palluconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanovsky, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davar, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">202</span>â <span class="NLM_lpage">210</span>, <span class="refDoi">Â DOI: 10.1016/j.pain.2008.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.pain.2008.01.024" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2008&pages=202-210&author=N.+R.+Gavvaauthor=J.+J.+Treanorauthor=A.+Garamiauthor=L.+Fangauthor=S.+Surapaneniauthor=A.+Akramiauthor=F.+Alvarezauthor=A.+Bakauthor=M.+Darlingauthor=A.+Goreauthor=G.+R.+Jangauthor=J.+P.+Kesslakauthor=L.+Niauthor=M.+H.+Normanauthor=G.+Palluconiauthor=M.+J.+Roseauthor=M.+Salfiauthor=E.+Tanauthor=A.+A.+Romanovskyauthor=C.+Banfieldauthor=G.+Davar&title=Pharmacological+blockade+of+the+vanilloid+receptor+TRPV1+elicits+marked+hyperthermia+in+humans&doi=10.1016%2Fj.pain.2008.01.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2008.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2008.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DGavva%26aufirst%3DN.%2BR.%26aulast%3DTreanor%26aufirst%3DJ.%2BJ.%26aulast%3DGarami%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DSurapaneni%26aufirst%3DS.%26aulast%3DAkrami%26aufirst%3DA.%26aulast%3DAlvarez%26aufirst%3DF.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DDarling%26aufirst%3DM.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DJang%26aufirst%3DG.%2BR.%26aulast%3DKesslak%26aufirst%3DJ.%2BP.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DPalluconi%26aufirst%3DG.%26aulast%3DRose%26aufirst%3DM.%2BJ.%26aulast%3DSalfi%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DRomanovsky%26aufirst%3DA.%2BA.%26aulast%3DBanfield%26aufirst%3DC.%26aulast%3DDavar%26aufirst%3DG.%26atitle%3DPharmacological%2520blockade%2520of%2520the%2520vanilloid%2520receptor%2520TRPV1%2520elicits%2520marked%2520hyperthermia%2520in%2520humans%26jtitle%3DPain%26date%3D2008%26volume%3D136%26spage%3D202%26epage%3D210%26doi%3D10.1016%2Fj.pain.2008.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zykova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carper, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langfald, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">779</span>â <span class="NLM_lpage">785</span>, <span class="refDoi">Â DOI: 10.1093/carcin/bgr037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1093%2Fcarcin%2Fbgr037" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=779-785&author=S.+Liauthor=A.+M.+Bodeauthor=F.+Zhuauthor=K.+Liuauthor=J.+Zhangauthor=M.+O.+Kimauthor=K.+Reddyauthor=T.+Zykovaauthor=W.-Y.+Maauthor=A.+L.+Carperauthor=A.+K.+Langfaldauthor=Z.+Dong&title=TRPV1-antagonist+AMG9810+promotes+mouse+skin+tumorigenesis+through+EGFR%2FAkt+signaling&doi=10.1093%2Fcarcin%2Fbgr037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgr037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgr037%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BO.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DZykova%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DW.-Y.%26aulast%3DCarper%26aufirst%3DA.%2BL.%26aulast%3DLangfald%26aufirst%3DA.%2BK.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DTRPV1-antagonist%2520AMG9810%2520promotes%2520mouse%2520skin%2520tumorigenesis%2520through%2520EGFR%252FAkt%2520signaling%26jtitle%3DCarcinogenesis%26date%3D2011%26volume%3D32%26spage%3D779%26epage%3D785%26doi%3D10.1093%2Fcarcin%2Fbgr037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatfield, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidgeon-Hart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, I.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagg, R.</span></span> <span> </span><span class="NLM_article-title">Do TRPV1 antagonists increase the risk for skin tumourigenesis? A collaborative in vitro and in vivo assessment</span>. <i>Cell Biol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">143</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1007/s10565-017-9407-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1007%2Fs10565-017-9407-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=28815372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCntb%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=143-162&author=M.+Parkauthor=A.+A.+Naidooauthor=A.+Burnsauthor=J.+K.+Choiauthor=K.+M.+Gatfieldauthor=M.+Vidgeon-Hartauthor=I.-H.+Baeauthor=C.+S.+Leeauthor=G.+Choiauthor=A.+J.+Powellauthor=Y.-H.+Parkauthor=R.+Fagg&title=Do+TRPV1+antagonists+increase+the+risk+for+skin+tumourigenesis%3F+A+collaborative+in+vitro+and+in+vivo+assessment&doi=10.1007%2Fs10565-017-9407-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Do TRPV1 antagonists increase the risk for skin tumourigenesis? A collaborative in vitro and in vivo assessment</span></div><div class="casAuthors">Park, Miyoung; Naidoo, Anita A.; Burns, Angie; Choi, Jin Kyu; Gatfield, Kelly M.; Vidgeon-Hart, Martin; Bae, Il-Hong; Lee, Chang Seok; Choi, Gyeyoung; Powell, Andrew J.; Park, Young-Ho; Fagg, Rajni</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-162</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A recent hypothesis suggesting that the pharmacol. target TRPV1 (transient receptor potential vanilloid subfamily, member 1) may function as a tumor suppressor, which potentially impacts the development of TRPV1 antagonist therapeutics for a range of conditions.  However, little is known about the long-term physiol. effects of TRPV1 blockade in the skin.  In vitro and in vivo studies suggested that the potent TRPV1 competitive antagonist AMG-9810 promoted proliferation in N/TERT1 cells (telomerase-immortalised primary human keratinocytes 1) and tumor development in mouse skin that was mediated through EGFR/Akt/mTOR signalling.  We attempted to reproduce the reported in vitro and in vivo findings to further explore this hypothesis to understand the underlying mechanism and the risk assocd. with TRPV1 antagonism in the skin.  In vitro proliferation studies using multiple methods and topical application with AMG-9810 and structurally similar TRPV1 antagonists such as SB-705498 and PAC-14028 were performed.  Although we confirmed expression of TRPV1 in primary human epidermal keratinocytes (HEKn) and spontaneously immortalised human keratinocytes (HaCaT), we were unable to demonstrate cell proliferation in either cell type or any clear evidence of increased expression of proteins in the EGFR/Akt/mTOR signalling pathway with these mols.  We were also unable to demonstrate skin tumor promotion or underlying mol. mechanisms involved in the EGFR/Akt/mTOR signalling pathway in a single-dose and two-stage carcinogenesis mouse study treated with TRPV1 antagonists.  In conclusion, our data suggest that inhibiting the pharmacol. function of TRPV1 in skin by specific antagonists has not been considered to be indicative of skin tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-VatNsWSUzLVg90H21EOLACvtfcHk0liShdZQ9fdI3Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCntb%252FM&md5=845a361fdb410f12889272cd80abd77a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs10565-017-9407-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10565-017-9407-8%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%26aulast%3DNaidoo%26aufirst%3DA.%2BA.%26aulast%3DBurns%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DGatfield%26aufirst%3DK.%2BM.%26aulast%3DVidgeon-Hart%26aufirst%3DM.%26aulast%3DBae%26aufirst%3DI.-H.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChoi%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DA.%2BJ.%26aulast%3DPark%26aufirst%3DY.-H.%26aulast%3DFagg%26aufirst%3DR.%26atitle%3DDo%2520TRPV1%2520antagonists%2520increase%2520the%2520risk%2520for%2520skin%2520tumourigenesis%253F%2520A%2520collaborative%2520in%2520vitro%2520and%2520in%2520vivo%2520assessment%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2018%26volume%3D34%26spage%3D143%26epage%3D162%26doi%3D10.1007%2Fs10565-017-9407-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">Soft drug design: general principles and recent applications</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">58</span>â <span class="NLM_lpage">101</span>, <span class="refDoi">Â DOI: 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10608921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=58-101&author=N.+Bodorauthor=P.+Buchwald&title=Soft+drug+design%3A+general+principles+and+recent+applications&doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drug design: general principles and recent applications</span></div><div class="casAuthors">Bodor, Nicholas; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-101</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 208 refs.  Soft drug design represents a new approach aimed to design safer drugs with an increased therapeutic index by integrating metab. considerations into the drug design process.  Soft drugs are new therapeutic agents that undergo predictable metab. to inactive metabolites after exerting their therapeutic effect.  Hence, they are obtained by building into the mol., in addn. to the activity, the most desired way in which the mol. is to be deactivated and detoxified.  In an attempt to systematize and summarize the related work done in a no. of labs., including ours, the present review presents an overview of the general soft drug design principles and provides a variety of specific examples to illustrate the concepts.  A no. of already marketed drugs, such as esmolol, remifentanil, or loteprednol etabonate, resulted from the successful application of such design principles.  Many other promising drug candidates are currently under investigation in a variety of fields including possible soft antimicrobials, anticholinergics, corticosteroids, Î²-blockers, analgetics, ACE inhibitors, antiarrhythmics, and others.  Whenever possible, pharmacokinetic and pharmacodynamic properties are briefly summarized and compared to those of other compds. used in the same field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphV1vhXwTl8LVg90H21EOLACvtfcHk0ljuu1NbOCb9jQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D&md5=e0ca493ba31d001e62a759be0fc4bcc8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200001%252920%253A1%253C58%253A%253AAID-MED3%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBodor%26aufirst%3DN.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSoft%2520drug%2520design%253A%2520general%2520principles%2520and%2520recent%2520applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D58%26epage%3D101%26doi%3D10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DÃ¶mling, A.</span></span> <span> </span><span class="NLM_article-title">Recent developments in isocyanide based multicomponent reactions in applied chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">17</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1021/cr0505728</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0505728" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FhslyntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=17-89&author=A.+D%C3%B6mling&title=Recent+developments+in+isocyanide+based+multicomponent+reactions+in+applied+chemistry&doi=10.1021%2Fcr0505728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in isocyanide based multicomponent reactions in applied chemistry</span></div><div class="casAuthors">Domling Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-89</span>
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtCMEx7SbgjiM8MEzWGjS9fW6udTcc2eZA3SB-KwaZebntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FhslyntA%253D%253D&md5=33b233fa9ca718d7e0e6db6fee49e5fd</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fcr0505728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0505728%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25B6mling%26aufirst%3DA.%26atitle%3DRecent%2520developments%2520in%2520isocyanide%2520based%2520multicomponent%2520reactions%2520in%2520applied%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D17%26epage%3D89%26doi%3D10.1021%2Fcr0505728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Domling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of multicomponent reactions</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">3083</span>â <span class="NLM_lpage">3135</span>, <span class="refDoi">Â DOI: 10.1021/cr100233r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100233r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ehsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=3083-3135&author=A.+Domlingauthor=W.+Wangauthor=K.+Wang&title=Chemistry+and+biology+of+multicomponent+reactions&doi=10.1021%2Fcr100233r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and Biology Of Multicomponent Reactions</span></div><div class="casAuthors">Domling, Alexander; Wang, Wei; Wang, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3083-3135</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors discuss the usefulness of multicomponent reactions (MCR) in medicinal chem. for drug discovery purposes.  An advantage of MCR chem. is the very large chem. space, probably the largest available chem. space for drug discovery and medicinal chem. purposes.  This also poses very high demands for the right choice of the discovery strategy, for example, high throughput screening or structure-based design.  A promising and complementary strategy which leverages the strength of MCR chem. is the use of computation screening and genetic algorithms.  In addn., MCRs can be of great value in natural product total synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwcvlT6_uy4rVg90H21EOLACvtfcHk0ljuu1NbOCb9jQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ehsbg%253D&md5=09577e3204db313fdb16807df21ab724</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fcr100233r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100233r%26sid%3Dliteratum%253Aachs%26aulast%3DDomling%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DChemistry%2520and%2520biology%2520of%2520multicomponent%2520reactions%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D3083%26epage%3D3135%26doi%3D10.1021%2Fcr100233r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Wang, M.</span></span> <i>Multicomponent Reactions in Organic Synthesis</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co.</span>: <span class="NLM_publisher-loc">Weinheim</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Zhu&author=Q.+Wang&author=M.+Wang&title=Multicomponent+Reactions+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26btitle%3DMulticomponent%2520Reactions%2520in%2520Organic%2520Synthesis%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, V.</span></span> <span> </span><span class="NLM_article-title">Multi-component reactions: emerging chemistry in drug discovery âfrom xylocain to crixivanâ</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">80</span>, <span class="refDoi">Â DOI: 10.2174/0929867033368600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2174%2F0929867033368600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=12570721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVSrtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=51-80&author=C.+Hulmeauthor=V.+Gore&title=Multi-component+reactions%3A+emerging+chemistry+in+drug+discovery+%E2%80%99from+xylocain+to+crixivan%E2%80%99&doi=10.2174%2F0929867033368600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-component reactions: emerging chemistry in drug discovery from xylocain to crixivan</span></div><div class="casAuthors">Hulme, Christopher; Gore, Vijay</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-80</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  With the recent emergence of combinatorial chem. and high-speed parallel synthesis for drug discovery applications, the multi-component reaction (MCR) has seen a resurgence of interest.  Easily automated one-pot reactions, such as the Ugi and Passerini reactions, are powerful tools for producing diverse arrays of compds., often in one step and high yield.  Despite this synthetic potential, the Ugi reaction is limited by producing products that are flexible and peptide-like, often being classified as "non drug-like".  This review details developments of new, highly atom-economic MCR derived chem. methods, which enable the fast and efficient prodn. of chem. libraries comprised of a variety of biol. relevant templates.  Representative examples will also be given demonstrating the successful impact of MCR combinatorial methods at different stages of the lead discovery, lead optimization and pre-clin. process development arenas.  This will include applications spanning biol. tools, natural products and natural product-like diversity, traditional small mol. and "biotech" therapeutics resp.  In particular, this review will focus on applications of isocyanide based MCR (IMCR) reactions.  A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe0RqQebnFkrVg90H21EOLACvtfcHk0lgl41XkMy0S3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVSrtA%253D%253D&md5=4a38e495aa941010cd026d2ace1004d5</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.2174%2F0929867033368600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033368600%26sid%3Dliteratum%253Aachs%26aulast%3DHulme%26aufirst%3DC.%26aulast%3DGore%26aufirst%3DV.%26atitle%3DMulti-component%2520reactions%253A%2520emerging%2520chemistry%2520in%2520drug%2520discovery%2520%25E2%2580%2599from%2520xylocain%2520to%2520crixivan%25E2%2580%2599%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D51%26epage%3D80%26doi%3D10.2174%2F0929867033368600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ruijter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orru, R. V.</span></span> <span> </span><span class="NLM_article-title">Multicomponent reactions - opportunities for the pharmaceutical industry</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e15</span>â <span class="NLM_lpage">e20</span>, <span class="refDoi">Â DOI: 10.1016/j.ddtec.2012.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.ddtec.2012.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=24050225" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=e15-e20&author=E.+Ruijterauthor=R.+V.+Orru&title=Multicomponent+reactions+-+opportunities+for+the+pharmaceutical+industry&doi=10.1016%2Fj.ddtec.2012.10.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2012.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2012.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DRuijter%26aufirst%3DE.%26aulast%3DOrru%26aufirst%3DR.%2BV.%26atitle%3DMulticomponent%2520reactions%2520-%2520opportunities%2520for%2520the%2520pharmaceutical%2520industry%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2013%26volume%3D10%26spage%3De15%26epage%3De20%26doi%3D10.1016%2Fj.ddtec.2012.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Passerini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isonitrili, I.</span></span> <span> </span><span class="NLM_article-title">Composti del pâisonitrileazobenzene con acetone e acidoacetico</span>. <i>Gazz. Chim. Ital.</i> <span class="NLM_year" style="font-weight: bold;">1921</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">126</span>â <span class="NLM_lpage">129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1921&pages=126-129&author=M.+Passeriniauthor=I.+Isonitrili&title=Composti+del+p%E2%80%93isonitrileazobenzene+con+acetone+e+acidoacetico"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasserini%26aufirst%3DM.%26aulast%3DIsonitrili%26aufirst%3DI.%26atitle%3DComposti%2520del%2520p%25E2%2580%2593isonitrileazobenzene%2520con%2520acetone%2520e%2520acidoacetico%26jtitle%3DGazz.%2520Chim.%2520Ital.%26date%3D1921%26volume%3D51%26spage%3D126%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, L.</span>; <span class="NLM_string-name">Riva, R.</span></span> <span> </span><span class="NLM_article-title">The Passerini reaction</span>. In  <i>Organic Reactions</i>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2005</span>; Vol.  <span class="NLM_volume">65</span>, pp  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1002%2F0471264180.or065.01" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=1-140&author=L.+Banfi&author=R.+Riva&title=Organic+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or065.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471264180.or065.01%26sid%3Dliteratum%253Aachs%26aulast%3DBanfi%26aufirst%3DL.%26atitle%3DThe%2520Passerini%2520reaction%26btitle%3DOrganic%2520Reactions%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2005%26volume%3D65%26spage%3D1%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarov-Yarovoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span> <span> </span><span class="NLM_article-title">Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">518</span>â <span class="NLM_lpage">524</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fnchembio.1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=26053297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ygsbrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=518-524&author=F.+Yangauthor=W.+Chengauthor=W.+Yangauthor=P.+Yuauthor=Z.+Songauthor=V.+Yarov-Yarovoyauthor=J.+Zhengauthor=X.+Xiao&title=Structural+mechanism+underlying+capsaicin+binding+and+activation+of+the+TRPV1+ion+channel&doi=10.1038%2Fnchembio.1835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel</span></div><div class="casAuthors">Yang, Fan; Xiao, Xian; Cheng, Wei; Yang, Wei; Yu, Peilin; Song, Zhenzhen; Yarov-Yarovoy, Vladimir; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">518-524</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Capsaicin (CAP) adds spiciness to foods by activating TRPV1 channel with exquisite potency and selectivity.  Although a capsaicin-bound channel structure was previously resolved by cryo-EM at 4.2- to 4.5-Ã resoln., capsaicin was registered as a small electron d., reflecting neither its chem. structure nor specific ligand-channel interactions - important details required for mechanistic understanding.  We obtained the missing at.-level details by iterative computation and confirmed them by systematic site-specific functional tests.  We obsd. that the bound capsaicin takes a 'tail-up, head-down' configuration.  The vanillyl and amide groups form specific interactions to anchor its bound position, while the aliph. tail may sample a range of conformations, making it invisible in cryo-EM images.  Capsaicin stabilizes TRPV1's open (O) state by 'pull-and-contact' interactions between the vanillyl group and the S4-S5 linker.  Our study provides a structural mechanism for the agonistic function of capsaicin and its analogs, and demonstrates an effective approach to obtain at.-level information from cryo-EM structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjPDL4IyhjWrVg90H21EOLACvtfcHk0lgl41XkMy0S3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ygsbrN&md5=3febf24841cb0c3e91b8449de45c4563</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1835%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DYarov-Yarovoy%26aufirst%3DV.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DX.%26atitle%3DStructural%2520mechanism%2520underlying%2520capsaicin%2520binding%2520and%2520activation%2520of%2520the%2520TRPV1%2520ion%2520channel%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D518%26epage%3D524%26doi%3D10.1038%2Fnchembio.1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foged, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, C.</span></span> <span> </span><span class="NLM_article-title">Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1124/mol.59.1.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fmol.59.1.9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=9-15&author=P.+Wahlauthor=C.+Fogedauthor=S.+Tullinauthor=C.+Thomsen&title=Iodo-resiniferatoxin%2C+a+new+potent+vanilloid+receptor+antagonist&doi=10.1124%2Fmol.59.1.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.1.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.1.9%26sid%3Dliteratum%253Aachs%26aulast%3DWahl%26aufirst%3DP.%26aulast%3DFoged%26aufirst%3DC.%26aulast%3DTullin%26aufirst%3DS.%26aulast%3DThomsen%26aufirst%3DC.%26atitle%3DIodo-resiniferatoxin%252C%2520a%2520new%2520potent%2520vanilloid%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D9%26epage%3D15%26doi%3D10.1124%2Fmol.59.1.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daddario, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriello, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">The taming of capsaicin. Reversal of the vanilloid activity of N-Acylvanillamines by aromatic iodination</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4663</span>â <span class="NLM_lpage">4669</span>, <span class="refDoi">Â DOI: 10.1021/jm050139q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050139q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFSmtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4663-4669&author=G.+Appendinoauthor=N.+Daddarioauthor=A.+Minassiauthor=A.+S.+Morielloauthor=L.+De+Petrocellisauthor=V.+Di+Marzo&title=The+taming+of+capsaicin.+Reversal+of+the+vanilloid+activity+of+N-Acylvanillamines+by+aromatic+iodination&doi=10.1021%2Fjm050139q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Taming of Capsaicin. Reversal of the Vanilloid Activity of N-Acylvanillamines by Aromatic Iodination</span></div><div class="casAuthors">Appendino, Giovanni; Daddario, Nives; Minassi, Alberto; Moriello, Aniello Schiano; De Petrocellis, Luciano; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4663-4669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arom. iodination ortho to the phenolic hydroxyl reverts the activity of the ultrapotent vanilloid agonist resiniferatoxin (RTX), generating the ultrapotent antagonist 5'-iodoRTX.  To better understand the role of iodine in this remarkable switch of activity, a systematic investigation on the halogenation of vanillamides, a class of compds. structurally simpler than resiniferonoids, was carried out.  The results showed that (a) the antagonistic activity depends on the site of halogenation and is maximal at C-6', (b) iodine is more efficient than chlorine and bromine at reverting the agonistic activity, and (c) iodine-carbon exchange decreases antagonist activity.  Iodine-induced reversal of vanilloid activity was also obsd. in vanillamides more powerful than capsaicin, but a poor correlation was found between agonistic and antagonistic potencies, suggesting that differences exist in the way vanillamides and their 6'-iodo derivs. bind to TRPV1.''.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_TtNSCuRwyrVg90H21EOLACvtfcHk0ljW5i6T4YhnyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFSmtbY%253D&md5=9def27ca7df975b545a8d23858d3c3c1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm050139q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050139q%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26aulast%3DDaddario%26aufirst%3DN.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DMoriello%26aufirst%3DA.%2BS.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DThe%2520taming%2520of%2520capsaicin.%2520Reversal%2520of%2520the%2520vanilloid%2520activity%2520of%2520N-Acylvanillamines%2520by%2520aromatic%2520iodination%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4663%26epage%3D4669%26doi%3D10.1021%2Fjm050139q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">N-acylanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3739</span>â <span class="NLM_lpage">3745</span>, <span class="refDoi">Â DOI: 10.1021/jm020844o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020844o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3739-3745&author=G.+Appendinoauthor=A.+Minassiauthor=A.+S.+Morelloauthor=L.+De+Petrocellisauthor=V.+Di+Marzo&title=N-acylanillamides%3A+development+of+an+expeditious+synthesis+and+discovery+of+new+acyl+templates+for+powerful+activation+of+the+vanilloid+receptor&doi=10.1021%2Fjm020844o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm020844o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020844o%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DMorello%26aufirst%3DA.%2BS.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DN-acylanillamides%253A%2520development%2520of%2520an%2520expeditious%2520synthesis%2520and%2520discovery%2520of%2520new%2520acyl%2520templates%2520for%2520powerful%2520activation%2520of%2520the%2520vanilloid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3739%26epage%3D3745%26doi%3D10.1021%2Fjm020844o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevisani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daddario, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriello, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzieri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geppetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Development of the first ultra-potent âcapsaicinoidâ agonist transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential</span>. <i>J. Pharm. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">561</span>â <span class="NLM_lpage">570</span>, <span class="refDoi">Â DOI: 10.1124/jpet.104.074864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fjpet.104.074864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=15356216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCnsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=561-570&author=G.+Appendinoauthor=L.+De+Petrocellisauthor=M.+Trevisaniauthor=A.+Minassiauthor=N.+Daddarioauthor=A.+S.+Morielloauthor=D.+Gazzieriauthor=A.+Ligrestiauthor=B.+Campiauthor=G.+Fontanaauthor=C.+Pinnaauthor=P.+Geppettiauthor=V.+Di+Marzo&title=Development+of+the+first+ultra-potent+%E2%80%9Ccapsaicinoid%E2%80%9D+agonist+transient+receptor+potential+vanilloid+type+1+%28TRPV1%29+channels+and+its+therapeutic+potential&doi=10.1124%2Fjpet.104.074864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential</span></div><div class="casAuthors">Appendino, Giovanni; De Petrocellis, Luciano; Trevisani, Marcello; Minassi, Alberto; Daddario, Nives; Moriello, Aniello Schiano; Gazzieri, David; Ligresti, Alessia; Campi, Barbara; Fontana, Gabriele; Pinna, Christian; Geppetti, Pierangelo; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">561-570</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Olvanil (N-9-Z-octadecenoyl-vanillamide) is an agonist of transient receptor potential vanilloid type 1 (TRPV1) channels that lack the pungency of capsaicin and was developed as an oral analgesic.  Vanillamides are unmatched in terms of structural simplicity, straightforward synthesis, and safety compared with the more powerful TRPV1 agonists, like the structurally complex phorboid compd. resiniferatoxin.  The authors have modified the fatty acyl chain of olvanil to obtain ultra-potent analogs.  The insertion of a hydroxyl group at C-12 yielded a compd. named rinvanil, after ricinoleic acid, significantly less potent than olvanil (EC50 = 6 vs. 0.7 nM), but more versatile in terms of structural modifications because of the presence of an addnl. functional group.  Acetylation and phenylacetylation of rinvanil reestablished and dramatically enhanced, resp., its potency at hTRPV1.  With a two-digit picomolar EC50 (90 pM), phenylacetylrinvanil (PhAR, IDN5890) is the most potent vanillamide ever described with potency comparable with that of resiniferatoxin (EC50, 11 pM).  Benzoyl- and phenylpropionylrinvanil were as potent and less potent than PhAR, resp., whereas configurational inversion to ent-PhAR and cyclopropanation (but not hydrogenation or epoxidn.) of the double bond were tolerated.  Finally, iodination of the arom. hydroxyl caused a dramatic switch in functional activity, generating compds. that behaved as TRPV1 antagonists rather than agonists.  Since the potency of PhAR was maintained in rat dorsal root ganglion neurons and, particularly, in the rat urinary bladder, this compd. was investigated in an in vivo rat model of urinary incontinence and proved as effective as resiniferatoxin at reducing bladder detrusor overactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyHSRYmqtTE7Vg90H21EOLACvtfcHk0ljW5i6T4YhnyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCnsb8%253D&md5=eb0a31cb066693c6a88d0a7cb1cdd353</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.074864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.074864%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DTrevisani%26aufirst%3DM.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDaddario%26aufirst%3DN.%26aulast%3DMoriello%26aufirst%3DA.%2BS.%26aulast%3DGazzieri%26aufirst%3DD.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DCampi%26aufirst%3DB.%26aulast%3DFontana%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DC.%26aulast%3DGeppetti%26aufirst%3DP.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DDevelopment%2520of%2520the%2520first%2520ultra-potent%2520%25E2%2580%259Ccapsaicinoid%25E2%2580%259D%2520agonist%2520transient%2520receptor%2520potential%2520vanilloid%2520type%25201%2520%2528TRPV1%2529%2520channels%2520and%2520its%2520therapeutic%2520potential%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D561%26epage%3D570%26doi%3D10.1124%2Fjpet.104.074864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigglesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J.</span></span> <span> </span><span class="NLM_article-title">Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic â³A-regionâ³</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2362</span>â <span class="NLM_lpage">2372</span>, <span class="refDoi">Â DOI: 10.1021/jm00068a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2362-2372&author=C.+S.+J.+Walpoleauthor=R.+Wrigglesworthauthor=S.+Bevanauthor=E.+A.+Campbellauthor=A.+Drayauthor=I.+F.+Jamesauthor=M.+N.+Perkinsauthor=D.+J.+Reidauthor=J.+Winter&title=Analogs+of+capsaicin+with+agonist+activity+as+novel+analgesic+agents%3B+structure-activity+studies.+1.+The+aromatic+%E2%80%B3A-region%E2%80%B3&doi=10.1021%2Fjm00068a014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a014%26sid%3Dliteratum%253Aachs%26aulast%3DWalpole%26aufirst%3DC.%2BS.%2BJ.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DBevan%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DE.%2BA.%26aulast%3DDray%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DI.%2BF.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DReid%26aufirst%3DD.%2BJ.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DAnalogs%2520of%2520capsaicin%2520with%2520agonist%2520activity%2520as%2520novel%2520analgesic%2520agents%253B%2520structure-activity%2520studies.%25201.%2520The%2520aromatic%2520%25E2%2580%25B3A-region%25E2%2580%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2362%26epage%3D2372%26doi%3D10.1021%2Fjm00068a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griglio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirali, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">The use of 2-hydroxymethyl benzoic acid as an effective water surrogate in the Passerini reaction: A straightforward access to Î±-hydroxyamides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4786</span>â <span class="NLM_lpage">4789</span>, <span class="refDoi">Â DOI: 10.1016/j.tetlet.2017.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2Fj.tetlet.2017.11.021" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=4786-4789&author=M.+Serafiniauthor=A.+Griglioauthor=E.+Obertoauthor=T.+Piraliauthor=G.+C.+Tron&title=The+use+of+2-hydroxymethyl+benzoic+acid+as+an+effective+water+surrogate+in+the+Passerini+reaction%3A+A+straightforward+access+to+%CE%B1-hydroxyamides&doi=10.1016%2Fj.tetlet.2017.11.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2017.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2017.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DSerafini%26aufirst%3DM.%26aulast%3DGriglio%26aufirst%3DA.%26aulast%3DOberto%26aufirst%3DE.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DThe%2520use%2520of%25202-hydroxymethyl%2520benzoic%2520acid%2520as%2520an%2520effective%2520water%2520surrogate%2520in%2520the%2520Passerini%2520reaction%253A%2520A%2520straightforward%2520access%2520to%2520%25CE%25B1-hydroxyamides%26jtitle%3DTetrahedron%2520Lett.%26date%3D2017%26volume%3D58%26spage%3D4786%26epage%3D4789%26doi%3D10.1016%2Fj.tetlet.2017.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La Spisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mossetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">An efficient synthesis of symmetric and unsymmetric bis-(Î²-aminoamides) via Ugi multicomponent reaction</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6044</span>â <span class="NLM_lpage">6047</span>, <span class="refDoi">Â DOI: 10.1021/ol302935y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol302935y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=6044-6047&author=F.+La+Spisaauthor=A.+Feoauthor=R.+Mossettiauthor=G.+C.+Tron&title=An+efficient+synthesis+of+symmetric+and+unsymmetric+bis-%28%CE%B2-aminoamides%29+via+Ugi+multicomponent+reaction&doi=10.1021%2Fol302935y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Synthesis of Symmetric and Unsymmetric Bis-(Î²-aminoamides) via Ugi Multicomponent Reaction</span></div><div class="casAuthors">La Spisa, Fabio; Feo, Alberto; Mossetti, Riccardo; Tron, Gian Cesare</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6044-6047</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A library of sym. and unsym. bis-(Î²-aminoamides) has been prepd. starting from sym. secondary diamines by using a double Ugi four-component reaction.  A sacrificial Mumm rearrangement, thanks to the use of 2-(hydroxymethyl)benzoic acid, is necessary to suppress the competing split-Ugi reaction, increasing the yield and simplifying the purifn. step.  The scope, the reaction conditions, and the role of water in trapping the nitrilium intermediate are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4qI64fofl7Vg90H21EOLACvtfcHk0liyFEdHUeNsIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs73I&md5=34920b54a116d0ef186f248a1f37f569</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fol302935y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol302935y%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BSpisa%26aufirst%3DF.%26aulast%3DFeo%26aufirst%3DA.%26aulast%3DMossetti%26aufirst%3DR.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DAn%2520efficient%2520synthesis%2520of%2520symmetric%2520and%2520unsymmetric%2520bis-%2528%25CE%25B2-aminoamides%2529%2520via%2520Ugi%2520multicomponent%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D6044%26epage%3D6047%26doi%3D10.1021%2Fol302935y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Giustiniano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tron, G. C.</span></span> <span> </span><span class="NLM_article-title">An efficient synthesis of 1-arylindazole-3-carboxamides using nitrile imines, isocyanides and 2-hydroxymethylbenzoic acid, followed by a chemoselective BuchwaldâHartwig intramolecular cyclization</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">34913</span>â <span class="NLM_lpage">34920</span>, <span class="refDoi">Â DOI: 10.1039/C6RA01442A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1039%2FC6RA01442A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1OqtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=34913-34920&author=M.+Giustinianoauthor=V.+Mercalliauthor=E.+Novellinoauthor=G.+C.+Tron&title=An+efficient+synthesis+of+1-arylindazole-3-carboxamides+using+nitrile+imines%2C+isocyanides+and+2-hydroxymethylbenzoic+acid%2C+followed+by+a+chemoselective+Buchwald%E2%80%93Hartwig+intramolecular+cyclization&doi=10.1039%2FC6RA01442A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient synthesis of 1-arylindazole-3-carboxamides using nitrile imines, isocyanides and 2-hydroxymethylbenzoic acid, followed by a chemoselective Buchwald-Hartwig intramolecular cyclization</span></div><div class="casAuthors">Giustiniano, M.; Mercalli, V.; Novellino, E.; Tron, G. C.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">34913-34920</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A convergent and efficient two-step synthesis of pharmaceutically relevant 1-arylindazole-3-carboxamides was reported.  These mols. were obtained in good to excellent yields (up to 98%) starting from a strategic reaction between isocyanides, 2-iodo-N-arylbenzohydrazonoyl chlorides and 2-hydroxymethylbenzoic acid followed by a chemoselective Buchwald-Hartwig intramol. cyclization.  This novel strategy provided an addnl. indazole synthesis to those already reported in literature both in the type of substrate as well as the substitution pattern obtainable in the products.  Furthermore benzylisocyanide was herein reported for the first time as a convertible isocyanide providing an expeditious access to N-arylindazole-3-carbonitriles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Bx0aJX-gfrVg90H21EOLACvtfcHk0ljE5DORFI3zjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1OqtLY%253D&md5=8b80974cabe0a9620ac39a6c0a056a20</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1039%2FC6RA01442A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA01442A%26sid%3Dliteratum%253Aachs%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DMercalli%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DTron%26aufirst%3DG.%2BC.%26atitle%3DAn%2520efficient%2520synthesis%2520of%25201-arylindazole-3-carboxamides%2520using%2520nitrile%2520imines%252C%2520isocyanides%2520and%25202-hydroxymethylbenzoic%2520acid%252C%2520followed%2520by%2520a%2520chemoselective%2520Buchwald%25E2%2580%2593Hartwig%2520intramolecular%2520cyclization%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D34913%26epage%3D34920%26doi%3D10.1039%2FC6RA01442A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couvreur, P.</span></span> <span> </span><span class="NLM_article-title">Squalenoylation: a novel technology for anticancer and antibiotic drugs with enhanced activity</span>. In  <i>Nanosciences and Nanotechnology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourtioz, J. M.</span>, <span class="NLM_string-name">Lahmani, M.</span>, <span class="NLM_string-name">Dupas-Haeberlin, C.</span>, <span class="NLM_string-name">Hesto, P.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">253</span>â <span class="NLM_lpage">272</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=253-272&author=P.+Couvreurauthor=J.+M.+Lourtioz&author=M.+Lahmani&author=C.+Dupas-Haeberlin&author=P.+Hesto&title=Nanosciences+and+Nanotechnology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCouvreur%26aufirst%3DP.%26atitle%3DSqualenoylation%253A%2520a%2520novel%2520technology%2520for%2520anticancer%2520and%2520antibiotic%2520drugs%2520with%2520enhanced%2520activity%26btitle%3DNanosciences%2520and%2520Nanotechnology%26aulast%3DLourtioz%26aufirst%3DJ.%2BM.%26pub%3DSpringer%26date%3D2015%26spage%3D253%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">The evaluation of the metabolic pathway was focused on hydrolytic behavior, as glucuronide or sulfate conjugates were not detected when the compounds were incubated in the presence of microsomal or cytosol liver fractions, confirming their resistance toward phase II metabolic enzymes (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadgrove, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jay, M.</span></span> <span> </span><span class="NLM_article-title">Biotransformation capacity of carboxylesterase in skin and keratinocytes for the penta-ethyl ester prodrug of DTPA</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1313</span>â <span class="NLM_lpage">1318</span>, <span class="refDoi">Â DOI: 10.1124/dmd.116.069377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fdmd.116.069377" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=1313-1318&author=J.+Fuauthor=M.+Sadgroveauthor=L.+Marsonauthor=M.+Jay&title=Biotransformation+capacity+of+carboxylesterase+in+skin+and+keratinocytes+for+the+penta-ethyl+ester+prodrug+of+DTPA&doi=10.1124%2Fdmd.116.069377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.069377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.069377%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DSadgrove%26aufirst%3DM.%26aulast%3DMarson%26aufirst%3DL.%26aulast%3DJay%26aufirst%3DM.%26atitle%3DBiotransformation%2520capacity%2520of%2520carboxylesterase%2520in%2520skin%2520and%2520keratinocytes%2520for%2520the%2520penta-ethyl%2520ester%2520prodrug%2520of%2520DTPA%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D1313%26epage%3D1318%26doi%3D10.1124%2Fdmd.116.069377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, C. K.</span></span> <span> </span><span class="NLM_article-title">Biotransformation of drugs in human skin</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">253</span>, <span class="refDoi">Â DOI: 10.1124/dmd.108.024794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fdmd.108.024794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=19005027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=247-253&author=C.+K.+Svensson&title=Biotransformation+of+drugs+in+human+skin&doi=10.1124%2Fdmd.108.024794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of drugs in human skin</span></div><div class="casAuthors">Svensson, Craig K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Although it is the largest organ of the human body, skin is often not considered in discussions of drug metab.  However, there is growing evidence that most common drug-metabolizing enzymes are expressed in the skin.  Evidence for expression of cytochromes P 450, flavin monooxygenases, glutathione-S-transferases, N-acetyltransferases, and sulfotransferases in human skin and skin cells are presented.  Addnl. discussion is focused on the evidence of actual metab. of drugs.  Finally, the potential clin. implications of metab. within the skin are discussed briefly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GNsGESefO7Vg90H21EOLACvtfcHk0ljE5DORFI3zjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D&md5=c7bb178e9cfcd22a11dee43b9c396ff8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024794%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DC.%2BK.%26atitle%3DBiotransformation%2520of%2520drugs%2520in%2520human%2520skin%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D247%26epage%3D253%26doi%3D10.1124%2Fdmd.108.024794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J- -H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Stereoselective characteristics and mechanisms of epidermal carboxylesterase metabolism observed in HaCaT keratinocytes</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">532</span>â <span class="NLM_lpage">536</span>, <span class="refDoi">Â DOI: 10.1248/bpb.30.532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1248%2Fbpb.30.532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=17329851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVSntb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=532-536&author=Q.-G.+Zhuauthor=J-+-H.+Huauthor=J.-Y.+Liuauthor=S.-W.+Luauthor=Y.-X.+Liuauthor=J.+Wang&title=Stereoselective+characteristics+and+mechanisms+of+epidermal+carboxylesterase+metabolism+observed+in+HaCaT+keratinocytes&doi=10.1248%2Fbpb.30.532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective characteristics and mechanisms of epidermal carboxylesterase metabolism observed in HaCaT keratinocytes</span></div><div class="casAuthors">Zhu, Quan-Gang; Hu, Jin-Hong; Liu, Ji-Yong; Lu, Song-Wei; Liu, Yan-Xia; Wang, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">532-536</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">There is increasing evidence that epidermal carboxylesterase may be involved in the stereoselective hydrolysis of prodrugs in percutaneous absorption.  The present study was designed to evaluate the stereoselective characteristics and mechanisms of ketoprofen Et ester hydrolysis by epidermal carboxylesterase expressed in HaCaT keratinocytes.  Ketoprofen Et ester was mainly hydrolyzed to R-ketoprofen by carboxylesterase of human HaCaT keratinocytes.  Human carboxylesterase-1 (hCE-1) and human carboxylesterase-2 (hCE-2) were intensively detected in L02 hepatocytes, hCE-2 was also intensively detected in HaCaT keratinocytes, but hCE-1 was not detected in HaCaT keratinocytes.  HCE-2 is thus an abundant carboxylesterase in HaCaT keratinocytes which may be responsible for stereoselective hydrolysis of ketoprofen Et ester.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOWzy6SiCLm7Vg90H21EOLACvtfcHk0ljE5DORFI3zjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVSntb8%253D&md5=6f27c6606a23f6a8f2d498eb81577c30</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.532%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DQ.-G.%26aulast%3DHu%26aufirst%3DJ-%2B-H.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DLu%26aufirst%3DS.-W.%26aulast%3DLiu%26aufirst%3DY.-X.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DStereoselective%2520characteristics%2520and%2520mechanisms%2520of%2520epidermal%2520carboxylesterase%2520metabolism%2520observed%2520in%2520HaCaT%2520keratinocytes%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D532%26epage%3D536%26doi%3D10.1248%2Fbpb.30.532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Eijl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶tz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R. J.</span></span> <span> </span><span class="NLM_article-title">Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e41721</span>, <span class="refDoi">Â DOI: 10.1371/journal.pone.0041721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1371%2Fjournal.pone.0041721" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e41721&author=S.+Van+Eijlauthor=Z.+Zhuauthor=J.+Cupittauthor=M.+Gierulaauthor=C.+G%C3%B6tzauthor=E.+Fritscheauthor=R.+J.+Edwards&title=Elucidation+of+xenobiotic+metabolism+pathways+in+human+skin+and+human+skin+models+by+proteomic+profiling&doi=10.1371%2Fjournal.pone.0041721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0041721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0041721%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BEijl%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCupitt%26aufirst%3DJ.%26aulast%3DGierula%26aufirst%3DM.%26aulast%3DG%25C3%25B6tz%26aufirst%3DC.%26aulast%3DFritsche%26aufirst%3DE.%26aulast%3DEdwards%26aufirst%3DR.%2BJ.%26atitle%3DElucidation%2520of%2520xenobiotic%2520metabolism%2520pathways%2520in%2520human%2520skin%2520and%2520human%2520skin%2520models%2520by%2520proteomic%2520profiling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De41721%26doi%3D10.1371%2Fjournal.pone.0041721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span> <span> </span><span class="NLM_article-title">Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">412</span>â <span class="NLM_lpage">431</span>, <span class="refDoi">Â DOI: 10.3390/molecules13020412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.3390%2Fmolecules13020412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=18305428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=412-431&author=M.+Hosokawa&title=Structure+and+catalytic+properties+of+carboxylesterase+isozymes+involved+in+metabolic+activation+of+prodrugs&doi=10.3390%2Fmolecules13020412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs</span></div><div class="casAuthors">Hosokawa, Masakiyo</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">412-431</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Mammalian carboxylesterases (CESs) comprise a multigene family whose gene products play important roles in biotransformation of ester- or amide-type prodrugs.  They are members of an Î±,Î²-hydrolase-fold family and are found in various mammals.  It has been suggested that CESs can be classified into 5 major groups denominated CES1-CES5, according to the homol. of the amino acid sequence, and the majority of CESs that have been identified belong to the CES1 or CES2 family.  The substrate specificities of CES1 and CES2 are significantly different.  The CES1 isoenzyme mainly hydrolyzes a substrate with a small alc. group and large acyl group, but its wide active site pocket sometimes allows it to act on structurally distinct compds. of either a large or small alc. moiety.  In contrast, the CES2 isoenzyme recognizes a substrate with a large alc. group and small acyl group, and its substrate specificity may be restricted by the capability of acyl-enzyme conjugate formation due to the presence of conformational interference in the active pocket.  Since pharmacokinetic and pharmacol. data for prodrugs obtained from preclin. expts. using various animals are generally used as refs. for human studies, it is important to clarify the biochem. properties of CES isoenzymes.  Further experimentation for an understanding of detailed substrate specificity of prodrugs for CES isoenzymes and its hydrolyzates will help researchers to design the ideal prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouTX8xLu6R1rVg90H21EOLACvtfcHk0lgh9L1VZw4yIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D&md5=2737ed528ff2b616b7d256ad01b5c1d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13020412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13020412%26sid%3Dliteratum%253Aachs%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DStructure%2520and%2520catalytic%2520properties%2520of%2520carboxylesterase%2520isozymes%2520involved%2520in%2520metabolic%2520activation%2520of%2520prodrugs%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D412%26epage%3D431%26doi%3D10.3390%2Fmolecules13020412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">The hydrolytic chemical stability of <b>17</b> and <b>36</b> was checked by storing aliquots of solid compounds at different temperature and humidity conditions (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf" class="ext-link">Supporting Information</a>). The two esters did not suffer from degradation due to prolonged temperature and humidity exposure (40 Â°C for 2 months, 60 Â°C for 15 days, and 80% relative humidity). Only compound <b>36</b> underwent a mild hydrolysis after storage in methanolâwater 95:5 solution for 15 days (85% residual substrate after exposure). Overall, the results suggested a good stability of the ester function.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonic-Kocijan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhac, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span> <span> </span><span class="NLM_article-title">TRPV1 channel-mediated bilateral allodynia induced by unilateral masseter muscle inflammation in rats</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">9</span>â <span class="NLM_lpage">68</span>, <span class="refDoi">Â DOI: 10.1186/1744-8069-9-68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1186%2F1744-8069-9-68" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=9-68&author=S.+Simonic-Kocijanauthor=X.+Zhaoauthor=W.+Liuauthor=Y.+Wuauthor=I.+Uhacauthor=K.+Wang&title=TRPV1+channel-mediated+bilateral+allodynia+induced+by+unilateral+masseter+muscle+inflammation+in+rats&doi=10.1186%2F1744-8069-9-68"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-9-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-9-68%26sid%3Dliteratum%253Aachs%26aulast%3DSimonic-Kocijan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DUhac%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DTRPV1%2520channel-mediated%2520bilateral%2520allodynia%2520induced%2520by%2520unilateral%2520masseter%2520muscle%2520inflammation%2520in%2520rats%26jtitle%3DMol.%2520Pain%26date%3D2013%26volume%3D30%26spage%3D9%26epage%3D68%26doi%3D10.1186%2F1744-8069-9-68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoon, M. A.</span></span> <span> </span><span class="NLM_article-title">Why we scratch an itch: the molecules, cells and circuits of itch</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">175</span>â <span class="NLM_lpage">182</span>, <span class="refDoi">Â DOI: 10.1038/nn.3619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1038%2Fnn.3619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=24473265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=175-182&author=D.+M.+Bautistaauthor=S.+R.+Wilsonauthor=M.+A.+Hoon&title=Why+we+scratch+an+itch%3A+the+molecules%2C+cells+and+circuits+of+itch&doi=10.1038%2Fnn.3619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Why we scratch an itch: the molecules, cells and circuits of itch</span></div><div class="casAuthors">Bautista, Diana M.; Wilson, Sarah R.; Hoon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Itch is described as an irritating sensation that triggers a desire to scratch.  However, this definition hardly seems fitting for the millions of people who suffer from intractable itch.  Indeed, the Buddhist philosopher Nagarjuna more aptly stated, "There is pleasure when an itch is scratched.  But to be without an itch is more pleasurable still." Chronic itch is widespread and very difficult to treat.  In this review we focus on the mols., cells and circuits in the peripheral and central nervous systems that drive acute and chronic itch transmission.  Understanding the itch circuitry is crit. to developing new therapies for this intractable disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocL800rrv887Vg90H21EOLACvtfcHk0lgh9L1VZw4yIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsrc%253D&md5=62d6635c23d76fe004f600a40987adb9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnn.3619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3619%26sid%3Dliteratum%253Aachs%26aulast%3DBautista%26aufirst%3DD.%2BM.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DHoon%26aufirst%3DM.%2BA.%26atitle%3DWhy%2520we%2520scratch%2520an%2520itch%253A%2520the%2520molecules%252C%2520cells%2520and%2520circuits%2520of%2520itch%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D175%26epage%3D182%26doi%3D10.1038%2Fnn.3619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, G. I.</span>; <span class="NLM_string-name">Genazzani, A. A.</span>; <span class="NLM_string-name">Pirali, T.</span>; <span class="NLM_string-name">Fernandez-Carvajal, A.</span>; <span class="NLM_string-name">Ferrer-Montiel, A. V.</span></span> TRPV1Modulator Compounds. <span class="NLM_patent">EP17382266.9</span>, May 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Devesa%2C+G.+I.%3B+Genazzani%2C+A.+A.%3B+Pirali%2C+T.%3B+Fernandez-Carvajal%2C+A.%3B+Ferrer-Montiel%2C+A.+V.+TRPV1Modulator+Compounds.+EP17382266.9%2C+May+11%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDevesa%26aufirst%3DG.%2BI.%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koganti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bley, K.</span></span> <span> </span><span class="NLM_article-title">In vitro hepatic and skin metabolism of capsaicin</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">670</span>â <span class="NLM_lpage">675</span>, <span class="refDoi">Â DOI: 10.1124/dmd.107.019240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1124%2Fdmd.107.019240" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=670-675&author=S.+Chandaauthor=M.+Bashirauthor=S.+Babbarauthor=A.+Kogantiauthor=K.+Bley&title=In+vitro+hepatic+and+skin+metabolism+of+capsaicin&doi=10.1124%2Fdmd.107.019240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.019240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.019240%26sid%3Dliteratum%253Aachs%26aulast%3DChanda%26aufirst%3DS.%26aulast%3DBashir%26aufirst%3DM.%26aulast%3DBabbar%26aufirst%3DS.%26aulast%3DKoganti%26aufirst%3DA.%26aulast%3DBley%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520hepatic%2520and%2520skin%2520metabolism%2520of%2520capsaicin%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D670%26epage%3D675%26doi%3D10.1124%2Fdmd.107.019240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of analogues of BCTC incorporating a pyrrolidinyl linker and biological evaluation as Transient Receptor Potential Vanilloid 1 antagonists</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">306</span>â <span class="NLM_lpage">311</span>, <span class="refDoi">Â DOI: 10.1111/cbdd.12661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1111%2Fcbdd.12661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=26360809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7vO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2016&pages=306-311&author=L.+Yanauthor=J.+Wangauthor=M.+Panauthor=Q.+Qiuauthor=W.+Huangauthor=H.+Qian&title=Synthesis+of+analogues+of+BCTC+incorporating+a+pyrrolidinyl+linker+and+biological+evaluation+as+Transient+Receptor+Potential+Vanilloid+1+antagonists&doi=10.1111%2Fcbdd.12661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists</span></div><div class="casAuthors">Yan, Lin; Wang, Jingjie; Pan, Miaobo; Qiu, Qianqian; Huang, Wenlong; Qian, Hai</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">306-311</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A series of novel pyrrolidinyl linker TRPV1 antagonists were prepd. in an effort to lower the hyperthermic side-effects of first-generation antagonist BCTC.  These compds. were studied for antagonism of hTRPV1 activation by capsaicin and acid in vitro.  Preliminary results suggested the four compds. had favorable TRPV1 antagonism activity.  In further studies in vivo, (S)-1-(4-(3-chloropyridin-2-yl)piperazine-1-carbonyl)-N-(4-(tert-butyl)phenyl)pyrrolidine-2-carboxamide comparable to BCTC, showed potent analgesic activity in capsaicin-induced and heat-induced pain models.  In addn., (S)-1-(4-(3-chloropyridin-2-yl)piperazine-1-carbonyl)-N-(4-(tert-butyl)phenyl)pyrrolidine-2-carboxamide indicated a reduced risk of body temp. elevation.  All of these demonstrated that (S)-1-(4-(3-chloropyridin-2-yl)piperazine-1-carbonyl)-N-(4-(tert-butyl)phenyl)pyrrolidine-2-carboxamide can be considered as a safe candidate for the further development of analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryAO-LFq0pRbVg90H21EOLACvtfcHk0ljfxhq1r2T3-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slu7vO&md5=52a09fb21dc6d0e4e4ffacfde606b04f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12661%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520analogues%2520of%2520BCTC%2520incorporating%2520a%2520pyrrolidinyl%2520linker%2520and%2520biological%2520evaluation%2520as%2520Transient%2520Receptor%2520Potential%2520Vanilloid%25201%2520antagonists%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2016%26volume%3D87%26spage%3D306%26epage%3D311%26doi%3D10.1111%2Fcbdd.12661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="note"><p class="first last">The synthesis of <b>36</b> is made of five synthetic steps, with an overall yield of 45%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ceruti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balliano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerst, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuber, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">208</span>, <span class="refDoi">Â DOI: 10.1016/0223-5234(87)90050-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1016%2F0223-5234%2887%2990050-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1987&pages=199-208&author=M.+Cerutiauthor=G.+Ballianoauthor=F.+Violaauthor=L.+Cattelauthor=N.+Gerstauthor=F.+Schuber&title=Synthesis+and+biological+activity+of+azasqualenes%2C+bis-azasqualenes+and+derivatives&doi=10.1016%2F0223-5234%2887%2990050-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2F0223-5234%2887%2990050-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0223-5234%252887%252990050-X%26sid%3Dliteratum%253Aachs%26aulast%3DCeruti%26aufirst%3DM.%26aulast%3DBalliano%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DF.%26aulast%3DCattel%26aufirst%3DL.%26aulast%3DGerst%26aufirst%3DN.%26aulast%3DSchuber%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520azasqualenes%252C%2520bis-azasqualenes%2520and%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1987%26volume%3D22%26spage%3D199%26epage%3D208%26doi%3D10.1016%2F0223-5234%2887%2990050-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceruti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fresta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolino, D.</span></span> <span> </span><span class="NLM_article-title">Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2535</span>â <span class="NLM_lpage">2546</span>, <span class="refDoi">Â DOI: 10.2147/IJN.S28114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.2147%2FIJN.S28114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=22679366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVyrtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2535-2546&author=D.+Coscoauthor=F.+Roccoauthor=M.+Cerutiauthor=M.+Vonoauthor=M.+Frestaauthor=D.+Paolino&title=Self-assembled+squalenoyl-cytarabine+nanostructures+as+a+potent+nanomedicine+for+treatment+of+leukemic+diseases&doi=10.2147%2FIJN.S28114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases</span></div><div class="casAuthors">Cosco, Donato; Rocco, Flavio; Ceruti, Maurizio; Vono, Margherita; Fresta, Massimo; Paolino, Donatella</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2535-2546</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: In this investigation, the antileukemic activity of a new nanomedicine based on the conjugation of 1,1',2-tris-nor-squalenic acid with cytarabine (Ara-C) was evaluated.  Methods: Squalenoyl-Ara-C conjugate (Sq-Ara-C) self-assembled nanosystems were obtained by the nanopptn. method and characterized in vitro and in vivo.  Results: This new nanomedicine, which had a mean diam. of approx. 150 nm, improved the in vitro antitumoral activity of Ara-C in different cancer cell lines (L1210, K562 and MCF-7).  Sq-Ara-C nanomedicine allowed redn. of the IC50 value with respect to the free drug and was also active against drug-resistant leukemic cells (L1210R).  A noticeable increase in the survival rate of mice with aggressive metastatic L1210R leukemia was obsd. after treatment with Sq-Ara-C (50 mg/kg) as compared with the free active compd. (100 mg/kg).  Finally, evaluation of the biodistribution and pharmacokinetic profiles of the drug demonstrated that these nanoaggregates preferentially localized to the liver and spleen and protected the drug from physiol. metab.  Conclusion: Squalenoylation of cytarabine offers several pharmacol. benefits both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpID6Zw1uy097Vg90H21EOLACvtfcHk0ljfxhq1r2T3-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVyrtbg%253D&md5=f6ce7980cd80d24423774dad04d9f089</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.2147%2FIJN.S28114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S28114%26sid%3Dliteratum%253Aachs%26aulast%3DCosco%26aufirst%3DD.%26aulast%3DRocco%26aufirst%3DF.%26aulast%3DCeruti%26aufirst%3DM.%26aulast%3DVono%26aufirst%3DM.%26aulast%3DFresta%26aufirst%3DM.%26aulast%3DPaolino%26aufirst%3DD.%26atitle%3DSelf-assembled%2520squalenoyl-cytarabine%2520nanostructures%2520as%2520a%2520potent%2520nanomedicine%2520for%2520treatment%2520of%2520leukemic%2520diseases%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D2535%26epage%3D2546%26doi%3D10.2147%2FIJN.S28114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, E.</span>; <span class="NLM_string-name">Mclellan, A.</span>; <span class="NLM_string-name">Reed, M. A.</span>; <span class="NLM_string-name">Sun, S.</span>; <span class="NLM_string-name">Weaver, D.</span></span> <span> </span><span class="NLM_article-title">Terpenoid Analogues and Uses Thereof for Treating Neurological Conditions</span>. U.S. Patent <span class="NLM_patent">WO 2012034232A1</span>, March 22, 2012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lu%2C+E.%3B+Mclellan%2C+A.%3B+Reed%2C+M.+A.%3B+Sun%2C+S.%3B+Weaver%2C+D.+Terpenoid+Analogues+and+Uses+Thereof+for+Treating+Neurological+Conditions.+U.S.+Patent+WO+2012034232A1%2C+March+22%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DE.%26atitle%3DTerpenoid%2520Analogues%2520and%2520Uses%2520Thereof%2520for%2520Treating%2520Neurological%2520Conditions" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lilja, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laulund, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsby, A.</span></span> <span> </span><span class="NLM_article-title">Insulin and insulin-like growth factor type-I up-regulate the vanilloid receptor-1 (TRPV1) in stably TRPV1-expressing SH-SY5Y neuroblastoma cells</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1413</span>â <span class="NLM_lpage">1419</span>, <span class="refDoi">Â DOI: 10.1002/jnr.21255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1002%2Fjnr.21255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=17385724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVWltbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=1413-1419&author=J.+Liljaauthor=F.+Laulundauthor=A.+Forsby&title=Insulin+and+insulin-like+growth+factor+type-I+up-regulate+the+vanilloid+receptor-1+%28TRPV1%29+in+stably+TRPV1-expressing+SH-SY5Y+neuroblastoma+cells&doi=10.1002%2Fjnr.21255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin and insulin-like growth factor type-I Up-regulate the vanilloid receptor-1 (TRPV1) in stably TRPV1-expressing SH-SY5Y neuroblastoma cells</span></div><div class="casAuthors">Lilja, Johanna; Laulund, Frida; Forsby, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1413-1419</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The capsaicin receptor, transient receptor potential, vanilloid type 1 (TRPV1), is a Ca2+-permeable ion channel activated by noxious stimuli eliciting pain.  Several reports have shown modulation of TRPV1 activity and expression by neuronal growth factors.  Here, we study the long-term effects on TRPV1 expression mediated by insulin-like growth factor type-I (IGF-I) and insulin in a stably TRPV1-expressing SH-SY5Y neuroblastoma cell line.  We show that, after 72 h of 10 nM IGF-I or insulin exposure, the TRPV1 protein level was up-regulated 2.5-and 2-fold, resp.  By blocking phosphatidylinositol-3-kinase [PI(3)K] or mitogen-activated protein kinase (MAPK) signaling, we concluded that the increase in total TRPV1 protein content induced by IGF-I was controlled by PI(3)K signaling, whereas insulin seemed to regulate TRPV1 protein expression via both PI(3)K and MAPK pathways.  Inhibiting protein kinase C (PKC) blocked the effects of both IGF-I and insulin.  Furthermore, the concns. causing a 50% Ca2+ increase (EC50) after insulin and IGF-I treatments were significantly lowered compared with untreated cells.  We conclude that IGF-I and insulin enhance TRPV1 protein expression and activity, and impaired pain sensation might result from distorted TRPV1 regulation in the peripheral nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAUho0Yqj3UbVg90H21EOLACvtfcHk0lj6O0d59Qnesg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVWltbg%253D&md5=b7f8eb003102d97cf13ea7e5b9d1bae4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21255%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DJ.%26aulast%3DLaulund%26aufirst%3DF.%26aulast%3DForsby%26aufirst%3DA.%26atitle%3DInsulin%2520and%2520insulin-like%2520growth%2520factor%2520type-I%2520up-regulate%2520the%2520vanilloid%2520receptor-1%2520%2528TRPV1%2529%2520in%2520stably%2520TRPV1-expressing%2520SH-SY5Y%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2007%26volume%3D85%26spage%3D1413%26epage%3D1419%26doi%3D10.1002%2Fjnr.21255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devesa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FerrÃ¡ndiz-Huertas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathivanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LujÃ¡n, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span> <span> </span><span class="NLM_article-title">Î±CGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">18345</span>â <span class="NLM_lpage">18350</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1420252111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;key=10.1073%2Fpnas.1420252111" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=18345-18350&author=I.+Devesaauthor=C.+Ferr%C3%A1ndiz-Huertasauthor=S.+Mathivananauthor=C.+Wolfauthor=R.+Luj%C3%A1nauthor=J.+P.+Changeuxauthor=A.+Ferrer-Montiel&title=%CE%B1CGRP+is+essential+for+algesic+exocytotic+mobilization+of+TRPV1+channels+in+peptidergic+nociceptors&doi=10.1073%2Fpnas.1420252111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420252111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420252111%26sid%3Dliteratum%253Aachs%26aulast%3DDevesa%26aufirst%3DI.%26aulast%3DFerr%25C3%25A1ndiz-Huertas%26aufirst%3DC.%26aulast%3DMathivanan%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DC.%26aulast%3DLuj%25C3%25A1n%26aufirst%3DR.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26atitle%3D%25CE%25B1CGRP%2520is%2520essential%2520for%2520algesic%2520exocytotic%2520mobilization%2520of%2520TRPV1%2520channels%2520in%2520peptidergic%2520nociceptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D18345%26epage%3D18350%26doi%3D10.1073%2Fpnas.1420252111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i100"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00109">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04711"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00109">10.1021/acs.jmedchem.8b00109</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_001.csv">CSV</a>)</p></li><li><p class="inline">Concentrationâresponse curves for selected agonists and antagonists in SH-SY5Y cells; metabolic stability in HaCaT homogenate, human plasma, liver S9, recombinant carboxylesterases (hCE1, hCE2), keratinocytes and fibroblasts homogenate; chemical stability study of compounds <b>17</b> and <b>36</b>; NMR spectra of compounds <b>17</b> and <b>36</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_001.csv">jm8b00109_si_001.csv (3.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00109/suppl_file/jm8b00109_si_002.pdf">jm8b00109_si_002.pdf (2.03 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00109&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-10%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00109%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00109" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b6c7eb892248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
